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ABSTRACT 
Duchenne muscular dystrophy is a X-linked muscle disease, which leads to 
alterations in membrane phospholipid fatty acid (FA) composition and skeletal muscle 
damage. Increased membrane saturated FA in muscular dystrophy may suggest its 
association with increased susceptibility (as being the cause or consequence) to muscle 
damage. It was hypothesised that increased saturation is positively correlated to increased 
muscle damage. Correlations were hypothesized to be greater in extensor digitorum 
longus (EDL) at 20 weeks compared to soleus (SOL) at 10 weeks in dystrophin deficient 
(mdx) mice.  Increased saturation was correlated to damage in EDL at both 10 and 20 
weeks, with stronger correlations at 10 weeks. The results suggest that membrane PL FA 
composition may be associated with damage through two possible means. Increased 
saturation may be a cause or consequence of membrane damage. Association of 
membrane composition with eccentric induced damage has underscored the importance 
of saturated PL FA compositions in damage to dystrophic myofibres. 
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CHAPTER 1: INTRODUCTION 
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Biological membranes 
Biological membranes are barriers surrounding the cell that define the boundary 
between the intracellular and extracellular environment.  Moreover, biological 
membranes are semi-permeable, allowing movement of macromolecules essential in cell 
metabolism, differentiation and regulation (Keren, 2011).  Furthermore, ion channels in 
membranes facilitate the production of excitation contraction coupling (ECC) by 
conducting action potentials along the membrane.  As a result, considering the central 
roles of biological membranes in cell signalling, regulation, and metabolism, 
understanding its constituents (lipids, carbohydrates and proteins) is of significant 
importance. 
Biological membranes are composed of different compounds, which vary among 
cells according to their function.  Biological membranes are assembled in a bilayer which 
is comprised mainly of lipids, in addition to proteins and carbohydrates (Alberts, et al., 
2002).  Proteins in biological membranes are located peripheral to the membrane or 
integral by spanning across the membrane. Carbohydrates are associated with lipids and 
proteins, forming glycolipids and glycoproteins, respectively (Voet & Voet, 2004). 
 
Membrane composition 
Membrane lipids 
There are three major types of lipids found in cell membranes; phospholipids, 
glycolipids, and cholesterol. These main classes of membrane lipids are amphipathic and 
the orientation of their hydrophobic and hydrophilic regions directs their location within 
the membrane bilayer (Alberts et al., 2002). Within these three classes of membrane 
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lipids, vast diversity in phospholipids is due to various combinations of head groups 
and/or fatty acyl tails. 
 
Phospholipids 
Phospholipids make up 80-85% of biological membrane structure (Dufourc et al., 
1992).  The main structure of a phospholipid contains either a glycerol (1, 2- diacyl- sn- 
glycerol) or sphingosine (N-acyl-sphingosine) backbone to which 2-4 fatty acyl chains 
(hydrophobic) and a phosphate head group are attached, thus forming 
glycerophospholipids or sphingophospholipids, respectively (Cooper, 1977; 
Dannenberger et al., 2007). The head group varies between phospholipids, resulting in 
different phospholipid species. Head groups that contain choline, serine, ethanolamine or 
inositol result in phosphotidylcholine (PC), phosphatidylserine (PS), 
phosphatidylethanolamine (PE), and phosphatidylinositol (PI), respectively.  Cardiolipin 
(CL) is known to be a double glycerophospholipid and consists of two 
phosphatidylglycerols connected with a glycerol backbone, forming a dimeric structure 
with four fatty acyl chains (Ritov et al., 2006).  Sphingomyelin (SM) is a 
sphingophospholipid having a unique structure with a sphingosine backbone, choline 
head group, and 2 fatty acyl chains. One of the SM FA tails is ceramide, which is 
comprised of an amide group and fatty acyl chain attached to a sphingosine molecule 
(Brown, 1998). Two forms of SM have been identified in cell membranes; sphingosile-1 
phosphorylcholine and sphingosile-1 phosphorylethanolamine (Ramstedt et al., 2002). 
Altogether, these phospholipids are present in differing biological cell membranes and in 
differing amounts (Table 1.1). 
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Glycolipids 
The glycolipids constitute 5% of lipids in biological membrane, exclusively 
located on the outer surface of membrane (Voet, 2004).  Glycolipids have a carbohydrate 
head group instead of phosphate as seen in phospholipids (Yamomoto et al., 1998).  
However, similar to phospholipids, the backbone structure could be glycerol or 
sphingosine, creating glyceroglycolipids and sphingoglycolipids, respectively. 
 
Cholesterol 
Cholesterol is a lipid molecule with a unique four linked hydrocarbon ring 
structure, hydrocarbon side chains and a hydroxyl group (Bell et al., 1976).  Cholesterol 
is also amphipathic where its hydroxyl group aligns with the phosphate head of 
phospholipids and its hydrophobic steroid rings stays adjacent to the fatty acyl tail.  
Cholesterol preferentially interacts with SM compare to other phospholipids due to 
interactive forces between its rigid ring structure and saturated fatty acids of SM (Yeagle, 
1990; Ramstedt & Slotte, 2002). Moreover, cholesterol is more abundant in micro-
domains, named lipid rafts, enriched with SM (Ramstedt & Slotte, 2002). 
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Table 1.1. Characteristics of the main lipids found in biological membranes. 
Lipid Composition Charge 
Primary fatty 
acids 
Location 
PC 30-35%
2
 Neutral
1
 
↑ 16:0, 18:2n6 
and ↓ 22:6n32 
Outer 
monolayer 
(66%)
3
 
PE 15-25%
4,5
 Neutral
4,5
 
↑18:03, 
20:4n6
3
, and 
18:2n6
6
 
Inner 
monolayer 
(~20%)
3,6
 
SM 2-15%
8,9
 Neutral 
8
 
↑ 16:0 and 
18:0, ↓ UFA, 
24:1 and 22:0
1,8
 
Outer 
monolayer
8,9
 
PI 10-15%
1
 Acidic
1
 
18:0 in sn-1, 
20:4 in sn-2
1
 
Inner 
monolayer 
PS 2-10% Acidic
1
 ↑22:6n3 
Inner 
monolayer 
CL 2-5%
9
 Acidic 
18:2n6
6, ↑ 
levels (80%) of 
unsaturation
7
 
Matrix facing 
leaflet of   
mitochondria
6
 
Cholesterol 10% Neutral  
Inner and 
outer 
monolayer 
Glycolipids 2-5% Neutral  
Outer 
monolayer 
 
Original data obtained from: 
1
(Voet, 2004), 
2
(Mitchell, et al., 2007), 
3
 (Clore, et al., 
1998), 
4
 (Bell GH, 1976), 
5 
(Bleijerveld, et al., 2007), 
6
 (Ritov, et al., 2006), 
7
 
(Tsalouhidou, et al., 2006),
8
 (Ramstedt & Slotte, 2002), 
9 
(Tsalouhidou, et al., 2006). PL, 
phospholipids; SM, sphingomyelin; PC, phosphatidylcholine; PS, phosphatidylserine; PI, 
phosphatidylinositol; PE, phosphatidylethanolamine; sn stereospecific numbering; UFA, 
unsaturated fatty acid. 
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Fatty acids 
Fatty acids are long chain carboxylic acids (mostly 14-20 carbons), containing a 
long alkyl chain with a carboxyl group at one end.  Normally FAs have an even number 
of carbon atoms and can be saturated (SFA), with no double bonds, or unsaturated, with 
one or more double bonds.  Unsaturated fatty acids are classified as monounsaturated 
fatty acids (MUFA, one double bond) and polyunsaturated fatty acids (PUFA, more than 
one double bond) (Hamilton, 2003).  PUFAs are further subclassified as n3 or n6, where 
the position of first double bond occurs on the 3
rd
 or 6
th
 carbon relative to the methyl end, 
respectively (Lauritzen et al., 2001). Additional classification of FAs is according to their 
configuration.   Fatty acids with double bonds have two types of configuration, known as 
cis and trans.  The cis configuration has the hydrogen atoms on the same side as     
 a   n- a   n d        nd  a   n  a 30    n   n       a n  Whitney et al., 1998) while 
the trans configuration has the hydrogen on opposite sides (Figure 1.1). Spatial 
configuration of FAs is important since it dictates how close FAs can associate with their 
adjacent FAs. 
The nomenclature of fatty acids is according to their carbon length, number of 
double bonds and the location of the first double bond. For example, 18:2n6 refers to an 
18 carbon long fatty acid with two double bonds with the first double bond at the 6
th
 
carbon from the methyl end. Both 18:2n6 and 18:3n3 PUFA are regarded as essential 
fatty acids due to the inability of mammals to introduce double bonds beyond carbon 9 
and 10 from the methyl end (Berg, 2002; Gurr, 2002; Pelley, 2011) therefore, they must 
obtain these fatty acids from their diet (Connor, 2000). 
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Figure 1.1 .View of cis and trans configurations of fatty acids. 
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Membrane proteins 
Membrane proteins carry out dynamic processes associated with the cell. These 
processes include enzyme activity, transportation across the membrane, cellular 
attachments, cell to cell communication, and signal transduction.   These processes are 
important in cellular function and its response to the environment (Houston, 2006). 
Membrane proteins are classified according to their association with the membrane into 
integral or intrinsic and peripheral or extrinsic proteins (Voet, 2004). Integral or intrinsic 
proteins are embedded within the membrane and may be exposed on one side of a 
membrane or span the membrane, being exposed on both sides of the membrane. 
Peripheral or extrinsic proteins are loosely bound to the head group of phospholipids or 
other integral proteins. 
 
Membrane fluidity 
The organization and interaction of the components of the membrane is said to be 
fluid, as explained by the fluid mosaic model. In this model of cell membrane structure, 
the membrane is envisioned as an assortment of individually inserted protein molecules 
drifting laterally in a fluid bilayer of phospholipids. This model best explains the fluidity 
and function of the membrane by modulating the interactions between lipids and proteins 
(Singer & Nicolson, 1972). Membrane fluidity is defined as the viscosity of the 
membrane and is characterized by ease of motion within the bilayer. Fluidity is an 
important factor in membrane function that influences many biological and biochemical 
processes within the cell such as metabolism, transportation of chemicals, cell fusion, and 
protein rotation and diffusion. Membrane fluidity is determined by the phospholipid 
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species, fatty acid composition and cholesterol content of the membrane (Garzetti et al., 
1993). 
 
Phospholipid species 
Phospholipids may adopt different molecular shapes according to their head 
group. PC, SM and PS adopt cylindrical shapes, whereas PE and CL have cone shapes. PI 
possesses a large polar head in compare to its fatty acids which formulates an inverted 
cone shape (Alberts, 2002; Ramstedt & Slotte, 2002; Figure 1.2).  Molecular shapes of 
PLs predict the packing nature of PL within a membrane. PLs with cone or inverse cone 
shapes are able to pack closely to each other, decreasing membrane fluidity. In contrast, 
PLs with cylinder shapes do not pack tightly in the membrane, resulting in increased 
membrane fluidity (Cullis & Kruijff, 1979; Figure 1.2). 
 
Fatty acid characteristics 
Fatty acyl chain length and degree of saturation modulate membrane fluidity. 
Long chain fatty acids have higher hydrophobic attractions compared to short chain fatty 
acids, resulting in more rigid membranes (Nikolaidis & Mougios, 2004).  Unsaturated 
FAs increase fluidity of the membrane. Specifically, within MUFAs, membrane fluidity 
is promoted when the double bond resides in the middle of an acyl chain, indicating that 
membrane order is minimized under this condition (Marsh, 1999). Similarly, PUFAs with 
multiple double bonds are less able to pack closely to each other increasing fluidity with 
increasing numbers of double bonds (Yang et al., 2011).  Additionally, unsaturated fatty 
acids can adopt cis or trans conformation. FAs with trans configuration pack closely   
10 
 
 
 
Figure 1.2. Molecular shapes of phospholipids incorporated in the membrane. 
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together and decrease membrane fluidity (Keogh at al., 1987; Stubbs et al., 19981).  
 
Cholesterol 
Cholesterol can impact fluidity according to its concentrations. Cholesterol has 
attached steroid rings which are able to pack tightly with PL FA chains, restrict motion 
and decrease membrane fluidity (Voet & Voet, 2004). However, at high concentrations 
within a membrane, cholesterol decreases acyl chain hydrocarbons from interacting, 
restricting tight packing and increasing fluidity (Voet & Voet, 2004).  However, the 
concentration of cholesterol in the membrane is largely dependent on the degree of 
unsaturation and length of the FA chains (Ramstedt & Slotte, 2002). With increased 
unsaturated FAs, as a result of cholesterol desorption, the concentration decreases 
(Ramstedt & Slotte, 2002). In contrast, with increase in SFA, cholesterol concentration 
increases due to attraction between SFA chains and the rigid steroid ring backbone of 
cholesterol (Ramstedt & Slotte, 2002). 
 
Membrane structure protein function relationship 
Protein function can be, in part, controlled and regulated by the local lipid 
environment, mediated partially through membrane fluidity.  Some proteins require a 
fluid lipid environment for optimum function while some proteins prefer a more rigid 
environment (Edidin, 2003). For example, band 3 anion transporter activity decreases 
after increasing membrane cholesterol and increases with depletion (Bataglia & 
Schimmel, 1997; Schubert & Boss, 1982). 
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Impact of lipid composition on protein function  
Specific lipids within membranes modulate biological function of the cell by their 
influence on membrane-associated proteins. The influence of lipids on membrane bound 
proteins is dependent on the asymmetrical distribution of lipids on each side of the 
bilayer.  PS, PI and PE are mainly located on the cytoplasmic surface of the bilayer, 
whereas PC and SM comprise the external mono layer. PI in the inner leaflet of the 
bilayer has shown to be an important mediator in membrane-cytoskeletal association by 
regulating actin filament assembly, polymerization, and promoting activity of proteins 
that are essential in regulation of actin assembly (Hilpela et al., 2004). External location 
of PS contributes to cell recognition for apoptosis and initiation of coagulation pathways 
(Hasegawa et al., 2006). Similarly, CL exclusive localization in the inner layer of 
mitochondria is related to its modulating and stabilizing activity of the mitochondrial 
electron transport chain (Ritov et al., 2006). Moreover, segregation of cholesterol and SM 
in lipid rafts provides an environment for proteins to partition into ordered raft domains 
to modulate their activity. Typical example includes the glycosylphosphatidylinositol 
(GPI) proteins, which are attached to the outer leaflet of the membrane via the GPI 
anchor in a lipid raft (Chatterjee & Mayor, 2001). Previous research has demonstrated 
that Na
+
-K
+
-ATPase activity can be influenced by the concentration of cholesterol in the 
area of the membrane where it is found (Yeagle, 1990). 
While lipids can impact regulatory processes within the cell by their influence on 
proteins associated with the membrane, proteins are capable of dictating the lipid 
composition of the membrane around said protein, also called the lipid annulus. An 
important characteristic of the lipid bilayer is its hydrophobic core thickness, which is 
13 
 
related to fatty acid chain length and saturation (Deborah et al., 1993; Killian, 1998). The 
hydrophobic thickness of the lipid bilayer is arranged to match the hydrophobic thickness 
of an integral membrane protein because of the high cost of exposing either fatty acyl 
chains or hydrophobic amino acids to an aqueous environment (Killian, 1993). Any 
mismatch between the hydrophobic thickness of embedded proteins and of the membrane 
cause lipids to bend, tilt and stretch to satisfy the hydrophobic matching at the interface 
(Figure 1.3; Webb et al., 1993; Fattal & Shaul, 1993). Alternatively, hydrophobic 
mismatching can be minimized by substituting mismatched annular phospholipids with 
better matching neighbouring phospholipids. This phospholipid movement is mediated by 
flippase enzymes to flip the phospholipids to the opposite leaflet, or by translocase 
enzymes to displace phospholipids laterally along the membrane (Martinak & Hamilton, 
2003; Hamilton, 2003; Jensen & Moritsen, 2004). Together, membrane lipid content 
influences cell regulatory process performed by proteins, where membrane proteins are 
able to assign or distribute specific phospholipids to areas along the membrane. 
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Figure 1.3. Schematic depiction of influence of proteins on physical properties of fatty 
acids. Shrinkage and bending of fatty acids corresponding to alterations in hydrophobic 
length of integral proteins. 
 
Skeletal muscle 
Skeletal muscle comprises 40% of body weight in normal weight individuals and 
is responsible for body movements (Owen et al., 1978). Skeletal muscle is made up of 
myofibres that run throughout the muscle length. Each myofibre contains bundles of 
myofibrils comprised of smaller units of actin and myosin filaments. Actin and myosin 
are arranged in repeating units of sarcomeres, and their patterned arrangement gives 
striated muscle its characteristic banded appearance. Myofibre populations have different 
characteristic that also varies among different muscle types.  
15 
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Skeletal muscle cell structure 
Skeletal muscle cells house a variety of subcellular organelles with specialized 
proteins taking part to provide essential functions. To initiate contraction, impulses are 
transmitted from nerve endings to motor end plates of muscle fibres causing the 
depolarization of the cell membrane when Na
+
 voltage-gated channels allow an influx of 
Na
+
.   Re-establishing resting membrane potential is the responsibility of the Na
+
/K
+
 
ATPase, where it pumps 3 Na
+
 and 2 K
+
.  
The skeletal muscle cell membrane or sarcolemma (SL) propagates the action 
potential across the membrane. SL is a three layer surface membrane including a lipid 
bilayer sandwiched between basal lamina and sub-membranous cytoskeletal network 
(Ozawa, 2001). The basal lamina is mainly composed of non-fibrillar collagen, non-
collagenous glycoproteins, and laminin covering the cell (Timpl & Rohrbach; 1972). The 
sub-membranous cytoskeletal network is a lattice of costamere proteins anchored to the 
bilayer (Ozawa et al., 2001; Campbell & Stull, 2003). The basal lamina and cytoskeletal 
network are known as mechanically tough layers and their structural coupling with the 
bilayer reinforces the fragile bilayer from any damage and maintains its function.  
The SL extends into the cell, creating t-tubule invaginations to propagate the 
action potential to the sarcoplasmic reticulum (SR) via dihydropyridine receptors 
(DHPR) located on t-tubules that are in tight association with ryanodine receptors on the 
terminal cisternae of the SR (Lee et al., 2002, Al-Qusairi & Laporte, 2011). The action 
potential transmitted to the SR results in Ca
+2
 release from the SR, which is essential for 
muscle contraction (Katz et al., 1986; Kadambi et al., 1997). 
17 
 
Tropomyosin and troponin C (TnC) are two other proteins integral to contraction. 
TnC is attached to tropomyosin and lies within the groove between actin filaments. In a 
relaxed state, tropomyosin blocks the attachment site for the myosin cross bridge, thus 
preventing contraction (Morphy et al., 1983). With the release of Ca
+2
 from SR, it binds 
to TnC, which promotes a change in the spatial configuration of the troponin-
tropomyosin complex (Zhao & Kawai, 1994). Tropomyosin slides over, exposing the 
binding sites on actin. 
With the binding of myosin to actin, actomyosin is primarily in a weakly bound 
low-force state. With the release of inorganic phosphate (Pi), the cross bridge 
subsequently transforms into a strongly bound high-force state. The myosin head 
hydrolyzes ATP, through myosin ATPase, and the energy is used to create the power 
stroke. Cross bridges return to a rigor complex state following the release of ADP. After 
this power stroke, ATP re-binds to myosin, causing it to be released from actin and forms 
the detached high-energy state. Once myosin is loaded with that potential energy, it binds 
to actin again, reforming the high-energy/attached state of the cross bridge (Figure 1.4). 
Cytoplasmic Ca
+2
 is pumped back into the SR through sarco(endo)plasmic reticulum Ca
+2
 
ATPase (SERCA) transporters on the SR. 
The source of ATP to supply the main ATP consuming processes (SERCA, 
myosin ATPase, and Na
+
/K
+ 
ATPase) is the mitochondria. There are two distinct 
mitochondrial subpopulations identified in skeletal muscles. Subsarcolemmal (SS) 
mitochondria are located underneath the sarcolemma whereas intermyofibrillar (IMF) 
mitochondria are interspersed between myofibrils (Ferriera et al., 2010).  
18 
 
 
 
Figure 1.4. Actinomyosin ATPase cycle, binding of ATP, power stroke and Pi release. 
(Modified from Fitts, 2008) 
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Skeletal muscle fibre types 
Skeletal muscles are classified into 4 main fibre types, slow oxidative (SO; type 
I), fast oxidative glycolytic (FOG; type IIa), fast glycolytic (FG; type IIb) (Pette & 
Staron, 2011) and a hybrid of IIa and IIb fibres identified as IId/x (Burkholder, 2005). 
Type I, or SO, fibres have high levels of aerobic oxidative enzymes and rely on 
oxidative phosphorylation to produce ATP. These fibres have a high content of 
mitochondria and myoglobin. Moreover, it is observed that type I fibres have higher 
transport rate for glucose, free fatty acids, and amino acids (Rose et al., 2005). As a 
consequence, type I fibres have a higher ability to generate more ATP through higher 
substrate entry into the cell. Due to ATP supply, these fibres show stability and fatigue 
resistance during prolonged submaximal activity, which makes them well adjusted for 
prolonged repetitive activities. Additionally, type I fibres have more and smaller motor 
units per muscle (Bottinelli et al., 1999). Therefore, they have high sensitivity and rate of 
recruitment making them suitable for involvement in postural activity (e.g. joint 
stability).  However, in terms of contractile properties, type I fibres have long twitch 
contraction times related to their low myosin ATPase kinetic activity and slow axonal 
conduction velocity that determines the slow contraction velocity of this fibre type (Moss 
et al., 1995; Schiaffino et al., 2007; Schiaffino and  Reggiani, 2011, Wasterblad et al, 
2010). Additionally, type I fibres have longer relaxation times explained by the lower rate 
and capacity for Ca
+2
 uptakes (Moss et al., 1995). Given that the peak rate of tension 
development is limited by the time required for actinomyosin transition in bridge cycles, 
type I fibres produce lower peak tension but due to the simplicity of their neuromuscular 
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junctions, they elicit power at low stimulus frequencies (Ariano et al., 1973; Scott et al., 
2001; Moss et al, 1995) (Table 1.2). 
Type IIa, or FOG, fibres have aerobic oxidative and glycolytic enzymes making 
them suitable for long term (minutes- hours) anaerobic activities (Scott, 2001). Type IIa 
fibres have a very high capacity to generate ATP through oxidative metabolic processes, 
and hydrolyze ATP at a very rapid rate, resulting in higher contraction velocity compared 
to type I fibres (Schiaffino et al., 2007).  They have a high content of mitochondria and 
myoglobin and are fatigue resistant, making them suitable for sustained contraction 
(Schiaffino et al., 2007) (Table 1.2). These fibres have short twitch contraction times with 
high myosin ATPase activity and short relaxation times related to more Ca
+2
 uptake by 
their SR. Compared to type I, type IIa fibres have higher rates of axonal conduction 
velocity and myosin ATPase activity creating shorter twitch contraction times (Ariano et 
al., 1973; Adams et al., 1993) (Table 1.2). 
Type IIb fibres have the fastest twitch contraction time and have high content of 
anaerobic glycolytic enzymes to provide a rapid source of ATP that does not rely on 
mitochondria.  However this pathway rapidly depletes glycogen storage and fatigue 
develops after brief usage (Hughes et al., 1999). Additionally, type IIb fibres are 
characterized by the short time course of twitch and relaxation time with larger peak 
power output (Moss et al., 1995; Scot et al., 2001; Schiaffino et al., 2007; Schiaffino and 
Reggiani, 2011, Wasterblad et al, 2010).  Moreover, their neuromuscular junction creates 
low sensitivity to their recruitment saving them for activities requiring high force in short 
duration (Moss et al., 1995; Schiaffino et al., 2007; Schiaffino and Reggiani, 2011, 
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Wasterblad et al, 2010). Thus, type IIb fibres are involved in short burst activities 
requiring high power output. 
Type IId/x fibres are a hybrid of type IIb and IIa fibres. They have a low content 
of mitochondria and ATP synthesis rates and rely on glycolysis to produce ATP.  
However, their glycolysis rates are lower than type IIb (Ariano et al., 1973; Delp & 
Duan, 1996; Schiaffino & Reggiani, 2011). Motor units composed of type IId/x fibres 
have twitch properties including contraction and half-relaxation time similar to those of 
IIa and IIb units, and their resistance to fatigue is intermediate between that of IIa and IIb 
units but similar to type IIb, IId/x fibres are involved in short duration, high force 
activities (Schiaffino & Reggiani, 2011). 
 
Skeletal muscle mechanics 
Fast and slow twitch fibre compositions are potential determinants for muscle 
biomechanical function. Excitation contraction coupling leads to a twitch response from 
muscle units. Accordingly, contraction of large muscle groups is derived from temporal 
and spatial summation of single twitches. Repeated and rapid stimuli to muscle fibres 
create an amplified, sustained contraction called tetanus (Figure 1.5). Interaction between 
the force generated by the muscle, result of power strokes from cross bridges, and the 
load on the muscle results in shortening (concentric), no length change (isometric), or 
lengthening (eccentric) contraction of the muscle. Twitch force (Pt) is determined by 
intracellular Ca
+2
 transients and Ca
+2
 sensitivity, whereas tetanus force (P0) is determined 
by peak of intra-cytoplasmic Ca
+2
 and the fraction of cross bridges that create force.  
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Table 1.2. Physical, contractile, and metabolic characteristics of mammalian muscle 
fibres. 
Characteristics Type I Type IIa Type IId/x Type IId 
Diameter Small
1
 Intermediate
1
 Large
1
 Larger
1
 
Motor unit size Small
2
 Intermediate
2
 Large
2
 Larger
2
 
Recruitment Early
2
 Intermediate
2
 Late
2
 Later
2
 
Contraction Slow
1
 Fast
1
 Faster
1
 Fastest
1
 
Twitch Long
1
 Short
1
 Shorter
1
 Shortest
1
 
Capillaries Abundant
3
 Intermediate
3
 Sparse
3
 Rare
3
 
Glycolytic capacity Low
1
 Intermediate
1
 High
1
 Highest
1
 
Oxidative capacity High
1
 High
1
 Intermediate
1
 Low
1
 
Myoglobin High
1
 Intermediate
1
 Low
1
 Lower
1
 
Glycogen Low
1
 Intermediate
1
 High
1
 Higher
1
 
Myosin ATPase Slow
1
 Fast
1
 Fast
1
 Faster
1
 
Resting [Ca
2+
] High Intermediate Low Lowest 
Peak [Ca
2+
] Low
1
 Intermediate
1
 High
1
 Highest
1
 
Ca
2+
 release Low
1
 Intermediate
1
 High
1
 Highest
1
 
RyR:DHPR Low
1
 Intermediate
1
 High
1
 Highest
1
 
Ca
2+
 uptake Low
1
 Intermediate
1
 High
1
 Highest
1
 
SERCA density Low
1
 Intermediate
1
 High
1
 Highest
1
 
Ca
2+
 Low
1
 Intermediate
1
 High
1
 Highest
1
 
1
(Scott et al., 2001), 
2
(Ariano et al., 1973), 
3
(Billeter et al., 1980) 
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Intracellular Ca
+2
 transients, peak of cytoplasmic Ca
+2
 and Ca
+2
 sensitivity are higher in 
fast fibre types. Comparing slow and fast twitch fibres, Pt to Po ratio is higher in fast 
(0.25) than slow (0.20). 
 
Isometric contractions 
Isometric contractions are characterized by having a constant muscle length 
during activation. The force generated during an isometric contraction is dependent on 
the length of the muscle while contracting. Maximal isometric force (Po) is produced at 
the muscle's optimum length, where the length of the muscle is at normal resting length. 
During isometric contractions, greater force is obtained when the number of available 
cross bridges is reduced by an increase in muscle length (Figure 1.6). The greater force 
capacity in longer muscle lengths is the collective results of active and passive tension of 
contractile protein and titin, respectively. 
 
Concentric contractions 
When the force produced by the muscle exceeds the force applied to the muscle, 
the muscle shortens. This is known as a shortening or concentric contraction. In 
concentric contractions, the force generated by the muscle is less than Po. Inter sarcomere 
dynamics can be responsible for shortening-induced depression of isometric force 
(Edman et al., 1992; Morgan, 1990). There are two conceptual possibilities explaining 
lower force of concentric contractions. The first possibility emphasizes an increased 
lateral spacing between actin and myosin filaments at short lengths reducing the 
probability of cross bridge interactions (Godt & Maughan, 1981). Interference of cross  
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Figure 1.5. Pattern of muscle twitch, summations and tetanus. 
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Figure 1.6. Length tension curve of a muscle. (Obtained from Gittings, 2009) 
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bridge interactions may occur with double overlap of thin filaments (Gordon et al., 1966). 
The second possibility suggests that in extremely shortened muscle lengths, proper cross 
bridge attachments may be limited because of deformed myosin filaments.  The deformed 
myosin heads create internal forces that may improperly position myosin in association 
with actin (Faulkner, 2003). However, deformation of myosin head occur only at 
extremely shortened lengths of sarcomere indicating that myosin deformity does not 
occur at typical physiological ranges of sarcomere lengths.  
 
Eccentric contractions 
When the force applied to a muscle exceeds the force produced by the muscle, the 
muscle lengthens. This is known as a lengthening or eccentric contraction. In eccentric 
contractions, the absolute muscle tensions are very high relative to Po (Lieber et al., 
1991). Additionally, unlike concentric contractions, the absolute tension is relatively 
independent of lengthening velocity (Herzog & Leonard, 2000). 
 
P Eccentric contraction > Po > P Concentric contractions 
 
Increased force in eccentric contractions could be related to decreased rate of 
cross bridge detachments, generating greater steady state force. Additionally, repeated 
eccentric contractions are known to cause substantial damage in myofibres that is 
mediated by injury to the elements of EC coupling machinery, including t-tubule rupture. 
When a muscle is stretched eccentrically, the t-tubules anchored to the contractile 
apparatus suffer a lateral stretch and get pulled out of position. This has an immediate 
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inhibitory impact on ECC as the voltage gated calcium channels within the t-tubule 
network must precisely align and physically couple with the ryanodine receptor gating 
the calcium vaults of the sarcoplasmic reticulum. Thus repeated eccentric contractions 
and failure in EC coupling leads to reduced Ca 
+2 
release and fall in tension (Warren et al. 
1993).   
 
Membrane lipid composition in mammalian skeletal muscles 
Membrane lipid composition can influence integral and peripheral membrane 
proteins, suggesting the composition of the membrane may be an important determinant 
of cellular function. Since fast and slow twitch fibres represent different contractile, 
metabolic and physical characteristics, it is suggested that membrane PL FA profiles may 
differ with muscle fibre type composition. Previous research suggests that membrane PL 
from fast and slow muscle types have similar amounts of PC and PE, which account for 
70-75% of the total membrane PLs (Fiehn & Peters, 1971; Fiehn & Peter, 1973; Blackard 
et al., 1997; Stefanyk et al., 2010). In addition, slow muscle types have a higher content 
of PUFA, particularly the long chain n-3 PUFA, related to a high proportion of type I 
fibre in humans (Kriketos et al., 1996). However, in rats, examinations of slow twitch 
oxidative SOL mitochondria revealed more SFA and less PUFA compared to fast twitch 
oxidative glycolytic red gastrocnemius and mixed plantaris mitochondrial membranes 
(Stefanyk et al., 2010), suggesting unique membrane PL FA composition of mitochondria 
in different muscle types with variable fibre type composition. Together, these 
observations reveal the importance of membrane composition as a difference in function 
and energy production in muscles with different fibre type composition.  
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Sarcolemma Functions 
The significance of the sarcolemma is attributed to its contributions to cellular 
functions such as synaptic transmission, action potential propagation, and excitation 
contraction coupling (Engel & Franzini-Armstrong, 1994). Besides the well-established 
physiological functions, the sarcolemma plays an essential structural role in skeletal 
muscle. During contractions it is of most importance for the myofibres to maintain their 
organization, which is provided, in part, through structural stability mediated by the 
sarcolemma (Ozawa et al., 2001; Campbell & Stull, 2003). 
 
Structural role 
During muscle contraction, longitudinal and radial forces are generated by cross-
bridges in the network of myofilaments. The generated force compresses the myofilament 
lattice, resulting in a radial force (Ozawa et al., 2001). Since the myofilaments are 
ultimately anchored to the surface membrane, such radial forces are transferred to the 
sarcolemma and thereby exert tension upon the membrane (Roy et al., 1999; Pardo et al., 
1983; Bloch & Gonzalez-Serratos, 2003; Shkryl et al., 2009). To counter this force, 
muscle fibre membranes have structural elements that make them capable of withstanding 
both longitudinally and radially-directed mechanical stresses. One of these structures is 
the costameric linkage (Figure 1.7) in the subsarcolemmal region that aligns with the Z-
disk and is physically coupled to the sarcolemma (Danowski et al., 1992; Ozawa et al., 
1995). The major costamere protein complex is the dystrophin glycoprotein complex 
(DGC) (Figure 1.8; Pardo et al., 1983). DGC is a large oligomeric complex with core 
components of dy    p  n, a  n  w    α and β   y  p     n   E va    et al., 2001; Ozawa 
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et al., 2001). T   α-glycoprotein subunit is a peripheral protein that binds to laminin 
   a  z d  n      a a   am na. T   β-glycoprotein unit is a transmembrane protein which 
links to dystrophin (Ervasti et al., 2001; Sciandra et al., 2003), and provides a physical 
linkage across the muscle membrane connecting the extracellular collagen matrix to the 
F-actin of the sarcomere unit (Figure 1.9; Crosbie et al., 2000; Ervasti & Campbell, 
1998). The DGC is associated with other mediator proteins that strengthen the non-
  va  n    nd  f  m dy    p  n    dy      y an β-subunits (e.g. sarcospans and 
syntrophins sarcoglycans) (Ervasti et al., 2001; Sciandra et al., 2003). Taken together, the 
DGC helps to anchor the muscle cytoskeleton to the cell membrane via dystrophin and its 
binding partners. Importantly, DGC generates a rib like lattice to provide support for the 
sarcolemma (Ervasti, 2000; Ozawa et al, 1995; Ozawa et al., 2001; Campbell & Stull, 
2003; Peter et al., 2011). Previous studies have revealed that there are at least two 
mechanisms whereby the DGC provides a flexible and elastic link between the actin 
cytoskeleton and the extracellular matrix to help stabilize the sarcolemma during muscle 
contraction. First, the DGC helps to distribute the mechanical forces associated with 
contraction over a broader membrane area by interacting with other structural elements 
exerting tension upon the sarcolemma. Second, the DGC transmits force across and 
beyond the membrane to the extracellular matrix to minimize increased force on the 
sarcolemma (Crossbie et al., 1972; Durbeej & Campbell, 2002).  This link helps to 
dissipate muscle contractile force from the intracellular cytoskeleton to the extracellular 
matrix. As a result, DGC aids to stabilize and preserve sarcolemma during contraction 
and prevent contraction-induced injury.  
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Figure 1.7. Demonstration of cellular location of costameres in skeletal muscle fibres. 
(Modified from Ervasti, 2003) 
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Figure 1.8. Schematic view of sarcolemma three layer structure (basal lamina, lipid 
bilayer and cytoskeletal network; modified from Roberts, 2001) 
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Cell signal transduction role 
In addition to a structural role, SL regulates cellular signalling and muscle 
excitability.  This regulation is possible through essential proteins embedded or anchored 
to the sarcolemma. One of the proteins involved in signaling pathways is the DGC. DGC 
and its associated protein networks are interconnected to signal regulatory proteins 
controlling calcium dependent activation of lytic enzymes. The most important signalling 
pathway associated with DGC is related to calcium and nitric oxide (NO). NO is 
produced by the Ca
2+-
 dependent enzyme neuronal nitric oxide synthase (nNOS), 
connected to DGC through the adaptor proteins syntrophins. The localization of nNOS at 
the SL regulates depolarization and subsequent calcium entry through voltage dependent 
calcium channels (Kim et al., 2009).  The regulation in calcium contributes to control for 
vasomodulation known to be important in contractile skeletal muscle. Additionally 
plasma membrane calcium/calmodulin ATPase pump (PMCA) localized to the SL is a 
known modulator of signal transduction pathways. There are many physical interactions 
between PMCA and other mediators to regulate and organize signaling transduction 
pathways. 
All together, the primary focus for regulator complexes (nNOS, PMCA and etc.) 
is SL, and the detail introduction of mediators involved in signalling is beyond the scope 
of this thesis. Together, the signal transduction cascades associated with the DGC play 
important roles in cell survival signaling, cellular defense mechanisms, and regulation of 
the balance between cell survival and cell death (Rando, 2001). As such, presence of the 
DGC and its pivotal components not only physically stabilizes the sarcolemma, but helps 
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to anchor signalling molecules and regulate survival signalling pathways essential for cell 
function. 
 Mutations of different components of DGC or its associated protein network leads 
to skeletal muscle damage and impairment in muscle function. These impairments, in 
turn, lead to muscular dystrophies which vary in severity, age of onset and involvement 
of different muscle groups. 
 
Muscular dystrophy 
Muscular dystrophies are a group of X- linked recessive inherited neuromuscular 
diseases involving the mammalian muscular system. This group of diseases are 
characterized by progressive weakness and degeneration of skeletal muscles, with smooth 
and cardiac muscle manifestations later over the course of the disease. The most common 
and severe form of muscular dystrophy in children is Duchenne muscular dystrophy 
(DMD) produced by a point mutation in the dystrophin gene affecting 1 in 3600 infant 
males (Emery, 2002).  
The symptoms usually appear before the age of 6 and may present as early as 
infancy. The first accompanying symptom is associated with motor muscular milestones 
causing a delay in the mean age of walking to 18 months. Progression of symptoms 
results in 90% of affected individuals to be wheelchair bound by 19-24 year of age 
(Emery, 2002; Worton, 1995; Darras et al., 2008). The life expectancy for DMD is 20-24 
years due to cardiac and respiratory muscle failure (Emery, 2002; Fauci, 2004).  
The dystrophin gene has been identified as the largest gene in the human genome 
with 79 exons (Ahn & Kunkel, 1993). The large size of the dystrophin gene is known to 
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be the primary reason for the high incidence of DMD as mutations that occur at multiple 
locations (Coffey et a., 1999; Ahn & Kunkel, 1993). Mutations in the dystrophin gene 
leading to DMD result from duplications and deletions, with deletions being the most 
common (Koeing et al., 1989).  
As highlighted above, cytoskeletal proteins contribute to lateral transmission of 
force, and thereby they diminish the extent of force upon membrane during contraction. 
The absence of dystophin, and resulting impact on the DGC, compromises its ability to 
transfer force beyond the membrane. As such, contractile force will be directed toward 
the membrane causing muscle damage characterized by an immediate weakness and 
mechanical tearing of the membrane (Ervasti & Campbell, 1999).  
 
Rodent model of muscular dystrophy, mdx mice 
The most frequently used model for characterization of structural and functional 
properties of dystrophin deficiency is the mdx mouse. The mdx mouse has an X-linked 
point mutation in the dystrophin gene that results in a defective truncated protein 
(Bulfield et al., 1984; Sicinski et al., 1989). The point mutation occurs in exon 23 where 
thymine is replaced by cytosine making a defective protein that is shortened to 27% of its 
normal length (Bulfield et al., 1984). The truncated protein is not able to bind to 
cytoskeletal elements, therefore, loses its role in providing stability for the membrane 
(Sicinski et al., 1989). 
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Muscular dystrophy etiology 
To explain the etiology for force reduction in muscular dystrophy, several 
hypotheses have been suggested.  The first hypothesis is based on the anchoring role of 
the DGC in linking sarcolemma to intra and extracellular structures. The second 
hypothesis refers to the involvement of dystrophin and the DGC in signaling mechanisms 
that may include calcium and calcium-dependent activation of lytic enzymes. The third 
hypothesis is related to the appearance of bifurcations and branching in dystrophic fibres, 
which make them prone to split and tear. 
 
Mechanical hypothesis 
The mechanical hypothesis for DGC dysfunction is based on the DGC being a 
link between the subsarcolemmal cytoskeleton and the extracellular matrix. The 
disruption of the DGC, due to an absent or truncated dystrophin, may lead to 
sarcolemmal instability, membrane tears, and eventually muscle fibre necrosis (Mendell 
et al., 1995, Campbell, 1995). The suggestion is that the DGC offers both structural and 
functional integrity to the sarcolemma by stabilizing it against stresses imposed during 
muscle contraction or stretch (Rybakova et al., 2000; Blake et al., 2002). 
Evidence for structural support of the DGC arises from several studies comparing 
force deficits of mdx mice compared to wild type. Although in vitro experiments for 
inducing damage are not consistent in the literature, immediate force loss and 
contraction-induced sarcolemmal damage has been observed after eccentric contractions 
(Head et al., 1992; Petrof et al., 1993; Deconinck et al., 1998; Raymackers, 2003; 
Consolino & Brooks, 2004; Chan et al., 2007). Force loss in the mechanical hypothesis is 
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explained by segmental necrosis of muscle fibres, so the structural continuity required for 
effective force transmission along the longitudinal axis is lost and fibres are functionally 
impaired in transmitting force (Ohlendieck & Campbell, 1991). Additionally, it has been 
suggested that lateral transmission of force to the inter-fibre connective tissue space may 
p  v d  a “  n   n  ypa  ” a   nd dama  d a  a  and help to maintain some force-
generating capacity in the presence of localized fibre injury (Huijing, 1999; Mass et al., 
2001). This compensatory mechanism might be defective in dystrophin deficiency given 
the predicted decrease in mechanical linkage between myofilaments and the extracellular 
matrix.  
 Other evidence in agreement with the mechanical hypothesis suggests that with 
development of membrane tears, the intracellular molecules leak out of the myocyte 
through the damaged membrane. One of the exclusive ex vivo surrogates of membrane 
damage are membrane impermeable low molecular weight dyes, specifically procion 
orange. Procion orange has a very lower molecular weight (630 g/mol), and infiltration 
into the myocyte is indicative of small tears in the membrane of damaged fibres (Petrof et 
al., 1993; Whitehead et al., 2006). Limitations of this method, however, are related to its 
potential toxicity and impact on peroxidation of membrane lipids producing additional 
membrane injury (Palacio et al., 2002). This limitation has resulted in the use of 
alternative techniques for assessment of membrane damage, specifically, creatine kinase 
(CK) and fibronectin. 
The muscle isoform of CK is an enzyme, ~81 kDa in size (or ~81,000 g/mol), 
which catalyzes the reversible conversion of creatine to phosphocreatine, consuming 
ATP. CK is normally found in the cytosol of skeletal muscle fibres and serum 
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concentrations are normally very low (~150 U/L) (Okinaka et al., 1959).  It is generally 
thought that if serum CK concentrations rise, it is due to sarcolemmal membrane damage, 
allowing muscle CK to leak out of the muscle fibre (Ozawa et al., 1999). Limitation of 
CK in the evaluation of membrane damage is related to its measurement in in vivo 
conditions. Moreover, the serum CK activity level is highly variable between mice 
influenced by multiple variables including age and prior muscle activity (Sorichter et al., 
1998; Spurney et al., 2009; Anderson et al., 1996). As such, effluxes of CK may only 
represent the presence of membrane damage and do not necessarily reflect the location of 
damage within a given muscle (Sorichter et al., 1998).  
Another molecule indicative of membrane permeability is intracellular 
accumulation of fibronectin. Fibronectin is predominantly secreted by fibroblasts and 
exists as a dimer composed of two identical monomers with a molecular weight of 450 
kDa, or ~450,000 g/mol (Pater et al., 1987). Fibronectin is a component of the 
extracellular matrix and its localization in the cell is indicative of membrane damage 
(Palacio et al., 2007). Despite considerable difference in molecular weight of fibronectin 
and procion orange (630 vs. 450,000 g/mol), fibronectin detection has demonstrated 
comparable results to procion orange (Palacio et al., 2002). Moreover, in contrast to CK, 
and further to its ex vivo measurement, the levels are not variable in mice, making it 
appear as an appropriate measure for evaluating fibre membrane damage (Palacio et al., 
2002).  
Together, despite limitations in different measures, the proportion of damaged 
fibres exhibiting procion orange have a direct association with decline in function as an 
aspect of muscle damage after injury (Petrof et al., 1993). Importantly, a decrease in 
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contractile function may be either a cause or consequence of muscle fibre damage as 
indicated with procion orange positive fibres.  Increase in procion orange uptake has also 
been associated with increase in Ca
+2 
entry and disturbed Ca
+2 
homeostasis resulting in 
necrosis suggesting procion orange is reflective of membrane micro-lesions and muscle 
damage in mdx (Whitehead et al., 2006).
 
 However, increased plasma CK has not shown 
an association with declined muscle functional and histological parameters of muscle 
damage, more reflective of the presence of membrane lesions (Anderson et al., 1996). 
With application of electrical stimulation to induce membrane injury, fibronectin was 
similarly detected in fibres positive for procion orange (Palacio et al., 2002). This suggest 
that although the techniques of procion orange and fibronectin identifications are based 
on markedly different molecular weights, they both result in detecting membrane lesions 
and muscle damage. As such, fibronectin can be used to examine membrane damage 
without impacting membrane lipids.   
There is evidence, however, that the mechanical hypothesis may not be solely 
responsible for the onset of DMD. With application of eccentric induced damage 
protocols to extensor digitorum longus (EDL) muscle of 9-12 day old control and mdx 
mice, it was discovered that the mdx genotype at a young age is resilient to injury and 
does not show additional damage (Grange et al., 2002). Therefore, evidence is not 
conclusive to support the mechanical hypothesis as a mechanism that initiates DMD 
during early maturation.  This has prompted questioning about the role of dystrophin in 
the protection of cell membranes in response to mechanical injury (Grange et al., 2002). 
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Calcium hypothesis 
The calcium hypothesis states that, in the absence of dystrophin, there would be 
an influx of calcium through the sarcolemma due to either abnormally functioning stretch 
activated channels (SAC) or cation-leak channels (Tutdibi et al., 1999). The increased 
calcium entry contributes to a rise in cytosolic free calcium, which, in turn, activates 
calcium dependent proteases and eventually leads to muscle necrosis (Mallouk et al., 
2000, Alderton & Steinhardt, 2000). Previous research demonstrated that prevention of a 
rise in intracellular calcium following eccentric contractions resulted in a significant 
reduction in mdx muscle damage (Yeung et al., 2005).  This demonstrates that the influx 
of calcium and a higher intracellular calcium concentration contributes to muscle fibre 
damage and ultimate necrosis. Of course, with development of muscle damage, more 
Ca
2+
 can enter the fibre and potentially activate more Ca
2+ 
leak channels, thereby 
providing an additional route for Ca
2+
 entry (Mallouk et al., 2000; Alderton & Steinhardt, 
2000). 
Within the calcium hypothesis, abnormal calcium homeostasis may not be a direct 
effect of the absence of dystrophin. The cause of abnormal calcium homeostasis may be 
either a secondary result of muscle degeneration or be related to transient sarcolemmal 
wounds as a result of contraction-induced injury. Calcium was used to measure the 
muscle membrane permeability of EDL in 14 and 40 day old mdx and control mice. 
Calcium accumulation in muscle from the extracellular fluid was normal in 14 day old 
mdx mice, but by age 40, calcium levels were 3 times higher than control (Whitehead et 
al., 2006). Assessment of membrane permeability with procion orange demonstrated that 
in 14 day old mdx mice, there was no evidence of abnormal muscle membrane 
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permeability, supporting the hypothesis that the alteration of membrane permeability was 
a secondary effect (McArdle et al., 1994, Grange et al., 2002). Additional support for the 
secondary effect of abnormal permeability is that, in mdx muscle, total calcium content 
rose acutely in muscle at an age that correlated with a period of necrosis and then 
returned to normal values during an ensuing regenerative phase (Reeve et al., 1997).  
In another study with the removal of calcium in the muscle-bath media or with the 
addition of streptomycin to block stretch activated channels, force declined to only 69–
76% of its control value compared to ~ 56% in the presence of calcium (Zhang et al., 
2008). This demonstrated that although force deficit was greater in the presence of 
calcium, the removal of calcium and prevention of calcium-mediated cytoskeletal 
dama  , f     d dn’    mp     y     v          n  ma  va   . This may suggests that 
calcium-mediated damage is not the only involved mechanism to explain why the 
absence of dystrophin causes muscles to be particularly susceptible to damage and 
degeneration.  
The increased frequency of transient sarcolemmal wounds sustained during 
contraction in dystrophic muscle may be exacerbated by abnormal calcium homeostasis 
(Alderton et al., 2000). When muscle contraction and activity in mdx muscle was 
inhibited through paralysis for 5-7 days, the abnormal rise in resting intracellular free 
calcium levels was mostly prevented. From this study, it was concluded that the damage 
from long-term contractile activity and increased calcium leak channel activity are the 
likely causes of differences in calcium homeostasis, but not the primary reason for the 
calcium influx from individual contractions (Alderton et al., 2000). Increased levels of 
intracellular calcium have been reported by several investigators in mdx mice as early as 
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3 weeks of age. More specifically, increased calcium has been shown to localize at the 
sarcolemma, which may be due to calcium leak channels (Rolland et al., 2006; 
Vandebrouck et al., 2002; Yeung et al., 2005). It is not yet clear if the increase in 
intracellular calcium is a primary or secondary outcome of the absence of dystrophin. The 
increased intracellular calcium associated with the onset of contraction in myofibres 
around 3 weeks of age, and lack of rise of calcium at 14 days with no change in 
membrane permeability, may suggest that calcium mediated damage may not be the 
initial event of the dystrophic pathology  (Alderton et al., 2000).   
 
Branching hypothesis 
The etiology of muscle degeneration in mdx mice is complicated by the fact that, 
as mdx muscle ages, the architecture of the dystrophic muscle fibres becomes 
abnormal.  The abnormal fibres have branched and split appearance, which are more 
prone to damage during contractions. This is explained by the high shear stress upon 
branching points during intense contractile activity, leading to fibre rupture at these 
points (Chan et al., 2007). With progression of disease, skeletal muscle fibres display 
more abnormal, branched and split appearance that is prominently seen in regenerated 
fibres (Figure 1.9; Head et al., 1992; Chan et al., 2007; Head, 2010; Chan & Head 2011; 
Head, 2011). In contrast to dystrophic fibres, branched fibres are hardly ever found in the 
muscles of dystrophin-positive control mice (Head et al. 1992; Chan et al. 2007; 
Lovering et al. 2009). Additionally, branched fibres are highly variable in their individual 
diameter size, leading to differing propagation velocities of action potentials with 
asynchronized contractile activity and extra stresses imposed on branching points (Isaacs 
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et al. 1973). Therefore, the change in morphology of dystrophic fibres contributes to fibre 
rupture after contractile activity and decline in force production during each contraction.  
Fibre branching and changes in morphology of dystrophic fibres increase with age (Isaacs 
et al. 1973; Schmalbruch, 1984; Head et al. 1992; Blake et al. 2002; Chan et al. 2007). 
One study on young mdx mice at the age of 6-8 weeks showed no significant force deficit 
compared to control. This age coincides with a period where fibre branching is minimally 
present so although the 6-8 week old muscles were identified as dystrophic, their force 
deficit was not significantly decreased (Chan et al., 2007). Thus, the branching 
hypothesis suggest that the lack of dystrophin itself does not make muscle more prone to 
contractile damage, because the muscles from the young mdx mice were not more 
damaged than control muscles (Head et al. 1992; Chan et al. 2007). However, with the 
presence of branching in older ~28 weeks old mdx mice, eccentric contractions resulted 
in a force deficit of 58%, compared with only 25% for control animals (Chan et al., 2007; 
Chan & Head, 2011). In another study using mouse pups aged 9–12 days old, EDL 
muscles from mdx mice showed no more damage than non-stretched muscles following 
eccentric contractions, as assessed by force deficit and dye uptake (Grange et al., 2002). 
Taken together, it can be postulated that the large increase in susceptibility to damage 
from lengthening contractions that occurs with advancing age in mdx mice could be 
related to the development of branched fibres. 
 
Chronology of mdx phenotype 
 Dysfunction in dystrophin is associated with a spectrum of pathologies including 
change in myofibre histology, abnormal biomechanical function, alterations in fibre type 
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and membrane lipid composition, and abnormal leaky membranes. This dystrophic 
phenotype is not similar through the lifespan and displays variable stages from mild to 
severe.   
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Figure 1.9. Demonstration of fibre branching in 28 wks old mdx mice. (Modified from 
Chan et al., 2007) 
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Skeletal muscle histology 
Dystrophic mice have a near normal life span (Blake et al., 2002). From birth to 5 
days of age, muscle fibres appear to be immature and there is no evidence of histological 
lesions (Durbeej et al., 2002). With increased activity and weaning at 10-15 days, muscle 
fibres began to differentiate into type 1 and 2 fibres with no difference in fibre type 
distribution than wild types (Durbeej et al., 2002). 
 At 3 weeks, muscles demonstrate excessive atrophy with variation in fibre size 
and degeneration of type II fibres (Bulfield et al., 1984). In addition, plasma 
measurements demonstrate elevated levels of creatine kinase and pyruvate kinase. 
Moreover, phagocytic cells begin to appear in place of lost fibres, but there is no 
replacement of lost muscle by connective tissue and adipose cells (Bulfield et al., 1984). 
The timing of muscular degeneration is highly variable within the literature, although it is 
generally agreed upon that maximum degeneration is seen between the 3rd and 10th week 
of age before decreasing to negligible levels after 10 weeks (DiMario et al., 1989, Karpati 
et al., 1990, Nagel et al., 1990). The precise reason for the acute onset of the pathology at 
3 weeks of age in fast twitch muscles is currently unknown. This may be related to adult-
type muscle activity or to developmental changes in expression of various genes. These 
genes include the components of the glycoprotein complex, specifically utrophin, which 
are anchored to one another to form stable lattice structures. Utrophin is a homologue of 
dystrophin that is exclusively located at the neuromuscular junction. Similar to 
dystrophin, it has domains that bind to actin and the glycoprotein complex. In the absence 
of dystrophin, utrophin is up-regulated, localizes throughout the entire sarcolemma, and 
is able to partially compensate for dystrophin, thus conferring a degree of stability to 
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attenuate muscle pathology (Tanabe et al., 1991; Gramolini et al., 2001). Dysfunction in 
any of these network components is accompanied by adaptive up regulated responses in 
utrophin, masking the expression of the phenotype. However, with down regulation in the 
expression of these compensatory proteins around 3 weeks of age, dysfunction of DGC 
components becomes apparent (Khurana et al., 1991).  
After 5 weeks of age there is a vigorous regeneration response with the 
appearance of many central nucleated fibres that originate from their precursors, satellite 
cells (Carnwath and Shotton, 1987). After 5 weeks of age, there are cycles of 
degeneration and regeneration occurring in mdx muscle until approximately 10-11 weeks, 
when muscle fibre degeneration and necrosis decrease significantly and are delayed until 
approximately 18 months of age (Stedman et al., 1991). In fact, after the initial wave of 
degeneration, mdx muscle only demonstrates low levels of damage with the disease 
following a more benign progression, maintaining a chronic but low grade of damage 
after 10 weeks of age (Grounds et al., 2008). Eventually the regenerative process 
becomes exhausted and muscle begins to show signs of atrophy, weakness and fibrosis 
similar to that of DMD (Hakim et al., 2011). Fibrosis is an excessive accumulation of 
extracellular matrix that is the end result of tissue damage and degeneration, resulting in 
permanent loss of fibres and replacement with connective tissue. Previous research has 
shown that mdx muscle at 8 weeks and 6 months display no apparent fibrosis. However, 
after 18 months fibrosis becomes evident (Hakim et al., 2011; Desguerre et al., 2012). 
Demonstration of fibrosis at late stages of the mdx phenotype indicates that the 
accumulation of collagen is cumulative and not apparent until late stages of disease 
progression. 
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Biomechanical functions 
Isometric force development has been extensively studied in the mdx mouse, at 
various age groups reporting differences in force production relative to age match 
controls. Specifically, force production and power output of dystrophic EDL muscle are 
reported to be normal at 9-12 days of age and only reduce significantly after 12 days 
(Grange et al., 2002). In support of early contractile dysfunction, EDL of 28 days old mdx 
mice displayed 15% less twitch force than control (Lowe et al., 2006), which supports 
previous research from several other groups (Petrof et al., 1993, Deconinck et al., 1998, 
Raymackers, 2003). However, later on, at 4-8 weeks of age, there was no difference in 
force development of dystrophic muscles compared to controls (McArdle et al., 1991; 
Deconinck et al., 1998; Chan et al., 2007). From 8-12 weeks of age, there is a more 
dramatic functional deficit of 15-25% in mdx muscle (Head et al., 1992; Chan et al., 
2007; Harcourt et al., 2007; Dellorosso et al., 2001; Deconinck et al., 1993) (Table 1.3).  
The force output continues to decline to 20% of control muscles at 12 weeks age, 30% at 
20 weeks, 15% at 24-28 weeks and ~30% at 45 weeks of age (Table 1.3) (Lynch et al., 
2001; Consolino & Brooks, 2004; Head et al., 1992). The variation in measured force 
deficits with age and the absence of a functional decline during 4- 8 weeks of age may be 
due to the variable nature of the contractile protocols. With regard to absolute tetanic 
force (P0), skeletal muscles of mdx mice demonstrate forces that are comparable to, or 
even exceed that produced by control animals (Lynch et al., 2001). This is especially 
common when animals are experimented on between 6-12 months of age, where 
hypertrophy of limb musculature occurs in mdx mice (De la Porte et al., 1999, Hayes and 
48 
 
Williams, 1998). However, when normalised to cross sectional area to give specific force, 
peak tetanic force is consistently lower in mdx muscle relative to wild type mice.  
Twitch kinetics, in general, are reported to be similar to that of control animals 
although some groups have reported a slowing of the twitch peak tension (TTP) and half 
relaxation times (HRT). Specifically, at 9-12 days the HRT and TPT of dystrophic 
muscle remained unchanged (Grange et al., 2002). However, at 4-6 weeks, both the TPT 
and HRT were prolonged (Kometani et al., 1989). Subsequently, at 10 weeks of age, the 
twitch kinetics showed to be similar to that of control (Deconinck et al., 1998; Harcourt 
et al., 2007). At 15 weeks a slowing of TTP and HRT has been reported (Watchko et al., 
2002). In contrast, at 13-52 weeks, faster TTP and HRT responses were obtained from 
mdx muscles (Pastoret & Sebille, 1993). Another study demonstrated that dystrophic 
muscle at 24 weeks reached peak tension significantly faster than controls (Hakim & 
Duan, 2012). However, HRT was prolonged at this age. The same pattern of decrease in 
TPT and increase in HRT was observed for dystrophic muscles at 20 months (Hakim & 
Duan, 2012).  Again, the differences for changes in TPT and HRT may be related to 
differences in experimental methods of dystrophic muscles. 
The impairment in the capacity of limb muscles in mdx mice to develop force 
early in life suggests that transient impairment in regenerated fibres may account for the 
decline in force development (Pastoret & Sebille, 1997). Embryonic and neonatal muscle 
fibres are known to have low capacities for the generation of force and the continued 
presence of embryonic and neonatal isoforms of myosin in regenerating muscle fibres in 
mdx mice may contribute to the functional impairments (Reisser et al., 1985; DiMario et 
al., 1991). Throughout later stages of the dystrophic phenotype, the hypertrophied state of  
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Table 1.3. Summary of studies demonstrating force deficits of normal and mdx fast-
twitch muscles following eccentric contractions. 
Study 
Age of the 
mice (wks) 
Muscle Significant force deficit 
Grange et al., 2002 1-2 EDL No 
Lowe et al., 2006 4  EDL Yes 
Chan et al., 2007 4-8 EDL No 
McArdle et al., 1991 5-6 EDL No 
Deconinck et al., 1998 6-8 Diaphragm Yes 
Deconinck et al., 1998 6-8 SOL Yes 
Deconinck et al., 1998 6-8 EDL No 
Dellorosso et al., 2001 8-12 TA Yes 
Harcourt et al., 2007 10 EDL Yes 
Deconinck et al., 1998 10 EDL Yes 
Raymackers, 2003 12 EDL Yes 
Petrof et al., 1993 12-15 EDL Yes 
Consolino & Brooks, 2004 20 EDL Yes 
Lynch et al., 2001 24-152 EDL Yes 
Head et al., 1992 >45 EDL Yes 
Chan et al., 2007 24- 28 EDL Yes 
EDL, extensor digitorum longus; SOL, soleus; TA, tibialis anterior.
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fast and slow muscles with no concomitant increase in force reflects an increase in non-
contractile tissue, likely due to the presence of degenerating and necrotic fibres.  The 
presence of non-contractile tissue results in lower values for normalized force in fast and 
slow twitch muscle types in older mdx mice (Faulkner et al., 1993). 
Fibre type composition 
Due to variations in fibre type composition of different muscles and frequency of 
their usage, the effect of the absence of dystrophin on overall muscle function and 
vulnerability to damage may not be uniform across different muscle types. Fast twitch 
fibres are known to be involved early in the progression of the dystrophic phenotype due 
to their size (smaller surface area to volume ratio) and lipid composition (less PUFAs) 
(Macpherson et al., 1996; Lieber & Friden, 1988). Soleus (predominantly type I fibres) 
has a higher resistance to exercise induce injury compared to EDL (majority type II 
fibres), possibly due to its involvement in activities such as maintenance of posture and 
balance (Passaquin et al., 2002). Experiments that relied on contractile damage similar to 
EDL in vitro demonstrated no difference in the susceptibility of soleus from both mdx 
and control mice to contraction-induced injury, suggesting the need for a more intense 
stretch injury protocol (Moens et al., 1993; Consolino & Brooks, 2007, Chamberlain et 
al., 2007). This resistance of soleus to damage may be explained by the high content of 
type I fibres (Table 1.4) (Augusto et al., 2004; Smith et al., 2013), and possible utrophin 
compensation. Type I fibres have a greater surface area to volume ratio that enables them 
to withstand forces produced by intense contractions. Moreover, type I fibres in mdx 
muscle demonstrate 3-4 times more up regulation of utrophin than type II fibres, 
providing compensation for stability of sarcolemma to damage (Selsby et al., 2012).
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Table 1.4. Fibre type composition of wild type adult mouse extensor digitorum longus 
and soleus. 
Data from Smith et al., 2013; EDL, extensor digitorum longus; SOL, soleus. 
  
 Type I Type IIA Type IID/X Type IIB 
EDL Less than 1% ~1% ~19% ~71% 
SOL ~32% ~42% ~15% ~1% 
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In mdx with increased age and moving from immature to more mature and older 
mice, the proportion of type I and II fibres undergo changes. In EDL, which is type II 
dominant, there was no difference in the proportion of type I fibres at 4 weeks compared 
to wild-type.  However, at 16 weeks, the proportion of type I fibres mildly increased as a 
result of changes in the activity of the original motor neurons, possibly as a compensatory 
response to muscle weakness (Carnwath & Shotton, 1986). At 24-32 weeks, type II fibres 
show a further decrease in number. In soleus, which is type I dominant, at the age of 6 
weeks there is no apparent fibre type alteration.  However, at 18 weeks, a decrease of 
type II fibres in mdx soleus was reported (Pastoret & Sebille, 1993). At 26 weeks there is 
a more pronounced shift from type II to type I fibres, with a rise of type I from 28% at 3 
weeks, to 58% at 26 weeks (Pastoret & sebille, 1993; Massa et al., 1997). A change in 
fibre type population in soleus is believed to attenuate muscle weakness as a result of 
dystrophic damage and helps to compensate the developed myopathy in mdx muscle.  
Membrane lipid composition 
Membrane lipid composition can influence integral and peripheral membrane 
proteins indicating the importance of membrane lipid composition as an essential 
modulator of cellular function. Analysis of mdx muscle membrane lipid composition with 
time-of-flight secondary ion mass spectrometry (TOF-SIMS) showed an increase in the 
ratio of 16:0 and 18:0 saturated fatty acids at 3 weeks of age in degenerated areas 
(Touboul et al., 2004). Although this age coincides with the onset of acute degeneration 
in mdx skeletal muscles, membrane phospholipid   mp      n a   a      a     a n’     n 
examined. Whole tissue analysis of phospholipid composition in mdx muscle 
demonstrated less PC and more PE and SM content during 8-10 weeks (Owens & 
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Hughes; 1970). Additionally, at 11-12 weeks, matrix-assisted laser desorption/ionization 
(MALDI) TOF mass spectrometry and tandem mass spectrometry analysis of 
phospholipid composition in skeletal muscle of mdx mice indicated a reduced 34:2 to 
34:1 FA ratio in PC between highly diseased versus less impacted regions (Benabdellah 
et al., 2009). It was inferred that the reduced 34:2 to 34:1 FA ratio in PC was due to a 
decrease in 18:2n6 to 18:1 FA ratio (assuming 16:0 being the other FA of PC). 
Subsequently, at 12 weeks, study on isolated mouse quadriceps demonstrated lower 
abundance of 22:6n3 and higher amount of 18:2n6 and 18:1, consistent with findings at 
16-20 weeks (Tuazon & Henderson, 2012). Lower contents of 22:6n3 are consistent with 
similar finding in fore and hind limb dystrophic mdx mouse, suggesting loss due to 
oxidative damage (Owens & Hughes, 1970). However, elevation in 18:2n6 of mdx 
quadriceps demonstrates a discrepancy, given most literature show a decrease in mdx 
mice (Kunze et al., 1975; Pearce et al., 1981; Parce & Kakulus, 1980). Such alterations 
suggest that with an increase in age, the dystrophic membrane demonstrates increased 
saturation, underscoring the potential role of membrane lipid composition in the 
progression of the disease. 
Taken together, throughout the available literature on PL FA content of mdx, there 
appears to be a consistent increase in the levels of PC and SM. Among fatty acids, 
increases in 18:1 have been reported most consistently.  In addition, either decreases or 
increases in18:2n6 levels have also been observed. Furthermore, given the different fibre 
type composition of slow and fast muscle, it is plausible that reported alterations of PL 
FAs in literature are dissimilar as a consequence of the muscle examined. Moreover, 
there are limitations in literature related to gaps in information about membrane 
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composition of mdx isolated skeletal muscle at different ages. As such, to evaluate PL FA 
composition in dystrophic muscle, it is important to consider the plausible associations 
between PL FAs alterations and muscle fibre types with age. 
Membrane PL FA composition is closely associated with cellular function. Type I 
and II fibres demonstrate unique contractile, physical and metabolic characteristics. 
Differences in fibre type distribution should therefore be considered as a determining 
factor when looking at the fatty acid profile in skeletal muscle membrane PL FAs. Fast 
twitch muscle in rats demonstrate more elongated and saturated FAs than slow twitch 
muscle. Additionally, type I fibres have been linked with increased proportion of longer 
and more highly unsaturated, particularly n-3 fatty acids, in muscle membrane PLs 
(Storlein et al., 1991; Lie et al., 1994). The correlation of fibre types to membrane lipid 
composition in mice has not been studied in detail. Moreover, the fibre type composition 
has a significant impact on metabolic and contractile function of skeletal muscle. 
Membrane lipid composition, however, is determined by fibre type composition. As such, 
the phenotype of muscular dystrophy is primarily explained by the fibre type 
composition. Indeed, the differences within PL FA composition of different fibre types 
may determine variations of metabolism and contractile functions within each muscle 
type.  
Membrane permeability 
 Disruption to membrane integrity is another characteristic of the dystrophic 
phenotype. Literature that demonstrates changes in membrane permeability is dependent 
on the age of the mouse and surrogate of membrane damage (Table 1.6). These 
surrogates used in the literature can be classified in two different sizes; small (Ca
+2 
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sensitive markers, 40 g/mol; procion orange, 630 g/mol) and large (fibronectin, 450,000 
g/mol; CK, 80,000 g/mol). Examination of mdx EDL at 2 weeks of age with small Ca
+2
 
sensitive dyes revealed no change in permeability (Whitehead et al., 2006). Similarly,   
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Table 1.5. Summary of studies identifying alterations in membrane lipid profile of 
skeletal muscles in muscular dystrophy in humans and mdx mice. 
mdx mice Age Muscle 
↑18:0/18:1  n PC  f d          d a  a ; 
↑16:0/16:1  n PC  f d         ed areas4 
 
3 wks Hind limbs 
↓ PC, ↑PE, ↑SM  f 8-16 wks 2 8- 12 wks Hind and fore 
limbs 
↑PC34:2 and ↑PC34:1; ↓PC34:2/34:1 3 11-12 wks Hind limbs 
↓n-3 FA, ↑n-6 FA 5 12 wks Quadriceps 
↓16:0 and↑18:1 f        PC and PE; 
↑18:2  n PC, ↓22:6  n PE1 
16-20 wks Hind limb 
 
PC, phosphatidylcholine; PE, phosphatidyl ethanolamine; FA, fatty acid; (Pearce & 
Kakulus, 1980)
1
, (Owens & Hughes, 1970)
2
, (Benabdellah et al., 2009)
3
, (Touboul, 
2004)
4
, (Tuazon & Henderson, 2012)
5
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with application of membrane impermeable procion orange at ~ 2 weeks (9-12 days), 
membrane permeability was still unaltered (Grange et al., 2002). However, at 5 weeks of 
age, by use of Ca 
+2   
sensitive markers, membrane permeability was shown to be 
increased (Whitehead et al., 2006). Later on, at 10-14 weeks, mdx EDL demonstrated 
increased permeability to procion orange (Petrof et al., 1993; Deconinck et al., 1998). 
Detection of membrane disruptions with high molecular weight CK demonstrated 
elevated levels of this enzyme in serum at 3-7 weeks of age (McArdle et al., 1994). The 
evidence in the literature suggest that during the first 2 weeks, mdx myofibres are not 
showing any increase in membrane permeability to even small markers of damage 
(Whitehad et al., 2006; Grange et al., 2002). However, due to a rise in serum CK at 3 
weeks, it is assumed that at this age membrane disruption membranes appears, allowing 
passage of even larger markers of damage (Whitehead et al., 2006).  Increased membrane 
p  m a     y w     ma     z  ma       a n’     n    d  d    w  n 2 and 5 weeks (Ca+2 
markers increased at 5 weeks; Whitehead et al., 2006). However, due to increased CK 
levels at 3 weeks, it is assumed that the lesions in membrane were large enough to 
allowing the passage of both small and large surrogates of damage. With increased age, at 
7-15 weeks, the membrane remains permeable to both procion orange and CK (McArdle, 
1994; Deconinck et al., 1998; Petrof et al., 1993). Together, measurements with small 
markers of damage indicate no change in the membrane permeability during the first 2 
weeks but after 3 weeks, membrane lesions accommodate the passage of both small and 
large damage markers. 
Lack of evidence of abnormal muscle membrane permeability at earlier ages may 
suggest that changes in membrane permeability are a secondary effect of absence of 
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dystropin (McArdle et al., 1994, Grange et al., 2002). Support for a secondary effect of 
abnormal permeability was that, in mdx muscle, total calcium content rose acutely at an 
age that correlated with a period of necrosis and then returned to normal values during the 
regenerative phase (Reeve et al., 1997). It may be possible that altered membrane 
permeability until 3 weeks of age may not be evident because mice at this age are not 
actively moving around the cage and, therefore, contraction of muscles may be limited. 
This is consistent with the abnormal calcium homeostasis and correlates with the onset of 
contraction in mdx myotubes, suggesting that contraction is necessary before changes in 
intracellular Ca
+2
 occur (Alderton et al., 2002).  
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Table 1.6. In vivo and ex vivo surrogates of muscle damage in evaluation of membrane 
damage 
Surrogate Molecular weight Muscle       Age (wk) Membrane leak 
PO 
Calcium 
CK 
Calcium  
PO 
PO 
Fibronectin 
630 
40 
82.000 
40 
630 
630 
450.000 
EDL 
EDL 
In vivo 
EDL 
EDL 
EDL 
EDL 
1-2 
2 
3-7 
6 
10 
14 
unknown 
Neg 
1
 
Neg 
2
 
Pos 
3
 
Pos 
2
 
Pos
4
 
Pos
5
 
Pos
6 
PO, procion orange; CK, creatine kinase; EDL, extensor digitorum longus; (Grange et al., 
2002)
1
, (Whitehead et al., 2006)
2
, (McArdle, 1994)
3
, (Deconinck et al., 1998)
4
, (Petrof et 
al., 1993)
5
, (Palacio et al., 2002)
6
. 
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Statement of the problem 
The membrane structure-protein function relationship indicates that an association 
exists between membranes and their associated proteins, because  a protein can modulate 
the membrane and vice versa. Evidence suggests that the absence of dystrophin mediates 
an alteration in the lipid composition of the sarcolemma membrane. Additionally, it has 
been revealed that the underlying factor that leads to muscle pathology early in life is 
independent from dystrophin dysfunction (Lowe et al., 2006). Potential influences of 
dystrophin dysfunction on skeletal muscle membrane composition have been suggested 
including increased SFA and MUFA and deceased PUFA (Pearce & Kakulus, 1980, 
Benabdellah et al., 2009). However, these findings, for the most part, have been based on 
dystrophic changes in lipid content in mixed hind limb muscle without examining 
muscles with predominant fibre type composition. Observed changes in membrane 
damage of mdx muscle, along with changes in membrane lipid composition, raises a 
plausible association between muscle damage and membrane composition. Moreover, the 
membrane lipid composition and susceptibility of mdx fast and slow twitch muscles to 
damage is not similar across ages. As the pathological features of muscular dystrophy are 
cumulative over time, examination of the phenotype at one age group with no 
consideration of its progression may be insufficient and mask or falsely suggest the 
associated damage. To     a     ’   n w  d  , there have been no studies that have 
addressed muscle-type specific responses to eccentric induced damage and fibrosis in 
dystrophic skeletal muscle and the relationship to membrane phospholipid fatty acid 
composition in different age groups. Thus the purpose of this thesis was to examine the 
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association of membrane PL FA composition and the susceptibility of fast and slow 
twitch skeletal muscle to eccentric induced damage and fibrosis. 
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Objectives 
The primary objective of the current research was to examine the association 
between skeletal muscle membrane PL composition and the role of absence of dystrophin 
in     m     ’  susceptibility to eccentric induced damaged and fibrosis.  This objective 
was accomplished by examining the FA profile of each PL species in skeletal muscles of 
varying fibre-type composition (soleus which is predominantly type I and less susceptible 
to damage and EDL which is predominantly type II and more susceptible to damage) in a 
rodent model of muscular dystrophy, the mdx mouse.  Specifically, the PL FA 
composition in each muscle type will be correlated against eccentric induced measure of 
membrane damage (identification of inter-fibre fibronectin after in vitro eccentric 
contraction damage), and fibrosis in dystrophic muscle compared to wild type. Moreover, 
since the dystrophic pathology increases with age, a group of young (10 weeks) and older 
(20 weeks) mdx mice were selected to examine the strength of association between 
alterations in membrane PL FA compositions and muscle damage with age. 
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Hypotheses 
It was hypothesised that alterations in membrane composition (increased SFA and 
MUFA, decreased PUFA) in the absence of dystrophin protein will be positively (SFA 
and MUFA) or negatively (PUFA) correlated to increased eccentric induced muscle 
damage and fibrosis. From this main hypothesis, it can also be hypothesized that: 
i. The correlations of altered membrane lipid composition with eccentric 
induced muscle damage and fibrosis listed above will be stronger at 20 
weeks, when the dystrophic phenotype is more severe, compared to 10 
weeks. 
 
ii. EDL, which has more type II fibres, will be more susceptible to damage 
and have more significant and stronger correlations listed above compared 
to soleus, which has more type I fibres. 
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CHAPTER 2: METHODS 
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Animals 
Ten control (C57BL/10) and dystrophin-deficient (C57BL/10ScSn-Dmd
mdx
/J) mice 
at age 8 weeks were    a n d f  m Ja    n’  La   a   y  Ba  Ha     , Ma n , USA).  
All mice were housed in the Brock University Comparative Biosciences Facility in an 
environment maintained at 22±1°C with a 12:12 hour light (6:00am to 6:00pm)-dark 
(6:00pm to 6:00am) cycle. Animals had access to rodent chow (14.3% protein, 4% fat, 
48% carbohydrate; 2014 Teklad Global 14% Protein Rodent Maintenance Diet, Harlan 
Laboratories, Mississauga, Ontario) and water ad libitum. All experimental procedures 
and protocols were approved by the Brock University Research Subcommittee on Animal 
Care and conformed to the Canadian Council of Animal Care guidelines.  
Experimental design  
For the purpose of this study, two groups of 10 (n WT: 5; n mdx: 5) and 20 (n WT: 5; 
n mdx: 5) week old mice were selected. Both extensor digitorum longus (EDL) and soleus 
(SOL) were isolated from hind limbs. One EDL and SOL was maintained as a control, 
while the muscles of the contralateral limb were used for stretch injury. After the stretch 
protocol, both stretched and control muscles were dissected into three equal parts, with 
the middle 1/3 used for histochemistry and the two proximal and distal 1/3 of muscle 
were snap frozen for lipid analysis (Fig. 2.1). 
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Figure 2.1. Over view of experimental design. WT, wild type; EDL, extensor digitorum 
longus; SOL, soleus.  
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In vitro muscle preparation 
Muscle isolation 
Each mouse was anesthetised through an intraperitoneal injection of sodium 
pentobarbital (60 mg/kg body weight). EDL and SOL from both hind limbs were 
removed. Specifically, the EDL proximal tendon was located lateral to the knee under the 
distal end of the rectus femoris, looped with 6-0 silk suture and cut at this point to 
maximize the length of the tendon stump. Tendon sutures were tied as close to the 
myotendinous junction as possible, but not in contact with the muscle fibres. Optimum 
placement of the sutures ensured less contribution of the tendon to compliance, and 
minimized failure of this attachment during stimulation. The distal tendon was located 
under the tibialis anterior (TA) tendon, loop sutured and all tendons leading to the toes 
were cut before removing the muscle. For dissection of SOL, first the distal achilles 
tendon (which includes the distal soleus tendon) was cut from tuber calcanei. This was 
followed by peeling all posterior compartment muscles away from the rest of the limb. 
The distal tendon of SOL was localized at the most posterior tendon of the peeled 
compartment and sutured. The proximal SOL tendon was identified on the interior 
surface of the muscles close to the knee, loop sutured and cut as close as possible to the 
back of the knee to maximize the length of the tendon stump. All the dissected muscles 
were placed into oxygenated Ringer solution (137mM NaCl; 24 mM NaHCO3; 11 mM d-
glucose; 5 mM KCl; 2 mM CaCl2; 1 mM NaH2PO4H2O; 1 mM MgSO4; 0.025 mM d-
tubocurarine chloride) at 25 ºC to equilibrate for 20 min.  
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Muscle attachment to apparatus 
After equilibration, EDL and SOL were maintained at resting length in bathing 
solution by using the silk sutures of proximal and distal end as anchors to maintain 
resting length. Resting length was achieved at a length in which the muscle was not 
stretched or compressed.  The contralateral muscle was mounted to the servomotor 
controlled by a dual-mode lever system (305B acquired through a 604C analog to digital 
interface) with one end of the muscle tied to the immovable pin, and the other end 
attached to the lever arm of the position feedback servomotor. Muscle stimulation was 
applied using flanking platinum electrodes driven by a Model 701B biphase stimulator 
(Aurora Scientific, Inc.). All aspects of muscle isolation, stimulation, servomotor control, 
force assessments and software control were performed by W. Gittings. 
 
Eccentric induced muscle damage 
Establishment of optimum length 
Muscles were adjusted to the optimum length (Lo) for the development of 
isometric twitch force. The muscles were stimulated with a single electrical pulse to 
produce a twitch response. Stimulation voltage was that which produced a maximal 
twitch response. Muscle length was adjusted very carefully and in small increments (or 
decrements) to longer (or shorter) lengths with 30 seconds of rest between twitch 
responses. Lo was achieved when twitch force was maximal. To measure Lo, the length 
between the myotendinous junctions was recorded using a graded magnifier and 
monitored prior to and after muscle stimulation to ensure Lo was maintained.  
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Establishment of frequency-force relationship 
Once Lo was achieved, the frequency force relationship was established. The 
muscle was stimulated at increasing frequencies, typically 10, 30, 50, 80, 100, 120, 150, 
180, 200, and 250 Hz for a period of 500 msec with periods of 3 minutes rest between 
stimuli. Maximum absolute isometric tetanic force (Po) was determined from the plateau 
of the frequency-force relationship. The plateau was achieved at 150 Hz for EDL and 100 
Hz for SOL.  
  Maximum isometric twitch and tetanus force 
  To provide a baseline for comparison, muscles were stimulated at 150 Hz for 
EDL and 100 Hz for SOL for 500 ms to obtain control maximum isometric tetanus. After 
3 minutes of rest, muscles were stimulated at 80 Hz for 0.2 ms to obtain the maximum 
isometric twitch force. The control maximum twitch and tetanic isometric force were 
measured and normalized for muscle cross section by dividing the mass of the muscle (g) 
by the product of its length (Lo, cm) and density (1.06 g/cm
3
) and expressed in square 
millimetre. 
 
EDL stretch injury 
In vitro eccentric damage for EDL was conducted as per Petrof et al. (1993). 
Briefly, muscles were left quiescent for 10 min. After establishment of Lo, maximum 
isometric twitch and tetani, muscles were stimulated at 80 Hz for 700 ms.  During the 
initial 500 ms of stimulus, muscles were maintained at their Lo (isometric contraction) 
and the last 200 ms, stretched at rate of 0.5 Lo/sec) to yield a total displacement of 0.1 Lo 
creating an eccentric contraction. With 4 minutes of rests in between each contraction, 
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muscle stretch injury was repeated five times. Post twitch and tetanic responses was 
obtained immediately and 15 minutes after the last stretch injury contraction.    
 
SOL stretch injury 
SOL damage was completed following Warren et al. (1994). Briefly, muscles 
were left quiescent for 10 min and Lo was determined. Initial measurements included 
isometric twitch force with a 0.5 ms pulse at 80 Hz and tetanic force at 500 ms trains of 
0.5 ms pulses at 100 Hz spaced 3 minutes apart. For stretch injury, muscle length was 
initially shortened from Lo to 0.9Lo followed by immediate lengthening from 0.9 Lo to 1.1 
Lo (V: 1.5 L0/S). During lengthening, SOL was stimulated at 125 Hz for 133 ms. 
Eccentric contractions was repeated 10 times with 4 minute of rest in between each series 
of stretch injury. Post injury measurements were obtained immediately and 15 minutes 
after last stretch injury contraction. 
 
Specific force calculation 
To obtain normalized forces from EDL and SOL and control for existing 
hypertrophy in mdx myofibres, the cross sectional area for each muscle was determined 
by dividing the mass of muscle (g) by the product of its optimum fibre length (Lf) and 
density of mammalian muscle (1.06 mg/mm
3
), and presented as specific force (sP; 
equation below).  Lf was determined by multiplying Lo by the previously determined 
muscle length to fibre length ratio, 0.44 for the EDL and 0.71 for the SOL (Brooks & 
Faulkner, 1988). 
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sP (g/mm
2
) = Tetanic or twitch force / (muscle mass/ Lf * 1.06)  
 
Histochemistry and Immunohistochemistry 
Muscle Embedding 
After stretch injury, the mid 1/3 of both damaged and control muscles from EDL 
and SOL were mounted on a small mound of cryomatrix on cork plates and cooled in 
methylbutane as per Steinbrecht & Zierold (1984). 
 
Fibronectin 
 Immunohistochemistry was completed on 5 µm sections obtained from a cryostat 
(HM 560 MV, Thermo Fischer Scientific) at -20 
o
C to identify intracellular accumulation 
of fibronectin as a marker of eccentric induced injury. This was achieved through the use 
of an avidin biotin complex method (Wilchek, 1935). To ensure proper tissue adhesion, 
superfrost colorfrost (VWR, PA) micro slides were used. Briefly, to further increase the 
adherence of tissue to the slides, tissue sections were initially fixed in cooled acetone (-20 
º 
C) for 15 minutes. After washing (3 times for 5 minute in Tris-buffered saline (TBS)), 
slides were incubated for 10 minutes at room temperature in 3% H2O2 diluted in 
methanol to block endogenous peroxidase activity. After another wash in TBS, non-
specific binding was blocked with 250 µl of blocking buffer (5% bovine serum albumin, 
0.3% triton X100 in TBS) for 30 min. Without washing, 250 µl of primary anti-mouse 
fibronectin monoclonal antibody produced in rabbit (Sigma) previously diluted to 1/100 
in blocking buffer was applied to the slide sections for 2 hours at room temperature. After 
washing with TBS (3 times for 5 min), 250 µl of anti-rabbit secondary biotinylated 
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antibody (Sigma) diluted to 1/150 in blocking buffer was applied to each tissue section 
for 30 min at room temperature. After another session of washing with TBS (3 times for 5 
min), 150 µl of strepavidin peroxidase was added to each slide for 30 min at room 
temperature and washed after in TBS (3 times for 5 min). Avidin peroxidase was 
previously prepared by m x n  10 μL  f av d n and 10 μL  f      n-peroxidase in 1 mL of 
TBS. To prepare the slides for visualization, slides were incubated for 1-2 min in 250 µl 
of  3, 3’d am n   nz d n  (DAB) diluted to 1% in double distilled water (DDW). DAB is 
oxidized in the presence of peroxidase resulting in the deposition of a golden brown 
precipitate at the site of enzymatic activity. DAB development was closely monitored 
followed by immediate immersion in DDW after precipitation. Finally, slides were 
washed in DDW 2 times for 3 min. Negative controls (no application of primary 
antibody) were used to determine non-specific binding of secondary antibody. Four 
regions (each 0.07 mm
2
, accounting for 20% of total cross section area)
 
of each slide 
were randomly selected and all the immune reactions were identified. The selected 
regions were scored to quantify the magnitude of fibronectin entry as a percentage of 
fibronectin-positive fibres on each muscle section (mean ± SE). 
 
Masson’s trichrome staining 
Ma   n’         m    a n n  wa     d    quantify fibrosis (collagen 
accumulation) and regeneration (centralized nuclei) in muscle sections as per Ruegg and 
Meinen (2014). Briefly, 12 µm sections on superfrost slides (VWR) were incubated in 
10% formalin and Bouin solution for 1 and 12 hours, respectively followed by 2 minutes 
of washing under running tap water followed by 1 min of wash with DDW. Slides were 
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treated with hematoxylin achieved by mixing equal parts of Weigert iron hematoxylin A 
(1% hematoxylin in ethanol) & B (30% ferric chloride and 7.5% HCL in DDW) 
(Trichrome staining kit, Sigma) for 5 minutes and washed in DDW for 3 minutes. Scarlet 
acid fuchsin/ Biebrich scarlet acid fuchsin (0.9 % Biebrich scarlet, 0.9% fuchsin, 1% 
acetic acid) was used for cytoplasm staining for 5 minutes, and washed for 3 minutes in 
DDW. To prepare the uptake of aniline blue that stains the collagen fibres dark blue, 
slides were incubated with phosphotungstic and phosphomolybdic acid (1 volume of 
phosphotungstic, 1 volume of phosphomolybdic and 2 volumes of DDW) for 10 minutes. 
Each section was incubated with aniline blue (2.5% in 2% acetic acid) and washed in 
DDW after 5 minutes. Slides were dehydrated in ascending concentration of ethanol at 
70%, 80%, 90%, 100% and xylene (98.5% xylenes in ethylbenzene basis) each for 3 min. 
Finally, slides were mounted with 1 drop of xylene based mounting media (Depex, Fisher 
Scientific) and stored at room temperature. High magnification photographs of each 
muscle cross section were taken using a computer based image processing software (NIS 
elements; series 4, Nikon & Image-Pro 7.0.1). Muscle cross-sectional area was measured 
manually by drawing around the outer border of the fibre. Fibrotic areas stained in blue 
were quantified in the whole cross section by drawing around each area, divided by the 
muscle cross-sectional area and reported as percentage of fibrosis across the muscle. 
Total fibres and fibres with centralized nuclei were identified manually in 4 region of 
muscle (each 0.07 mm
2 
for ~20% of cross section), and reported as percentage of 
regenerated fibres. 
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Myosin ATPase staining 
Myosin ATPase was quantified as per Brooke & Kaiser (1970).  Briefly, sections 
of muscle (12 µm) were pre-incubated in alkaline solution (alkaline solution: 7.05% 
glycine, 18 mM calcium chloride, 0.1 N sodium hydroxide in DDW, pH 10.2) for 15 
minutes. After rinsing, tissue sections were incubated in ATP solution (2.7 mM ATP 
dissolved in alkaline solution, pH 9.4) for 15 minutes. After 3 washes with 1% calcium 
chloride, slides were incubated with 2% cobalt chloride. Final step was completed by 
incubating the slides for a few seconds in 1% ammonium sulfide used to provide a black 
precipitate.  Slides were then dehydrated by submersing in rising concentration of ethanol 
at 70%, 80%, 90%, 100% and xylene (Sigma, cat no. 247642) each for 3 min. Finally, 
slides were mounted with 1 drop of xylene based mounting media (Depex, Fisher 
Scientific) and stored at room temperature.  
 
Lipid analysis 
Lipid extraction 
Frozen muscle samples were homogenized in 10 volumes of Tris HCL (pH 8.0).  
Lipids were extracted from the homogenate according to Bligh & Dyer (1959). Briefly, 
70 µl of whole muscle homogenates were added to 3.75 ml of chloroform: methanol (1:2) 
supplemented with 0.1% butylated hydroxytoluene and vortex for 2 minutes. Samples 
were vortexed briefly after the addition of 1.25 ml of chloroform. DDW was added (1.25 
ml), samples were vortexed and spun at 720g for 6 minutes. Lipids were then isolated by 
collecting the bottom chloroform phase, and stored at –20°C until further analysis. 
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Thin layer chromatography 
Thin layer chromatography (TLC) was used to separate individual PL species as 
per Mahadevappa and Holub (1987). Briefly, pre-coated silica gel 60 plates (EMD, 
Mississauga, ON, CA) were heated at 110°C for 20 minutes and kept in a desiccating 
chamber to cool before use. Samples were dried down under nitrogen and re-suspended 
in chloroform: methanol (2:1) and spotted onto the plate. The plates were then placed in a 
chamber containing a solvent system (chloroform: methanol: acetic acid: water; 
50:37.5:3.5:2) for approximately 2 hours. The plate was removed and set to dry before 
being sprayed with dichloroflouroscene (DCF) solution (1:1 methanol: water and 2',7'-
DCF filtered and washed with petroleum ether) and set in a chamber containing 25% 
ammonium hydroxide in DDW for 5 minutes to develop. The plate was viewed under 
ultraviolet light and the bands marked (from origin: sphingomyelin, phosphatidylcholine, 
phosphatidylserine, phosphatidylinositol, phosphatidylethanolamine, cardiolipin) and 
scraped into individual 15mL kimex tubes. 
 
Methylation 
The scrapings were methylated as per Mahadevappa & Holub (1987). In brief, 6% 
H2SO4 in methanol was added to each tube with 10 µg of internal standard (tridecanoic 
acid; 13:0) and incubated at 80°C for 2 hours. Samples were allowed to cool, 1 mL of 
water and 2 mL of petroleum ether were added, and the solution was vortexed before 
being centrifuged for 6 minutes at 720g. The top phase was extracted and put into a 
microvial (Fisher Scientific, CA, USA), dried down under nitrogen and resuspended in 10 
µL of dichloromethane for analysis by gas chromatography. 
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Gas chromatography 
The FA composition of each PL was analyzed by gas chromatography (GC; 
Bradley, et al., 2007). A 1 μ   amp    f fa  y a  d m   y          FAME) f  m  a   
sample was injected into a GC (Trace GC Ultra, Thermo Electron Corp, Milan, Italy) 
supplied with a split/splitless injector, a fast flame ionization detector (FFID), and Triplus 
AS auto sampler (Trace GC Ultra, Thermo Electron Corp, Milan, Italy). With helium as a 
carrier gas, FAMEs were separated on a UFM RTXWAX analytical column (Trace GC 
Ultra, Thermo Electron Corp, Milan, Italy) and identified by comparison of their 
retention times with those of a known standard solution (Supelco 37 component FAME 
mix, Supelco, Bellefonte, PA, USA). The areas of each individual peak were converted to 
concentrations with the aid of tridecanoic acid (13:0) as the internal standard.  
 
Statistical analysis  
Values are expressed as mean ± standard error (SE). To assess differences 
between groups (WT vs. mdx) and age (10 wks and 20 wks), a two way analysis of 
va  an    ANOVA) wa     d  R        am, A     a, V  nna, 2013). P        T   y’       
was used to determine differences within groups and ages for variables of interest (fibre 
type composition, PL FA composition, intracellular fibronectin, fibrosis, and twitch 
characteristics).  Linear correlations between variables (PLFA composition, intracellular 
fibronectin and fibrosis) were determined with Pearson correlation coefficients. Statistical 
significance was defined as P < 0.05 for all analysis.  
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CHAPTER 3: RESULTS  
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Morphometric 
At 10 weeks of age, body mass was similar between mdx (29.2 ± 3.9g) and WT 
(25.2 ± 1.0g), however at 20 weeks of age, mdx mice were significantly heavier (35.5 ± 
1.5g) compared to 20 week old WT (28.9 ± 3.3g) and 10 week old mdx. Both EDL and 
SOL muscle masses were greater in mdx compared to WT for both age groups (Table 
3.1). Cross sectional areas and percent fibre types were similar between genotypes and 
ages for each muscle, with the exception that type I fibres were higher and type II fibres 
were lower in EDL of 20 week old mdx compared to 10 week olds. 
 
Contractile properties before and after the stretch injury 
A series of 5 eccentric contractions at the rate of 0.5 Lo/S in dystrophic EDL at 10 
weeks resulted in ~30% decline in maximum isometric twitch after 15 min of fatigue 
recovery, which was ~2.5 times greater than the WT (Table 3.2). At 20 weeks, there was 
an ~55% depression in force output in mdx EDL, compared to ~4.5 % in WT. Moreover, 
the lengthening contractions resulted in 25% tetanic force depression in mdx EDL at 10 
weeks, which was ~2 times greater than in WT. At 20 weeks, force declined to 65% after 
15 min of rest, which was ~3 times more than that of WT. The half relaxation time (HRT) 
and time to peak tension (TPT) of dystrophic and WT EDL remained unaltered across 
both 10 and 20 weeks. 
In SOL, after 10 eccentric contractions at 1.5 Lo/S and 15 minutes of fatigue 
recovery, the isometric twitch and tetanic responses remained unchanged across WT and 
mdx at 10 and 20 weeks (Table 3.3). After recovery from fatigue, the HRT and TPT were 
unaltered across dystrophic and WT SOL at 10 and 20 weeks. 
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Table 3.1. Body mass, muscle mass, muscle cross sectional area and percent fibre type of 
extensor digitorum longus and soleus muscles for 10 and 20 week old wild type and mdx 
mice. 
 Body 
mass 
(g) 
 EDL  SOL 
Mass 
(g) 
XSA 
(mm
2
) 
L0  
(mm) 
Type I 
Fibres 
(%) 
Type II 
Fibres 
(%) 
Mass 
(g) 
XSA 
(mm
2
) 
L0 
(mm) 
Type 
I 
Fibre
s (%) 
Type 
II 
Fibre
s (%) 
WT-
10 
27.7 ± 
0.5 
12.7 ± 
1.6 
2.2 ± 
0.2 
11.8 ± 
0.1 
5.0 ± 
2.0 
95.7 ± 
5.5 
14.1 ± 
2.7 
1.3 ± 
0.2 
12.2 
± 0.1 
36.3 
± 7.1 
64.7 
± 2.2 
mdx-
10 
27.8 ± 
0.2 
18.2 ± 
6.1 
3.0 ± 
1.4 
11.9 
±0.3 
5.1 ± 
2.4 
96.0 ± 
2.4 
18.7 ± 
4.8* 
2.2 ± 
0.7 
11.9 
± 0.2 
40.7 
± 8.5 
60.0 
± 5.5 
WT-
20 
31.7 ± 
0.2 
12.9 ± 
2.8 
1.1 ± 
0.3 
12.2 ± 
0.3 
7.2 ± 
1.3 
93.8 ± 
4.3 
15.6 ± 
2.0 
1.0 ± 
0.2 
12.7 
± 0.2 
38.4 
± 4.1 
63.6 
± 4.1 
mdx-
20 
35.4 ± 
0.2 
18.8 ± 
3.6* 
1.4 ± 
0.2 
12.4 ± 
0.2 
18.5 ± 
1.3*† 
82.9 ± 
6.0*† 
19.4 ± 
2.2* 
1.1 ± 
0.3 
13.1 
± 0.2 
43.2 
± 2.8 
57.3 
± 4.4 
Values are mean ± SEM; n=5; EDL, extensor digitorum longus; SOL, soleus; WT-10, 
wild type 10 weeks old; WT-20, wild type 20 weeks old; mdx-10, mdx 10 weeks old; 
mdx-20, mdx 20 weeks old; XSA, cross sectional area; * denotes significantly different 
f  m WT  f      am  a  ; † d n        n f  an  y d ff   n  f  m 10 w  . 
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Table 3.2. Contractile parameters obtained from EDL of WT and mdx at 10 and 20 weeks of age.  
EDL WT mdx 
 10 wks 20 wks 10 wks 20 wks 
Control Post 15min 
Post 
Control Post 15min 
Post 
Control Post 15min 
Post 
Control Post 15min 
Post 
Twitch 
(g/mm
2
) 
1.93 ± 
0.3 
1.19 ± 
0.4 
1.20 ± 
0.34 
2.25 ± 
0.34 
1.58 ± 
0.34 
 
1.46 ± 
0.33 
1.59 ± 
0.40 
0.95 ± 
0.31 *
 
0.97 ± 
0.26 *
 
1.6 ± 
0.26 
0.54 ± 
0.09 
*†¥ 
0.72 ± 
0.06 
*†¥ 
Tetanus 
(g/mm
2
) 9.5 ± 1.3 
6.98 ± 
1.57 
7.74 ± 
1.69 
10.4 ± 
1.45
 
7.86 ± 
1.26 
8.68 ± 
1.45 
6.7 ± 1.6 
3.79 ± 
1.02 *
 
4.74 ± 
1.15 * 
6.59 ± 
0.95 
1.96 ± 
0.58 
*†¥ 
3.36 ± 
0.65 
*†¥ 
Twitch 
HRT 
(ms) 
27.1 ± 
7.4 
9.8 ± 1.3 
22.8 ± 
5.9 
21.4 ± 
2.1 
12.1 ± 
0.9 
19.2 ± 
3.1 
23.1 ± 
2.6 
16.5 ± 
2.8 
23.1 ± 
4.2 
22.5 ± 
4.7 
15.2 ± 
1.1 
24.6 ± 
2.2 
Twitch 
TPT 
(ms) 
19.2 ± 
2.8 
16.0 ± 
0.4 
17.3 ± 
0.8 
21.4 ± 
1.5 
16.4 ± 
1.2 
17.1 ± 
0.6 
18.3 ± 
0.8 
17 ± 0.4 
16.5 ± 
1.3 
20.9 ± 
3.5 
17.7 ± 
1.9 
17.3 ± 
1.4 
Values are expressed as mean ± SEM; EDL, Extensor digitorum longus; WT, Wild type; HRT, half relaxation time; TPT, time to peak 
tension * denotes significant from controls. † d n        n f  an   from WTs within same age. ¥ denotes significance from 10 wks 
within same genotype. 
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Table 3.3. Contractile parameters obtained from SOL of WT and mdx at 10 and 20 weeks of age.  
SOL WT mdx 
 10 wks 20 wks 10 wks 20 wks 
Control Post 15min 
Post 
Control Post 15min 
Post 
Control Post 15min 
Post 
Control Post 15min 
Post 
Twitch 
(g/mm
2
) 
1.51 ± 
0.21 
1.10 ± 
0.17 
1.19 ± 
0.19 
1.61 ± 
0.10 
1.16 ± 
0.08 
¥ 
1.21 ± 
0.08 
0.95 ± 
0.2 
0.60 ± 
0.15
 
0.67 ± 
0.16
 
1.44 ± 
0.18 
0.8 ± 
0.11
 
0.94 ± 
0.12
 
Tetanus 
(g/mm
2
) 
9.49 ± 
0.88 
8.63 ± 
0.76 
8.80 ± 
0.76 
10.03 ± 
0.64 
8.9 ± 0.6 
9.11 ± 
0.71 
6.3 ± 
1.17 
5.66 ± 
0.99 *
 
5.75 ± 
1.02 
10.00 ± 
1.21 
8.52 ± 
0.99 *
 
8.53 ± 
0.99
 
Twitch 
HRT 
(ms) 
38.7 ± 
2.1 
32.5 ± 
4.7 
32.4 ± 
1.3 
51.9 ± 
2.1 
48.3 ± 
4.1 
43.4 ± 
1.7 
61.3 ± 
4.2 
60.2 ± 
3.9 
58.4 ± 
2.1 
58.9 ± 
5.2 
51.7 ± 
3.6 
55 ± 4.6 
Twitch 
TPT 
(ms) 
37.2 ± 
2.1 
35.2 ± 
3.8 
34.8 ± 
2.7 
38.7 ± 
2.0 
36.2 ± 
6.1 
36.1 ± 
3.1 
32.5 ± 
2.1 
31.1 ± 
3.6 
31.3 ± 
2.7 
33.9 ± 
1.8 
31.7 ± 
1.5 
30.5 ± 
2.4 
Values are expressed as mean ± SEM; SOL, Soleus; WT, Wild type; HRT, half relaxation time; TPT, time to peak tension. * denotes 
significant from control. 
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Membrane composition 
Membrane lipid analysis demonstrated decreased PC and increased SM in 
dystrophic EDL at 10 and 20 weeks compared to WTs (Fig. A.4). In general, among the 
four major FA classes, MUFA were increased and n6 PUFA were decreased in mdx EDL 
at 10 and 20 weeks compared to WTs. Specifically, among PL species, 18:0 and MUFA 
(mainly 18:1) were increased and PUFA (mainly 18:2n6) was decreased in mdx EDL 
compared to WT at 10 and 20 weeks in PC and PS (Table A.1, Table A.4). Moreover, 
MUFA (mainly 18:1) was increased and n6 PUFA were decreased in mdx EDL at 20 
weeks in SM and PE compared to WT (Table A.2, Table A.3). In PI and CL FAs, there 
was an increase in MUFA and a decrease in PUFA in mdx at both age groups compared 
to WTs (Table A.5, Table A.6). 
In SOL, among PL classes, CL was increased in mdx at 10 and 20 weeks 
compared to WTs. In general, MUFA remained unchanged at 10 weeks in dystrophic 
phenotype compared to WTs but increased at 20 weeks. Moreover, n6 PUFA was 
decreased at 10 and 20 weeks in mdx compared to WTs (Fig. A.7). Specifically in CL, 
SM, and PE, there was increased MUFA with decreased n6 PUFA in mdx SOL in 20 
weeks compared to WT (Table A.7-A.9). In PC, only MUFA were increased in mdx at 10 
and 20 week (Table A.10). Finally, in PI and PS, MUFA was increased and PUFA 
(mainly 18:2n6) was decreased (Table A.11, Table A.12).  
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Eccentric induced muscle damage 
Intracellular fibronectin 
In general, the percentage of total fibres that were fibronectin positive did not 
differ between stretched and non-stretched EDL (Fig 3.1). The only exception was that 
the percentage of fibronectin-positive fibres was higher in stretched 20 week old mdx 
compared to non-stretched 20 week old mdx, 20 week old WT, and 10 week old mdx. 
The percentage of total fibres that were fibronectin positive did not differ between 
stretched vs. non-stretched SOL (Fig 3.2). However, the percent fibronectin-positive 
fibres were higher in both non-stretched and stretched 20 week old mdx SOL compared 
to 10 week old mdx and 20 week old WT. 
Overall, type II fibres in both EDL and SOL muscles of WT and mdx in both age 
groups were the majority of fibres with intracellular fibronectin (Fig 3.1 and Fig. 3.2). In 
EDL, the ratio of fibronectin positive type I to type II fibres was increased in 20 wks old 
mdx compared to their WTs, but the ratio remained unchanged in 10 wks old mdx mice. 
In SOL, the ratio was unaltered in mdx at both 10 and 20 week. Moreover, in SOL 
independent of membrane damage, the proportion of type I and II fibres positive 
forfibronectin remained unchanged across WTs and mdx at both age groups. 
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Figure 3.1. Percent fibronectin-positive fibres in wild type and mdx stretched and non-
stretched extensor digitorum longus muscle at 10 and 20 weeks of age. Percentage of 
fibronectin positive fibres represents the fibres with intracellular fibronectin divided by 
the total number of fibres. Type I and II fibres represent the fibres with intracellular 
fibronectin from stretched muscle. Values are mean ± SEM; WT, wildtype; * denotes 
significance from non-stretched; † d n        n f  an   f  m WT w    n the same age 
group; ¥ denotes significance from 10 weeks of age within the same genotype; + denotes 
significance from type I fibres. 
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Figure 3.2. Percent fibronectin-positive fibres in wild type and mdx stretched and non-
stretched soleus muscle at 10 and 20 weeks of age. Percentage of fibronectin positive 
fibres represents the fibres with intracellular fibronectin divided by the total number of 
fibres. Type I and II fibres represent the fibres with intracellular fibronectin from 
stretched muscle. Values are mean ± SEM; WT, wildtype; † d n        n f  an   f  m 
WT within the same age group; + denotes significance from type I fibres. 
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Influence of membrane lipid composition on eccentric induced muscle damage 
To assess the correlation of membrane lipid composition on eccentric induced 
muscle damage, only the PL and FAs that significantly changed in EDL or soleus were 
selected.   
For SM FA, the general trend was that saturated and monounsaturated fatty acids 
demonstrated a positive correlation with percent fibronectin-positive fibres whereas 
polyunsaturated fatty acids were negatively correlated (Fig 3.3).  Specifically, SM 16:0 
(10 wks; r: 0.73, p: 0.04, 20 wks; r:0.12, p:0.05), 18:0 (10 wks; r: 0.97, p:0.02, 20 wks; 
r:0.42, p: 0.04), and 18:1 (10 wks; r:0.67, p:0.03, 20 wks; r: 0.59, p: 0.03) were 
significantly positively correlated with percent fibronectin- positive fibres in both 10 and 
20 week old mdx EDL. In contrast, only 20 week old WT SM 16:0 (r=0.89, p=0.03), 18:0 
(r=0.39, p=0.04), and 18:1 (r=0.31, p=0.05) were significantly positively correlated to 
percent fibronectin-positive fibres. SM 18:2n6 was significantly negatively correlated in 
10 week old mdx (r=-0.73, p=0.03) and WT (r=-0.77, p=0.03) and approached 
significance (p=0.07) in 20 week old mdx. 
 For PC FA, the general trend was 16:0 and 18:2n6 demonstrated a negative 
correlation with percent fibronectin-positive fibres whereas 18:0 and 18:1 demonstrated a 
positive correlation (Fig 3.4).  Specifically, these correlations were significant in mdx for 
all PC FA in both age groups (16:0 at 10 wks mdx; r=-0.63, p=0.02, 16:0 at 20 wks mdx, 
r=-0.81, p=0.07, 18:0 at 10 wks mdx; r:=0.93, p=0.01, 18:0 at 20 wks mdx; r=0.59, 
p=0.04, 18:1 at 10 wks mdx, r=0.83, p=0.04; 18:1 at 20 wks mdx, r=0.89, p=0.01; 18:2n6 
at 20 weeks mdx, r=-0.74, p=0.04), with the exception of 18:2n6 at 10 weeks of age.  In 
contrast, significance was only found with 18:0 (r=0.79, p=0.01), 18:1 (r=0.88, p=0.04),  
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Figure 3.3. Linear fitted regression model of eccentric induced damage correlated with 
membrane sphingomyelin (SM) A) 16:0 at 10 weeks (WT, r=0.11, p=0.25; mdx, r=0.73, 
p=0.04), B) 16:0 at 20 weeks (WT, r=0.89, p=0.03; mdx, r=0.12, p=0.05), C) 18:0 at 10 
weeks (WT, r=0.17, p=0.07; mdx, r=0.97, p=0.02), D) 18:0 at 20 weeks (WT, r=0.39, 
p=0.04; mdx, r=0.42, p=0.04), E) 18:1 at 10 weeks (WT, r=0.21, p=0.07; mdx, r=0.67, 
p=0.03), F) 18:1 at 20 weeks (WT, r=0.31, p=0.05; mdx, r=0.59, p=0.03), G) 18:2n6 at 
10 weeks (WT, r=-0.77, p=0.03; mdx, r=-0.73, p=0.03), and H) 18:2n6 at 20 weeks (WT, 
r=-0.14, p=0.81; mdx, r=-0.87, p=0.07) in wild type (WT; solid lines) and mdx (dashed 
lines) extensor digitorum longus muscle.  
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and 18:2n6 (r=-0.91, p=0.02) at 10 weeks of age and 16:0 (r=-0.94, p=0.01) and 18:1 
(r=0.91, p=0.02) at 20 weeks of age in WT. 
In contrast to EDL, SOL membrane damage was not significantly correlated to 
any CL FA (Fig. 3.5). 
 
Fibrosis 
Fibre regeneration and fibrosis 
Percentage of fibres with central nuclei was higher in mdx compared to WT in 
both fibre types at 10 weeks and 20 weeks of age for EDL (Fig 3.6) and SOL (Fig 3.7).  
Fibrosis was highest in 20 week old mdx compared to 10 week old mdx and 20 week old 
WT for EDL and soleus (Figure 3.8).  
 
Influence of membrane lipid composition on fibrosis 
Similar to correlations to eccentric induced muscle damage, only the PL and FAs 
that significantly changed in EDL (SM 16:0, 18:0, 18:1, 18:2n6 and PC 16:0, 18:0, 18:1, 
18:2n6) and soleus (CL) were selected (Appendix A Table A.2, A.3, A.8). 
For SM FA in EDL, most of the correlations were not significant. The exceptions 
were 16:0 in 10 week old mdx (r=0.70, p=0.01), 18:1 in 20 week old mdx (r=0.42, 
p=0.04), and 18:2n6 in 10 week old WT (r=0.37, p=0.05) were significantly positively 
correlated with percent fibrosis, whereas 18:2n6 in 10 week old mdx (r=-0.49, p=0.03)   
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Figure 3.4. Linear fitted regression model of eccentric induced damage correlated with 
membrane phosphatidylcholine (PC) A) 16:0 at 10 weeks (WT, r=-0.14, p=0.82; mdx, r=-
0.63, p=0.02), B) 16:0 at 20 weeks (WT, r=-0.94, p=0.01; mdx, r=-0.81, p=0.07), C) 18:0 
at 10 weeks (WT, r=0.79, p=0.01; mdx, r=0.93, p=0.01), D) 18:0 at 20 weeks (WT, 
r=0.45, p=0.08; mdx, r=0.59, p=0.04), E) 18:1 at 10 weeks (WT, r=0.88, p=0.04; mdx, 
r=0.83, p=0.04), F) 18:1 at 20 weeks (WT, r=0.91, p=0.02; mdx, r=0.89, p=0.01), G) 
18:2n6 at 10 weeks (WT, r=-0.91, p=0.02; mdx, r=-0.09, p=0.87), and H) 18:2n6 at 20 
weeks (WT, r=-0.20, p=0.73; mdx, r=-0.74, p=0.04) in wild type (WT; solid lines) and 
mdx (dashed lines) extensor digitorum longus muscle.  
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Figure 3.5. Linear fitted regression model of eccentric induced damage correlated with 
membrane cardiolipin (CL) A) 16:0 at 10 weeks (WT, r=0.34, p=0.56; mdx, r=-0.001, 
p=0.99), B) 16:0 at 20 weeks (WT, r=0.65, p=0.23; mdx, r=0.08, p=0.89), C) 18:0 at 10 
weeks (WT, r=-0.32, p=0.58; mdx, r=-0.14, p=0.81), D) 18:0 at 20 weeks (WT, r=0.84,  
p=0.06; mdx, r=0.42, p=0.47), E) 18:1 at 10 weeks (WT, r=0.45, p=0.43; mdx, r=0.53, 
p=0.34), F) 18:1 at 20 weeks (WT, r=0.53, p=0.34; mdx, r=0.52, p=0.36), G) 18:2n6 at 
10 weeks (WT, r=-0.41, p=0.49; mdx, r=-0.45, p=0.43), and H) 18:2n6 at 20 weeks (WT, 
r=-0.12, p=0.84; mdx, r=-0.02, p=0.9) in wild type (WT; solid lines) and mdx (dashed 
lines) soleus muscle. 
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Figure 3.6. Percentage of type I and II fibres with central nuclei in wild type and mdx 
extensor digitorum longus at 10 and 20 weeks of age. Values are mean ± SEM; WT, wild 
type; * denotes significance from WT within the same age group.  
 
* 
*  
* 
* 
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Figure 3.7. Percentage of type I and II fibres with central nuclei in wild type and mdx 
soleus at 10 and 20 weeks of age. Values are means ± SEM; WT, wild type; * denotes 
significance from WT within the same age group. 
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Figure 3.8. Percentage of fibrosis in extensor digitorum longus and soleus. Values are 
means ± SEM; WT, wild type; * denotes significance from WT at 20 weeks. 
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and 20 week old WT ( r=-0.39, p=0.03) were significantly negatively correlated (Fig 
2.9). 
Similar to SM, most of the PC FA correlations in EDL were not significant.  The 
only exceptions were that in 10 week old mice, 16:0 in mdx (r=0.85, p=0.05) and 18:0 in 
WT (r=0.73, p=0.05) were significantly positively correlated with fibrosis (Fig 3.10). 
There were no clear trends in soleus CL FA when correlated against fibrosis (Fig 
3.11).  At 10 weeks of age, 16:0 was significantly positively correlated with fibrosis in 
both mdx (r=0.76, p=0.03) and WT (r=0.29, p=0.05) whereas 18:0 was significantly 
negatively correlated (WT, r=-0.22, p=0.04; mdx, r=-0.97, p=0.03).  At 20 weeks of age, 
16:0 for mdx (r=-0.90, p=0.03) and WT (r=-0.73, p=0.05), 18:0 for WT (r=-0.89, 
p=0.04), and 18:2n6 for mdx (mdx, r=-0.87, p=0.04) were significantly negatively 
correlated with fibrosis, whereas 18:1 in mdx was significantly positively correlated. 
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Figure 3.9. Linear fitted regression model of fibrosis correlated with membrane 
sphingomyelin (SM) A) 16:0 at 10 weeks (WT, r=-0.06, p=0.12; mdx, r=0.70, p=0.01), 
B) 16:0 at 20 weeks (WT, r=0.36, p=0.21; mdx, r=0.13, p=0.38), C) 18:0 at 10 weeks 
(WT, r=0.77, p=0.12; mdx, r=-0.46, p=0.42), D) 18:0 at 20 weeks (WT, r=0.39, p=0.51; 
mdx, r=0.64, p=0.23), E) 18:1 at 10 weeks (WT, r=0.01, p=0.97; mdx, r=0.10, p=0.86), 
F) 18:1 at 20 weeks (WT, r=0.60, p=0.28; mdx, r=0.42, p=0.04), G) 18:2n6 at 10 weeks 
(WT, r=0.37, p=0.05; mdx, r=-0.49, p=0.03), and H) 18:2n6 at 20 weeks (WT, r=-0.39, 
p=0.03; mdx, r=-0.18, p=0.07) in wild type (WT; solid lines) and mdx (dashed lines) 
extensor digitorum longus muscle.  
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Figure 3.10. Linear fitted regression model of fibrosis correlated with membrane 
phosphatidylcholine (PC) A) 16:0 at 10 weeks (WT, r=0.71, p=0.06; mdx, r=0.85, 
p=0.05), B) 16:0 at 20 weeks (WT, r=0.22, p=0.71; mdx, r=-0.33, p=0.57), C) 18:0 at 10 
weeks (WT, r=0.73, p=0.05; mdx, r=0.60, p=0.07), D) 18:0 at 20 weeks (WT, r=0.36, 
p=0.11; mdx, r=0.10, p=0.47), E) 18:1 at 10 weeks (WT, r=0.21, p=0.13; mdx, r=0.25, 
p=0.14), F) 18:1 at 20 weeks (WT, r=-0.21, p=0.15; mdx, r=0.10, p=0.47), G) 18:2n6 at 
10 weeks (WT, r=-0.77, p=0.12; mdx, r=-0.04, p=0.42), and H) 18:2n6 at 20 weeks (WT, 
r=-0.39, p=0.51; mdx, r=-0.64, p=0.23) in wild type (WT; solid lines) and mdx (dashed 
lines) extensor digitorum longus muscle.  
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Figure 3.11. Linear fitted regression model of fibrosis correlated with membrane 
cardiolipin (CL) A) 16:0 at 10 weeks (WT, r=0.29, p=0.05; mdx, r=0.76, p=0.03), B) 
16:0 at 20 weeks (WT, r=-0.73, p=0.05; mdx, r=-0.90, p=0.03), C) 18:0 at 10 weeks 
(WT, r=-0.22, p=0.04; mdx, r=-0.97, p=0.03), D) 18:0 at 20 weeks (WT, r=-0.89,  
p=0.04; mdx, r=-0.67, p=0.20), E) 18:1 at 10 weeks (WT, r=-0.42, p=0.09; mdx, r=0.19, 
p=0.35), F) 18:1 at 20 weeks (WT, r=0.14, p=0.43; mdx, r=0.76, p=0.04), G) 18:2n6 at 
10 weeks (WT, r=-0.12, p=0.83; mdx, r=-0.31, p=0.27), and H) 18:2n6 at 20 weeks (WT, 
r=-0.45, p=0.12; mdx, r=-0.87, p=0.04) in wild type (WT; solid lines) and mdx (dashed 
lines) soleus muscle. 
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CHAPTER 4: DISCUSSION  
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The present study examined the association of membrane phospholipid fatty acids 
of muscles with varying fibre-type composition with eccentric induced damage and 
fibrosis in 10 and 20 week old mdx and WT mice. To our knowledge this is the first 
study that has assessed the severity of the dystrophic phenotype in relation to alterations 
in membrane PL FA composition in fast and slow muscle types.  
The major novel finding from the present study is that membrane PL FA 
composition is associated with skeletal muscle markers of eccentric induced damage.  
Specifically, membrane SFA and MUFA are positively correlated to eccentric induced 
muscle damage, while PUFA are negatively correlated. Membrane PL FA composition, 
however, was not associated with skeletal muscle markers of fibrosis. It was also 
demonstrated that; 1) EDL was more susceptible to eccentric induced damage, with more 
significant and stronger correlations to membrane PL FA compositions compared to 
SOL, and 2) membrane PL FA composition was correlated to eccentric induced damage 
in mdx, and less so for WT, at both 10 and 20 weeks.  
Model of muscular dystrophy, mdx 
The mdx mouse has been studied extensively to better understand muscle 
pathology in the dysfunction of the DGC. The current research has attempted to further 
build our understanding of the contractile properties, alterations in membrane 
permeability with in vitro eccentric induced damage,, fatty acids composition, 
histopathology and fibre type populations of two muscle types (predominant type I and 
II) at two ages (10 and 20 weeks) in mdx mice. 
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Fibre type involvement in mdx 
Type II fibres are believed to be more susceptible to damage within a dystrophic 
phenotype, whereas type I fibres are more resistant. Moreover, with increased age, as a 
potential compensatory mechanism, type I:II ratio increases (Pastoret & Sebille, 1993).  
In the present study, type II fibres were the majority of fibres displaying damage in EDL. 
Additionally in dystrophic EDL, the percentage of type II fibres decreased from 97% to 
70% from 10 to 20 weeks of age. Consistent with the present findings, type II fibres in 
dystrophic EDL were reported to gradually decrease with age going from ~93% at 6 
weeks to ~90% at 16 weeks and finally to ~78% at 32 weeks (Carnwath & Shotton, 
1987). Since type II fibres have been previously reported to be more susceptible to 
dystrophic damage (Lieber & Friden, 1988), increase of type I fibre types population 
possibly represent a compensatory response to the disease.  
In SOL, despite demonstrating that type II fibres in mdx were most susceptible to 
damage, fibre type percentages were unaltered at 10 and 20 weeks.  A decrease in type II 
fibres in mdx SOL was previously reported to occur at 26 week (Carnwath & Shotton, 
1987). This later involvement might be related to the resistant nature of type I fibres in 
SOL to a dystrophic phenotype due to their wider Z lines and larger isoforms of 
sarcomeric proteins creating a more stable sarcomere assembly (Agarkova et al., 
2004; Prado et al., 2005). Therefore, because of resistance of SOL to the dystrophic 
phenotype, examination of fibre types at 20 weeks may not reflect the fibre type 
alterations.  
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Histopathological changes in mdx myofibres 
Findings of the present study demonstrated increased centrally located nuclei in 
myofibres, indicative of regeneration in both EDL and SOL at 10 and 20 weeks of age 
compared to WT. Additionally, dystrophic EDL at 20 weeks showed an increase in the 
rate of regeneration compared to 10 weeks as before. Increased regeneration in mdx is in 
agreement with previous literature reporting that the dystrophic myofibres undergo 
regeneration starting at 7 weeks and the process continues until 52 weeks in both EDL 
and SOL (Bullfield et al., 1983; Tanabe et al., 1986; Pastoret & Sebille, 1994). 
Specifically, in agreement with the current study, examination of EDL in weekly 
intervals after birth showed an increase in the rate of regeneration with age (8 to 26 
weeks, Carnwath & Shotton, 1987). Together, both mdx EDL and SOL at 10 and 20 
weeks demonstrated regeneration to compensate for dystrophic degeneration 
respectively.  
Fibrosis and collagen accumulation are pathological hallmarks of muscular 
dystrophy in mdx muscle in which myofibres are replaced by progressive deposition of 
collagen when degradation outpaces regeneration. Absence of significant differences in 
fibrosis at 10 weeks between WT and dystrophic EDL in the present study (0-1%) is 
likely due to adequate regeneration at this age, as was previously reported (Bulfield et al., 
1984). However, at 20 weeks of age there was ~2.5% fibrosis of mdx EDL compared to 
WT. The 2.5% fibrosis at 20 weeks is also in agreement with a previous study reporting 
no apparent perimysial or endomysial fibrosis at 18 weeks in mdx and 5% at 24 weeks 
(Tanabe et al., 1986). Increased fibrosis in dystrophic EDL at 20 weeks compared to WT 
is assumed to be related to ongoing regeneration to compensate for muscle fibre 
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degeneration. Substantial increases of up to 30% in collagen area fraction have been 
reported only after 52 weeks of age, which coincides with a decrease in regeneration 
(Pastoret & Sebille, 1994, Smith & Barton, 2014). As such, mdx EDL and SOL from 10 
and 20 weeks demonstrate degeneration of myofibres with some but not complete 
regeneration, with small increases in fibrosis, respectively.  
 
Alterations in membrane phospholipid fatty acid composition 
Dysfunction in dystrophin is associated with changes in membrane PL FA 
composition. Findings of the present study demonstrated increased MUFA and decreased 
PUFA, which is in agreement with previous studies demonstrating increased MUFA and 
decreased PUFA in degenerated regions of mixed muscle hind limb (Hughes, 1972; 
Kunze et al., 1975; Pearce et al., 1981; Taboul et al., 2004).  Moreover, findings revealed 
that changes in membrane MUFA and PUFA were similar for mdx EDL at both 10 and 
20 weeks suggesting that a 10 week increase in age may not alter the phenotype of PL 
FA composition in dystrophic EDL.  
In SOL, similar to EDL, membrane MUFA experienced an increase while PUFA 
were decreased in mdx compared to WTs, and this did not differ between 10 and 20 
weeks. Although this is the first study to examine membrane PL FA composition in SOL, 
the general trend of increased MUFA and decreased PUFA is in agreement with previous 
examination of mdx hind limb or quadriceps muscles (Pearce & Kakulus, 1980; Owens & 
Hughes, 1970; Benabdellah et al., 2009; Touboul, 2004; Tuazon & Henderson, 2012). 
Together, these findings indicate that dystrophic EDL and SOL demonstrate similar 
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change in membrane composition, which remains unaltered with an increase in age from 
10 to 20 weeks.   
Changes in lipid composition of membranes may be dictated by the membrane 
structure protein functional relationship. Dysfunctional dystrophin may result in changes 
to the membrane composition to allow for more saturated (increase in 18:0 and 18:1) and 
less unsaturated (decrease in 18:2n6) PL. The degree of saturation in membrane PLs 
plays an important role in membrane stability and its susceptibility to oxidative damage. 
Such oxidative damage has been proposed as a possible mediator of the dystrophic 
pathology, possibly through excessive intracellular calcium (Terrill, 2013). Role for 
oxidative stress is supported by a wealth of preclinical studies in mdx mice that report 
benefits such as improved muscle pathology and decreased necrosis with many 
antioxidant drugs (Dorchies et al., 2006; Buetler et al., 2002). Furthermore, PUFA are 
extremely sensitive to oxidation (Song et al., 2000). Consequently, a high concentration 
of PUFAs in phospholipids makes them prime targets for reaction with oxidizing agents, 
such as free radicals. However, in dystrophic membranes, given the heightened oxidative 
stress, membrane PL FA may demonstrate an adaptive response to oxidative condition by 
decreasing the abundance of PUFAs and increasing MUFA or SFA. This adaptation 
enables the membranes to obtain a higher structural stability and a lower susceptibility to 
oxidative damage. This highlights the potential importance of membrane composition in 
vulnerability to dystrophic damage. Identification of such changes is important because it 
may help to better understand the role of membrane lipid composition in dystrophic 
damage and progression of the disease. 
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Muscle damage after stretch injury protocol 
In the present study, the stretch injury protocol was successful in inducing 
significant force deficit after stretch injury in EDL. Findings indicate a decrease in 
maximal isometric tetanic properties in mdx myofibres of 25% and 65% in 10 and 20 
weeks old mdx EDL after 15 minutes of fatigue recovery which was ~2 and ~3.5 times 
greater than wild types (Table 3.2). Force deficits at 10 weeks are in agreement with 
results obtained from EDL of 12-14 weeks old mdx showing 30-40 % decline in 
isometric force after similar stretch injury experiments (Petrof et al., 1993). Importantly, 
although some research demonstrated a 20-30 % decrease in isometric force in mdx at 
12-16 weeks, the observed discrepancies may be related to the experimental stretch 
injury protocols, including differences in the rate of passive stretches and number of 
repeated eccentric contractions (Moens et al., 1993). Importantly, eccentric contractions 
with faster velocities are more likely to subject the muscle to injury due to the greater 
levels of produced tension above that compared to slower velocity of eccentric 
contractions (Armstrong et al., 1983). This is the first study that has stretched dystrophic 
EDL at 0.5 Lo/sec at 10 and 20 weeks, with previous experiments being on different age 
groups and/or applying faster or slower velocities of eccentric contractions (Moens et al., 
1993; McArdle et al., 1991; Deconinck et al., 1998; Raymackers et al., 2003; Consolino 
& Brooks, 2004).  
EDLs of mdx at 20 weeks had ~1.5 times greater maximal isometric force 
depression compared to 10 weeks, which was ~60% of that produced in WT. Greater 
force depressions at 20 weeks was in agreement with earlier research in mdx EDL at the 
age of 16-24 weeks showing 20- 55% decrease in isometric force (McCully & Faulkner, 
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1985; Sacco et al., 1992). However, it is difficult to compare the magnitudes of maximal 
isometric force deficits obtained from the current study with the ones reported in the 
literature because the protocols including the lengthening velocities were different or the 
force was measured on different ages other than 20 weeks. 
Force decline of mdx EDL after damage suggests that in the absence of 
dystrophin, the threshold level for muscle damage is decreased, rendering the muscles 
more susceptible to damage induced by eccentric contractions. Specifically, in the 
absence of dystrophin, the structural continuity that is provided by dystrophin and its 
associated proteins for an effective force transmission along the longitudinal axis is lost, 
which in turn, results in fibres that are functionally impaired in transmitting force 
(Ohlendieck & Campbell, 1991). The precise underlying mechanism for decreased force 
output in mdx EDL may be related to failures in ECC. Eccentric contractions in the 
absence of dystrophin lead to structural changes in the sarcomere resulting in 
overstretched sarcomere with Z-line streaming throughout the fibre (Fridén et al., 1981).  
This, in turn, results in changes to the structure of the sarcomere and a persistent opening 
of stretch-activated channels (Allen, 2004). Since these channels are permeable to Na
+
, 
increased [Na
+
]i is observed. Consequently, Na
+
 pumps extrude the excess intracellular 
Na
+
 with osmotically equivalent water putting hydraulic load onto the t-tubules causing 
dilation. The change in property of t-tubules, therefore, reduces effective action potential 
propagation down the t-tubules, which, in turn, reduce SR Ca
2+
 release and tension 
development (Yeung et al., 2002; Yeung et al., 2003; Franco et al., 1990). Moreover, the 
present study showed that older mdx EDL had an increase in the proportion of type I 
fibres. As such, it can also be assumed that a deficit in isometric force generation at 20 
106 
 
weeks in mdx EDL may be a result of a shift from type II to I fibres (Table 3.1). 
Although increased non-contractile fibrotic tissue may further compromise contractile 
function of muscle, especially in older mdx, observed fibrosis in the current study is 
believed to be too small to account for a decline in contractile function (Bulfield et al, 
1983; Leronimakis et al., 2013). Thus the influence of fibre type alteration and defective 
regeneration are assumed to explain the severity of damage associated with age.  
In SOL, force production after the stretch injury protocol with lengthening at the 
rate of 1.5 Lo/S, did not differ between mdx and WT. Previous literature examining 
mechanical damage with different stretch injury protocol in SOL showed a 20% drop in 
force in both mdx and WT strains at 4-6 weeks and 10 % in 12-20 weeks (Moens et al., 
1993, Warren et al.1992). In the current study the velocity of eccentric contraction was 
1.5 Lo/S repeated 10 times, but literature protocols applied different rate of lengthening 
contractions ranging from 1.5 Lo/S at 4-6 weeks repeating for 15 times and 1.7 Lo/S at 
12- 20 weeks repeated for 6 times (Moens et al., 1993, Warren et al.1992). Overall, in 
mdx SOL muscle, eccentric contractions did not cause a large force drop that implies the 
threshold for damage is higher in these muscles, in agreement with the finding that fast 
muscle fibres are preferentially affected by the disease (Webster et al., 1988). The 
underlying mechanism responsible for less vulnerability of type I fibres to eccentric 
damage is likely related to the ultrastructural differences between type I and type II 
fibres. Type I fibres have wider Z-lines compared to type II fibres, which reflect more 
attachments for thick and thin filaments inferring higher stability (Yamaguchi et al., 
1985). Moreover, type I fibres contain larger isoforms of the sarcomeric proteins, which 
play a role in sarcomere assembly (Agarkova et al., 2004; Prado et al., 2005). Also, these 
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fibres express a higher molecular weight, and more elastic, isoforms of non-contractile 
proteins (i.e. titin) than type II fibres. The higher compliance of non-contractile proteins 
(titin) in slow fibres may transmit less stress during eccentric contractions on these fibre 
types, which in turn, may result in type I fibres being more resistant eccentric damage  
(Prado et al., 2005).  
The force deficit after muscle damage is proportional to the force developed 
during stretch, which is produced at higher velocities of lengthening (McCully & 
Faulkner 1986, Warren et al. 1993). Moreover, there is widespread agreement that 
damage increases with the number of eccentric contractions and with the length of the 
stretch (McCully & Faulkner, 1985, Warren et al. 1993; Lieber & Friden, 1988, Brooks 
et al. 1995). As such, to ensue damage in type I dominant SOL, increases in length and 
rate of stretch parallel to increases in the number of eccentric contractions may lead to 
deficiency in the development of isometric force. 
Taken together, the stretch injury protocol was successful in inducing 2-3.5 fold 
greater force depression in dystrophic EDL compared to WTs. In SOL, however, the 
stretch injury experiment did not contributed to force deficit. The force deficit in 
dystrophic EDL but not SOL may suggest that the stretch injury protocol resulted in 
contraction induced damage to EDL, which, due to absence of force decline after stretch 
injury, was not present for SOL. 
 
Membrane damage after eccentric contraction 
Eccentric stretch injury in mdx EDL did not show increased fibronectin entry at 
10 weeks but resulted in a ~2 fold increase in fibronectin entry at 20 weeks. This is the 
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first study to assess membrane damage in dystrophic muscles at 10 and 20 weeks using a 
large molecular weight marker in fibronectin. Membrane damage has been detected in 
mdx EDL using procion orange, a much smaller molecular weight molecule which can 
infiltrate through disrupted cellular membranes allowing for the detection of microtears 
in the membrane. At 8-10 weeks, after 10 eccentric contractions at the rate of 1.5 Lo/S, 
procion orange uptake was increased to 10% in mdx EDL (Whitehead et al., 2006). By 
the age of 12-14 weeks of age, after 5 eccentric injuries at the rate of 1.5 Lo/S, uptake 
was increased to 18% in dystrophic muscle (Petrof et al., 1993). At 15-20 weeks, with 
application of 6 eccentric contractions at the velocity of 1.7 Lo/S, procion uptake was 
present in 15% of fibres (Moens et al., 1993). Finally, at 20 weeks, after a single 
lengthening contraction at 30% of strain, 15% of fibres were procion positive (Consolino 
& Brooks, 2003). Altogether, identification of procion dye in dystrophic fibres in 
literature demonstrates higher damage than to the present study due to the size of the 
membrane damage marker.  Fibronectin is ~750 times larger and may not have the ability 
to pass through microtears similar to the way smaller procion orange can. Detection of 
intracellular fibronectin is reported to be an effective alternative marker for identifying 
altered membrane permeability (Palacio et al., 2000), indicating larger disruptions in the 
membrane. Specially, the microtears in dystrophic EDL at 20 weeks may be large enough 
to accommodate a greater uptake of fibronectin compared to 10 weeks, further suggesting 
that intracellular accumulating of fibronectin is indicative of larger membrane damage. 
Moreover, the association of fibronectin positive fibres with force deficit in dystrophic 
EDL suggests that fibronectin indeed its slow infiltration due to its larger molecular size 
may be an adequate marker for detection of membrane damage. However, irrespective of 
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the technique of quantifying damage, this study showed that following stretched 
contractions, membrane permeability of mdx muscles progressively increased with age.  
The present study demonstrated decrease in force output of dystrophic EDL 
(~25% at 10 weeks and ~65% at 20 weeks) after eccentric contractions. However, 
fibronectin positive fibres indicating membrane damage was increased to 5 %. This 
finding firstly suggests that the extent of force loss exceeds the percentage of fibronectin 
containing fibres. Secondly, the correlation of membrane damage with force deficit in 
dystrophic EDL at 20 weeks demonstrated that membrane damage has significant 
contributions to force loss (Appendix A.3, r: 0.48, p< 0.05). Association of membrane 
damage with force loss has previously been reported in dystrophic EDL at 10-12 weeks 
with infiltration of procion orange (r: 0.6, p, 0.02) where 20% of fibres were infiltrated 
with procion orange (Petrof et al., 1993). Moreover, marked 60% force deficit in mdx 
EDL after stretch injury at 9-12 days was associated with 9% uptake in procion orange 
(Grange et al., 2002). Disproportional decrease in force output and membrane damage 
may indicate to involvement of additional mechanisms in muscle damage other than 
membrane damage. Loss of contractile strength is induced not only by damage 
observable by light microscopy (infiltration of markers) but also by breakdown of ECC 
(Balnave & Allen 1995; Warren et al. 2002). This EC uncoupling may occur as a result 
of damage to the mechanosensitive Ca
+2
 channels, Na
+
 channels and intracellular Na
+
 
concentrations that were not indicated by infiltration of extracellular markers. Altogether, 
despite larger size of fibronectin for detection of membrane damage findings further 
support the role of membrane damage in force deficit of dystrophic muscles after 
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eccentric contractions. Further research may provide insight on the initial role of 
underlying factor in membrane damage after eccentric contractions.  
In the present study, 10 eccentric contractions at the rate of 1.5 Lo/S did not result 
in fibronectin uptake by SOL at 10 and 20 weeks. This is in agreement with the literature 
as stretch injury (6 lengthening at 1.7 Lo/S) in 15 week old mdx SOL did not demonstrate 
differences in procion orange entry (Moens et al., 1993).  Absence of damage using 
procion orange as a marker was also observed in 20 week old mdx SOL (single 60 % 
stain at 2 Lo/S) (Consolino & Brooks, 2004). Despite the differences in the surrogates of 
damage used in the current study and the literature, SOL myofibres demonstrated greater 
resistance to stretch injury than before. This finding may be attributed to their higher 
proportion of type I fibres, with different biomechanical properties (i.e. wider Z- lines, 
larger sarcomeric proteins, more elastic titin)  that infer higher resistance to membrane 
damage. 
Correlation of membrane composition with eccentric induced damage muscle 
damage  
The membrane structure-protein functional relationship may provide insight into 
the association of dystrophin dysfunction and membrane composition.  Alterations in 
membrane lipid composition have been examined in current and previous research. 
Moreover, examination of mdx myofibres strongly supported the idea that one of the 
associated factors in a dystrophic phenotype is alterations in membrane permeability, 
implying an a n  ma  y “  a y” membrane. As such, to better understand the role of 
alteration of membrane lipid composition in pathogenesis of the disease it is important to 
111 
 
examine how the changes in membrane lipid composition may be associated with 
membrane damage. 
As previously highlighted, membrane PL FA composition demonstrated similar 
changes in increased SFA and MUFA with decrease in PUFA in dystrophic muscles with 
progression from 10 to 20 weeks. However, parallel to increase in mdx age, the 
fibronectin positive fibres suggestive of eccentric induced damage were increased from 
10 to 20 weeks. In addition, fibrosis was elevated from 10 to 20 weeks in dystrophic 
muscle. Progression of eccentric induced damage and fibrosis from 10 to 20 weeks 
despite unaltered membrane PL FA composition may suggest different trajectory 
between changes in membrane PL FA composition and eccentric induced damage and 
fibrosis. Despite no differences between 10 and 20 weeks in membrane lipids, the 
correlations to eccentric induced damage and fibrosis might still be present. Examination 
of such correlations is important as it may provide insights about the role of altered PL 
FA composition in muscle damage. 
 
EDL 
In the present study, it was hypothesized that alterations in membrane 
composition in mdx EDL may be associated with eccentric induced damage. Indeed, 
findings indicated significant correlation between an increase in membrane saturation 
with fibronectin-positive myofibres compared to WT. Muscle damage was more evident 
in membranes with higher percent mole fraction of SM 18:1, PC 18:0 and lower SM 
18:2n6 and PC 18:2n6. It is important to note that since previous examination of isolated 
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sarcolemma by mechanical skinning demonstrated PC and SM as the major constituents 
of sarcolemma than to other PL species (Fajardo et al., 2013), it is assumed that these 
PLs obtained from whole muscle membrane analysis are somewhat reflective of the 
sarcolemma.  
 It has previously been established that increases in eccentric induced muscle 
damage due to increases in saturation is of importance because eccentric induced damage 
to the muscle would be accompanied by an influx of calcium and disturbance of calcium 
homeostasis (Leijendekke, 1996). However, since a correlation of membrane PL FA with 
eccentric induced damage does not imply causality; two possible theories might explain 
the association of membrane PL FA with eccentric induced damage. (Fig.4.1). In both 
theories, it is implied  that there would be a rise in [Ca
2+
]i, a subsequent impairment in 
Ca
2+
 homeostasis and activation of various degradation pathways, which would lead to 
muscle fibre necrosis (Whitehead et al., 2006). Moreover, since dysfunctional dystrophin 
was not associated with increased membrane permeability during the first 2 weeks of age 
(Grange et al., 2002; Head et al., 2004), both models are only applicable to ages after 3 
weeks, in which the membrane demonstrates contraction-induced damage. Alternatively, 
the absence of dystrophin is accompanied by altered membrane lipid composition that 
makes the membrane more susceptible to contraction-induced damage (Fig 4.1.B). 
The first theory suggests increased susceptibility of dystrophic muscles to 
contractions lead to series of events driving increased membrane saturation. Firstly, 
dysfunctional dystrophin is associated with diminished support for the membrane during 
contraction, leading to contractile force directed into the membrane resulting in 
membrane damage (Fig 4.1 A). Muscle damage after eccentric contractions is supported 
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by a decrease in contractile performance of dystrophic muscle after mechanical damage 
(Head et al., 1992; Petrof et al., 1993; Deconinck et al., 1998; Raymackers, 2003; 
Consolino & Brooks, 2004; Chan et al., 2007).  Increase in membrane damage is 
evidenced by the 
  
114 
 
 
      
 
      
 
 
Figure. 4. 1. Presentation of two possible models in association of membrane 
phospholipid fatty acid composition with muscle damage with dysfunction in dystrophin. 
A; Muscle damage after eccentric contrations as associated with dysfunctional dystrophin 
is the leading event driving membrane damage, followed by oxidative damage to the 
membrane ultimately resulting change in membrane lipid composition. B; Change in PL 
FA composition as associated with dysfunctional dystrophin driving muscle damage after 
eccentric contraction, leading to membrane damage with subsequent oxidative damage to 
the membrane. PL, phospholipid; FA, fatty acid.  
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finding that dystrophin offers both structural and functional integrity to the sarcolemma 
by stabilizing it against stresses imposed during muscle contraction or stretch (Blake et 
al., 2002). Secondly, damage to the membranes drives an increase in membrane 
permeability, mediating the influx of Ca
+2
 through the sarcolemma. Increased 
permeability of membranes has been shown with small and large surrogates of membrane 
damage in dystrophic muscles after contraction (Whitehead et al., 2006; McArdle et al., 
1994; Petrof et al., 1993). Thirdly, the increased calcium entry contributes to an 
approximately threefold rise in cytosolic free calcium as previously reported in mdx 
muscle (Mallouk et al., 2000, Alderton & Steinhardt, 2000). This rise in cytosolic 
calcium activates proteases which promote the activation of phospholipase (especially 
phospholipase A2 (PLA2)), which in turn attacks mitochondrial and other membrane 
phospholipids, giving rise to lysophospholipids and free FAs. Lysophospholipids disrupt 
membrane lipid organization and free fatty acids may have a detergent action, causing 
membrane damage. This is derived from evidence that increased Ca 
+2 
concentration 
activates PLA2, based on the observation that enzyme efflux (e.g. CK) from 
experimentally damaged muscles suffering Ca
+2
 overloads can be blocked by PLA2 
inhibitors (Jackson et al., 1984).  Moreover, among the free fatty acids liberated is 
arachidonic acid, which may promote reactive oxygen species (ROS) production by the 
mitochondria (Gissel, 2005). Additionally, accumulation of Ca
+2
 in mitochondria linked 
to disturbances in Ca
+2
 homeostasis  promote generation of ROS by the mitochondria that 
leads to peroxidation of membrane lipids (Gissel, 2005; Reppeto et al., 2012). Finally, 
free oxygen radicals initiate further chain reactions resulting in conversion of PUFA to 
further fatty acid radicals (Reppeto et al., 2012), stabilized by rearrangement into more 
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saturated forms (as seen with increased SFA, MUFA and decrease in PUFA; Owens & 
Hughes, 1970; Pearce & Kakulus, 1980). Noteworthy, free radical mediated damage in 
muscular dystrophy is attributed to the defect in neuronal nitric oxide synthase (nNOS) 
known as a member of dystrophin complex, which is lost in dystrophin deficiency 
(Brenman et al., 1995). Nitric oxide (NO), a product of nNOS, has rapid and versatile 
reactions with free radicals preventing a redox environment in myofibres (Tidball & 
Wehling-Henricks, 2007). Therefore, with loss of the protective role of NO in scavenging 
free radicals, oxidative stress increases in dystrophic myofibres. Evidence demonstrating 
the importance of nNOS deficiency in the pathology of mdx is the prevention of 
histological pathology and sarcolemmal lesions in mdx by expression of transgene nNOS 
in dystrophic muscles (Wehling et al, 2001). It is also important to note that although the 
initial leading event for muscle damage is the contraction induced membrane micro-
lesions, these processes ultimately lead to increased saturation of membranes, causing 
further influx of calcium, and activation of a continuous cycle that ultimately contributes 
to further membrane damage. As such, in the first theory muscle damage as a result of 
calcium entry may underlie the increased saturation of the PL FA compositions of the 
membrane.  
The alternative theory suggests that increased contraction-induced membrane 
damage is a result of events from increased saturation in membranes (Fig 4.1.B). Firstly, 
due to the membrane structure-protein functional relationship, dysfunction in dystrophin 
may be associated with increased SFA and decreased PUFA in membranes (Owens & 
Hughes, 1970; Pearce & Kakulus, 1980). Secondly, the shift from unsaturated towards 
saturated FAs in membrane increases the van der Waals forces between the hydrocarbon 
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chains due to increased interaction between FA chains (Yang et al., 2011).  As a possible 
result of increased interaction, the sarcolemma folding (ratio of membrane surface to cell 
volume) may decrease (Hutter, 1991). Thus, during an eccentric contraction, a membrane 
with fewer sarcolemma folds may not accommodate the stretch, which subjects the 
membrane to stress and likely leads to membrane damage (Hutter, 1991, Grange et al., 
2002). Examination of the mechanical strength of the dystrophic myofibre membranes, 
which report a fourfold decrease in membrane stiffness of mdx myotubes than that of WT 
(Pasternak et al., 1995), further supports decreased resistance of dystrophic fibres to 
stretch.  Thirdly, decreased resistance of membranes to mechanical perturbations gives 
rise to the development of transient membrane tears, evidenced by increased membrane 
permeability (Whitehead et al., 2006; McArdle et al., 1994; Petrof et al., 1993). 
Increased membrane permeability, in turn, allow extracellular Ca 
2+ 
to rapidly enter the 
fibre (Mallouk et al., 2000) leading to activation of proteases as wells as peroxidases. 
This finally results in generating oxidative damage to the membrane (Gissel, 2005). This 
theory focuses on the governing role of the lipid bilayer in driving resistance to injury 
and membrane damage. Thus, in this theory, it is likely that the intrinsic strength of the 
sarcolemma is a property of lipid bilayer, not under the impact of membrane damage, 
which is affected in the absence of dystrophin, leading to membranes that are susceptible 
to dystrophic damage. 
 As highlighted previously, with increased age in mdx, the dystrophic phenotype 
including membrane susceptibility to damage become more severe from 9 weeks to 24 
weeks of age (Head et al., 1992; Deconinck et al., 1998; Blake et al., 2002; Consolino & 
Brooks, 2004; Chan et al., 2007).  Thus, in the present study, it was also hypothesized 
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that the extent of eccentric induced damage fibronectin positive fibres would have 
stronger associations with increased membrane saturation in older mdx at 20 weeks. This 
was not seen as the association of membrane lipid composition with eccentric induced 
damagemuscle damage at 10 week of age was stronger compared to 20 weeks. 
Specifically, despite an increase in the susceptibility of dystrophic EDL to damage at 20 
weeks, membrane lipid composition remained unaltered. The weakening correlations at 
20 weeks might be related to the shift in fibre type composition from 10 to 20 weeks. 
Specifically, at 20 weeks of age there is continued preferential loss of type II fibres with 
an increase in the proportion of type I fibres in dystrophic EDL, which in turn, may 
change the membrane composition. These type I fibres have more PUFA in their 
membranes and less SFA (Kriketos et al., 1996; Stefanyk et al., 2010). Moreover, the 
proportion of type II fibres decreased from 10 to 20 weeks with increased age. Type II 
fibres are composed of more saturated FAs (Kriketos et al., 1996; Stefanyk et al., 2010).  
As such, possibly due to reciprocal influences of both fibre type shifts and dystrophic 
phenotype on membrane composition, this may have contributed to weaker correlations 
at 20 weeks of age in mdx EDL. 
 
SOL 
Soleus is composed mostly of type I fibres. Type I fibres have different 
sarcomeric assembly resulting in more resistance to dystrophic damage than type II 
dominant muscle types (larger sarcomeric proteins, higher compliance in titin and wider 
Z-lines) (Agarkova et al., 2004; Prado et al., 2005). Additionally, type I fibres have more 
SFA and less PUFA (especially n6 PUFA) in their membranes (Stefanyk et al., 2010). 
119 
 
Importantly, due to unsaturation, PUFA side chains have higher susceptibility to 
oxidative stress, and more easily attacked by free radicals than SFA (Song et al., 2000). 
Thus lower abundance of PUFA in SOL may provide some stability against dystrophic 
injury.  
Stretch injury in SOL at the velocity of 1.5 Lo/S repeated for 10 times did not 
result in increased fibronectin entry in either WT or dystrophic mice at 10 and 20 weeks. 
In terms of membrane PL FA, only CL demonstrated changes with phenotype, which is 
an exclusively mitochondrial PL (Bleijerveld, et al., 2007).  As a result, membrane 
composition in dystrophic SOL did not correlate strongly with eccentric induced damage 
. Future studies should examine stretch injury protocols that induce greater fibronectin 
entry post-injury.   
Changes in mitochondrial membrane composition of SOL without increases in 
muscle damage may raise the possibility that muscle damage may be a preceding event to 
alterations in membrane composition (Fig.4.A). Dysfunctional dystrophin in SOL is 
associated with muscle damage after eccentric contractions and membrane damage (not 
detected due to insufficient stretch injury protocol or large size of damage marker). As a 
result of sarcolemma micro-lesions, Ca
+2
 loads on muscle increases, which in turn leads 
to elevated mitochondrial Ca
+2 
concentrations and activation of phospholipase (Gissel, 
2005). This finally leads to increased ROS production in mitochondria, and with it, the 
risk of attacking mitochondrial membrane lipids (converting PUFA to MUFA or SFA). 
Since mitochondria act as a
 
regulator in Ca 
+2 
overloads, the changes in its membrane 
composition may be a prelude to changes in sarcolemma composition. Impact of 
mitochondria Ca
+2 
overloads on its membrane was demonstrated with increased activity 
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of the transition pore (Duchen, 2004). Thus increased saturation in mitochondria 
membrane composition without changes in SL may be indicative to the initial role of 
membrane damage in driving alterations in mitochondrial membrane composition with 
further involvement of SL due to failure in Ca
+2 
homeostasis. It is assumed that with the 
application of more severe stretch injury, more Ca
+2
 may accumulate in the fibres, 
resulting in changes to more than mitochondria PL, including SL.  
 
Correlation of membrane composition with fibrosis  
As highlighted previously, fibrosis is characterized by alterations in extracellular 
matrix deposition as a consequence of persistent muscle damage following eccentric 
induced tissue injury without sufficient regeneration (Antonio et al., 2011). Fibrosis or 
chronic muscle damage in mdx mice is a late onset process with dramatic increases after 
52 weeks of age (Pastoret & Sebille, 1994). In the present study, fibrosis was increased at 
20 weeks in EDL (2.5% fibrosis compared to WT), which is consistent with 5% fibrosis 
of mdx EDL at 24 weeks (Tanabe et al., 1986), and not in SOL. 
 
EDL 
It was hypothesised that membrane PL FA composition of dystrophic fibres 
would be correlated with fibrosis. Findings showed that fibrosis accumulation in EDL 
was not highly correlated to membrane PL FA composition. It is important to note that 
fibrosis is the end stage of muscle damage, and represents the loss of myofibres. In the 
present study, membrane composition, however, characterizes the altered membrane PL 
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FA of healthy, degenerated and regenerated myofibres. Increase in SFA and MUFA with 
decrease in PUFA might be attributed to a chain reaction that initiated only after 
eccentric induced damage and fibrosis might not further influence changes in FA 
composition of the membrane. Moreover, the present study demonstrated increased 
amounts of myofibre regeneration at 20 weeks compared to 10 weeks (Fig 3.6), 
indicating a compensation for damaged fibres. As such, due to only 2.5% fibrosis and 
increased regeneration at 20 weeks, association of fibrosis with membrane PL FA of 
remaining fibres was weak. Furthermore, type I and II fibres have different PL FA 
composition, especially type II being dominantly composed of less PUFA/more saturated 
FA than to type I fibres (Kriketos et al., 1996; Stefanyk et al., 2010). In parallel to 
increased age, the proportion of type I/II increases, which resulted in increased saturation 
in dystrophic membranes at 20 weeks. Thus increased age not only results in increased 
PUFA in membranes creating more stability for the membranes but shift of type II fibres, 
which are known to be more susceptible to fibrosis. The PL FA analysis, however, was 
completed on whole muscle tissue including membranes of both fibre type populations. 
Therefore, the changes in fibre type composition may mask some of the true changes in 
PL FA between fibres and the association with fibrosis. 
 
SOL 
Increased fibrosis is associated with elimination of susceptible fibres to damage, 
which tend to be type II fibres. Since SOL is a type I dominant muscle, it was 
hypothesized that the correlation of membrane composition in remaining fibres to 
fibrosis would be weaker compared to EDL, which is type II dominant muscle.   Findings 
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of the present study indicate increased membrane MUFA and decreased PUFA through 
increases 18:1 and deceased 18:2n6, respectively. Despite these findings, there was no 
evidence of fibrosis in mdx soleus at 10 or 20 weeks of age. Previous research has 
identified fibrogenesis in soleus in late stages at 52 weeks (Tanabe, 1986), related to 
influence of lower susceptibility of type I fibres to damage, which suggest fibrosis would 
occur in SOL after 20 weeks. 
Lack of association between increased saturation in membrane lipid composition 
and fibrosis in SOL is assumed to be related to two underlying factors. First, the high 
proportion of type I fibres in SOL, making up 37-40 % of the fibre types (Augusto et al., 
2004; Smith et al., 2013), result in a higher mitochondrial density.  Mitochondria act as 
Ca
+2
 buffer with rapid uptake of surplus Ca
+2
, avoiding detrimental changes in Ca
+2
 
concentrations within the muscle.  Participation of mitochondria in Ca
+2 
handling may 
results in less Ca
+2
-derived muscle damage, lower susceptibility of membrane lipid to 
peroxidation, and less changes to membrane composition (Gissel, 2006). Although 
membrane composition of dystrophic EDL and SOL demonstrated similar changes, this 
may be due to continuous involvement of SOL in maintenance of posture compared to 
the locomotory function of EDL.  As such, SOL with higher ratio of type I fibres may be 
more resistant to repeated degeneration and necrosis with less evidence present of 
membrane damage. 
Secondly, in addition to the influence of fibre types, regenerated myofibres might 
be an underlying factor in the lower susceptibility of mdx soleus to fibrosis. Examination 
of central nucleated myofibres in SOL suggests ongoing regenerative responses in mdx at 
both 10 and 20 weeks with a total of 65% and 72% regenerated fibres, respectively. Since 
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regenerated fibres restore muscle structure and function upon injury, mdx SOL myofibres 
do not show evidence of fibrosis.  Moreover, since SOL is a type I dominant muscle 
type, respective regenerated myofibres are mainly type I, known to have lower 
susceptibility to fibrosis. Thus, as fibrosis was absent in dystrophic SOL, the analyzed PL 
FA represents the whole membranes of SOL myofibres, showing increased in 
PUFA/MUFA. Increased saturation may be a result of eccentric induced damage, which 
due to inadequate stretch injury and relatively high molecular weight marker of damage 
was not detected.  As such, no link was detected between membrane PL FA and fibrosis 
in dystrophic SOL at 10 and 20 weeks. 
 
Summary and conclusions 
The present study demonstrated that absence of dystrophin in mdx is associated 
with various pathologies. These include switch in fibre type populations, histopathology 
(i.e. regeneration and fibrosis), change in the membrane PL FA composition, contractile 
properties and membrane permeability. Moreover, this research highlighted the 
underlying associations between membrane composition and dystrophic-derived injuries.  
Examination of fibre type involvement in dystrophic muscles revealed the 
majority of involved fibres were type II, and with increased age, the percentage of 
dystrophic type II fibres decreased. Such an alteration in fibre types may highlight a 
compensatory response of dystrophin deficient muscle to contraction-mediated damage 
by shifting to type I fibres, which appear to be more resistant. Moreover, dystrophic 
muscle demonstrates abnormal histology compared to WT, including myofibre 
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regeneration (central nucleated fibre) and fibrosis. This research demonstrated increased 
regeneration in EDL and SOL at 10 and 20 weeks, suggesting compensation for 
dystrophic degeneration. Moreover, fibrosis was only minimally present in dystrophic 
muscle (especially EDL) at 20 weeks. The histopathology of mdx muscles indicate that 
regeneration of muscle has an important role in preventing fibrosis especially at 10 and 
20 weeks.  Furthermore, dysfunctional dystrophin is linked to an alteration in membrane 
PL FA composition. Examination of whole muscle membrane lipid composition 
demonstrated increased saturation in mdx EDL and SOL at 10 and 20 weeks. These 
changes support the idea that as a result of oxidative damage, lipids of membranes 
experience oxidative stress that is manifested as a possible conversion of PUFA to SFA. 
Additionally, the dystrophic phenotype is involved with altered membrane permeability. 
Identification of fibronectin after eccentric stretch demonstrated increase in membrane 
damage in dystrophic EDL at 20 weeks, suggesting disruption of cell membrane integrity 
in 5 % of fibres after eccentric contractions. 
Increased saturation of membrane was correlated to susceptibility of the EDL, but 
not SOL, to eccentric induced damage.  In dystrophic EDL, eccentric induced damage to 
the muscle may have been accompanied by an influx of Ca
2+
, a subsequent loss of Ca
2+
 
homeostasis and the activation of lipid oxidation pathways targeting membrane lipid 
composition, which in turn resulted in increased saturated forms of PL FA in the 
membrane. Alternatively, due to membrane structure-protein functional relationship, 
increased saturation in dystrophic membranes was possibly accompanied by decreased 
mechanical strength of sarcolemma, which after eccentric contractions mediated 
membrane damage, followed by Ca
+2 
entry,
 
disturbed Ca
+2 
homeostasis and final 
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oxidative damage.  In dystrophic SOL, alterations in membrane lipid composition were 
not linked with susceptibility to eccentric induced damage. This may be related to 
unsuccessful mechanical damage in SOL due to the relatively high proportion of type I 
fibres, which are more resistant to mechanical damage. Furthermore, despite a lack of 
evidence for membrane damage, mitochondrial membrane PL FA of dystrophic SOL was 
altered, suggesting eccentric induced muscle damage may proceed changes to membrane 
lipid composition in this muscle.    
It is important to note that expression of a muscle-specific nNOS transgene in 
dystrophic muscle prevented the majority of histologically discernible pathology in mdx 
mice, including a reduction in sarcolemmal lesions (Wehling et al, 2001). However, a 
recent study showed that there is not a simple relationship between decreasing oxidative 
stress (increase nNOS) at the sarcolemma and the severity of dystrophic damage (Harper 
et al., 2002). Moreover, this research suggested that increase in saturation accompanied 
by decrease susceptibility to oxidative damage was not linked to alleviation of damage. 
This might be in contrary to the speculations that by decreasing the susceptibility of 
membranes to oxidative stress (increase saturation, increase nNOS), the respective 
dama   d    a   . T      v d n    a     n     n  w    a “ w       yp       ”  Rand , 
2001) because it might indicate that decreased susceptibility to oxidative damage may 
not be the only mechanism in pathology of dystrophic muscles.  This interpretation is 
supported by the study showing nNOS null mutant mice, which have heightened 
susceptibility to oxidative stress does not demonstrate pathologies (Crosbie et al., 1998). 
Therefore, it indicates that although increased saturation may be an adaptation to 
oxidative stress, it is not sufficient to prevent pathology in dystrophin deficient muscles. 
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It further indicates that in addition to oxidative stress to the membranes that results in 
increased saturation, other pathways may be involved in the expression of the pathology.  
Alterations in membrane lipid composition, however, did not appear to be linked 
to the vulnerability of mdx myofibres to fibrosis. In both EDL and SOL, this may be due 
to very little to no fibrosis along with increased proportion of type I fibres that may have 
impacted the composition of the membrane of remaining fibres. Moreover, observed 
changes in membrane lipid composition of dystrophic muscle (increased saturation) may 
be a consequence of a cascade of events following eccentric induced muscle damage, and 
fibrosis may not influence the lipid composition of membranes.   
Taken together, the results of this research demonstrated the mdx muscle 
pathology and its progression with age. It also suggests that membrane lipid composition 
is associated with dystrophic damage. In this association, altered membrane lipid 
composition or increased membrane damage may be the preceding event. Specifically an 
increase in saturated membrane maybe linked with greater contraction induced damage. 
This further implicates the significance of membrane composition in modification of 
damage in muscular dystrophy.  
 
Limitations and future studies 
Despite the association of muscular dystrophy phenotypes in muscle damage and 
membrane PLFA compositions, there are number of limitations to the study that require 
future research. 
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 First, findings of the present study have assessed the association of phenotypes 
including eccentric induced damage and fibrosis with membrane PL FA composition. 
However, fibre type compositions and the supporting role of regeneration on 
susceptibility of mdx myofibres to damage, the relation of alteration in membrane PL FA 
composition and muscle damage was solely correlative and not causative. As such, we 
were not able to demonstrate alterations of membrane PL FA composition as an 
underlying initial etiology of muscle damage in muscular dystrophy. To address this 
limitation, it is suggested to examine the pathology of mdx before 5 weeks of age where 
regeneration is minimal. Assessment of isolated fast and slow twitch myofibres may also 
provide insight about the underlying role of membrane PL FA composition in the 
presentation of dystrophic process at different ages without the influence of fibre type 
shifts. 
Second, the symptoms of the dystrophic pathology are cumulative and there are 
several different stages in the severity of the disorder between growth, maturation and 
aging (Keeling et al., 2007).  After 10 weeks of age, degeneration of dystrophic fibres 
subside, that results in chronic but low grade damage (Grounds et al., 2008). However, 
from 20 weeks onward the cycles of regeneration gradually decrease. In the present 
study, we have utilized two groups of age at 10 and 20 weeks of age, that led to a narrow 
age range of 10 weeks that may not represent the temporal changes of the phenotype 
from early to later ages. To address this limitation, it is suggested to examine all aspects 
of phenotype before 3 weeks (degeneration is not present and myofibres are not 
susceptible to damage) and after 18 months of age (fibrosis prominently increases, 
regeneration highly decreases) to examine the trajectory of the association between 
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membrane PL FA and muscle susceptibility to damage (Grange et al., 2002; Whitehead 
et al, 2005; Stedman et al., 1991).  Examination of dystrophic phenotypes before 3 weeks 
contributes to investigate the association between phenotypes with minimum influence of 
myogenesis. Moreover, evaluation of mdx muscle damage after 18 months may provide 
more concrete evidence of the cumulated fibrosis that may not be apparent at 20 weeks of 
age.   
 
Practical advantages of investigating PL FA of skeletal muscle fibres 
Emerging evidence from a wide variety of muscle models has established the 
importance of membrane lipid content in mammalian skeletal muscles.  As these 
emerging studies become more conventional, the ability to detect, identify, and 
characterize lipid changes in various skeletal muscle disorders will promote the 
understanding of the important role of cell membrane in human disease. While the 
genetic defect for DMD was identified in 1987, there is still no effective treatment for 
DMD (Odom et al., 2007; Radley et al., 2007). The therapeutic research approach that 
has received most attention to present is replacement of functional dystrophin complex 
by genetic, cell transplantation or molecular interventions (Chakkalakal, 2005; Lovering, 
2005). Thus the mechanism by which regenerated mdx fibres restore adequate function in 
the absence of dystrophin may help provide clues to effective non-genetic interventions 
for muscular dystrophy in humans. 
This research has underscored the importance of certain PL FA compositions in 
mitigation of damage to dystrophic myofibres. In parallel, membranes and their lipid 
profile can be influenced by administration of exercise and exogenous nutritional or 
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pharmaceutical factors to possibly reduce the extent of myofibre pathology. Involvement 
of PUFA in membranes may be associated with change in membrane fluidity (Garzetti et 
al., 1993). Through alteration in such membrane physical parameters, dystrophin 
deficient muscles may be more capable to endure the shearing force of contractions. 
Therefore, it would be of interest to examine dystrophic muscles phenotype after 
involvement with pharmaceutical, dietary and exercise interventions. 
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APPENDIX A 
Supplementary results 
Stiffness  
 
Fig.A.1. Stiffness responses for each of 5 stretches in 10 and 20 week mdx and WT EDL. 
Values are mean ± SEM. Lack of significant changes in stiffness from stretch 1 to 5 
within and between groups. 
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Fig A.2. Representative force outputs of extensor digitorum longus (EDL) and solues 
(SOL) at mdx and WT at 20 and 20 weeks. Values are mean ± SEM. * denotes 
significance from WT.  
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Fig A.3. Linear fitted regression model of percentage of fibronectin positive fibres after 
eccentric induced damage with force deficit in extensor digitorum longus (WT, r:0.22, 
p<0.05; mdx,r: 0.48, p<0.05).   
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Fig. A.4. Phospholipid species from WT and mdx mice EDL in 10 and 20 week of age. 
Va     a   m an  ± SEM. * d n        n f  an   f  m WT . † d n        n f  an   f  m 
10 wks old. 
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Fig. A.5. Four major fatty acid classes of EDL obtained from 10 and 20 wks old WT and 
mdx mice. Values are mean ± SEM. * denotes significance from WT within same age 
group. 
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Fig.A.6. Phospholipid species from WT and mdx mice SOL in 10 and 20 weeks of age. 
Values are means ± SEM. * denotes significance from WTs. 
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Fig. A.7. Four major fatty acid classes of SOL obtained from 10 and 20 wks old WT and 
mdx mice. Values are mean ± SEM. * denotes significance from WT within same age 
group.  
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Table A.1. Percent mole fraction of phosphatidylcholine of extensor digitorum longus 
muscles from mdx and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
12:0 1.4 ± 0.5 1.4 ± 0.8 1.3 ± 0.8 1.5 ± 0.7 
14:0 3.3 ± 1.2 3.3 ± 2.9 1.8 ± 0.7 2.1 ± 0.8 
15:0 1.4 ± 0.7 1.3 ± 0.7 1.7 ± 1.0 1.9 ± 0.7 
16:0 17.2 ± 2.9 18.6 ± 6.1 18.9 ± 9.3 19.7 ± 10.6 
17:0 2.9 ± 1.7 3.9 ± 1.3 3.1 ± 1.1 2.7 ± 1.0 
18:0
 
12.4 ± 3.6 11.6 ± 2.8 21.7 ± 9.6* 23.2 ± 5.6* 
20:0 1.7 ± 0.8 2.5 ± 1.2 2.1 ± 1.3 2.3 ± 0.7 
22:0 2.7 ± 0.7 2.8 ± 1.5 2.1 ± 1.4 1.9 ± 1.1 
23:0 0.9 ± 0.4 1.2 ± 0.8 0.9 ± 0.7 1.1 ± 0.8 
15:1 0.5 ± 0.3 0.7 ± 0.3 1.9 ± 0.5 2.3 ± 0.5 
16:1
 
3.1 ± 1.7 3.2 ± 1.4 5.7 ± 2.4 6.9 ± 0.8 
17:1 0.8 ± 0.2 1.1 ± 0.4 1.4 ± 0.9 1.7 ± 0.4 
18:1
 
9.2 ± 3.7 10.6 ± 3.2 16.2 ± 5.3* 
 
21.1 ± 8.1* 
20:1 1.2 ± 0.4 1.3 ± 0.7 1.2 ± 0.5 1.1 ± 0.4 
22:1 nd nd 1.4 ± 0.7 1.7 ± 0.6 
18:3n3 1.1 ± 0.6 1.3 ±0.6 0.9 ± 0.4 1.1 ± 0.4 
20:3n3 10.3 ± 3.6 9.2 ± 2.7 7.6 ± 1.3 7.0 ± 1.5 
20:5n3 2.1 ± 0.9 1.9 ± 0.8 1.1 ± 0.1 1.1 ± 0.6 
22:6n3
 
4.8 ± 1.2 4.1 ± 1.5 3.9 ± 1.2 4.0 ± 1.3 
18:2n6 9.3 ± 1.2 9.2 ± 1.3 3.3 ± 0.5* 2.2 ± 1.3* 
18:3n6 1.1 ± 0.3 1.3 ± 0.5 1.1 ± 0.4 0.7 ± 0.4 
20:2n6 1.3 ± 0.8 1.1 ± 0.3 0.9 ± 0.6 0.8 ± 0.3 
20:3n6 3.3 ± 1.2 3.1 ± 1.5 1.8 ± 1.2 1.6 ± 1.1 
20:4n6 7.6 ± 1.2 7.3 ± 3.1 3.1 ± 2.3 1.9 ± 0.6 
22:2n6 0.9 ± 0.6 1.2 ± 0.8 nd nd 
Total saturates 47.1 ± 8.3 48.1 ± 6.7 45.2 ± 3.6 38.7 ± 10.2 
Total monoenes 16.1 ± 5.2 16.5 ± 1.4 38.9 ± 6.5* 44.9 ± 4.8* 
n3 polyenes 13.3 ± 2.9 12.2 ± 2.7 10.2 ± 1.4 7.2 ± 1.7 
n6 polyenes 23.5 ± 5.1 23.2 ± 3.2 5.7 ± 3.8* 5.0 ± 1.4* 
UI 137 ± 6 131 ± 5 110 ± 7 95 ± 4*† 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; UI,  n a   a   n  nd x = ∑mi×ni where mi is the mole percentage and ni is the number of carbon-
carbon double bonds of the fatty acid. 
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Table A.2. Percent mole fraction of sphingomyelin of extensor digitorum longus muscles 
from mdx and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
12:0 1.1 ±0.4 1.1 ± 0.4 0.9 ± 0.3 0.7 ± 0.2 
14:0 1.9 ±0.7 1.7 ± 0.8 1.6 ± 0.7 1.6 ± 0.5 
15:0 2.5 ± 0.9 2.6 ± 0.4 2.3 ± 0.5 2.2 ± 0.6 
16:0 18.7 ± 5.6 18.3 ± 3.9 16.9 ± 1.3 16.8 ± 3.4 
17:0 3.9 ± 1.0 3.5 ± 1.2 3.1 ± 1.0 2.9 ± 0.4 
18:0
 
13.9 ± 2.5 13.7 ± 9.1 12.9 ± 4.3 12.3 ± 3.9 
20:0 2.9 ± 0.8 2.8 ± 5.3 2.6 ± 1.2 2.4 ± 0.7 
22:0 8.3 ± 2.4 8.3 ± 3.2 7.9 ±3.5 7.4 ± 2.4 
23:0 1.6 ± 0.5 1.3 ± 0.8 1.1 ± 0.4 1.1 ± 0.1 
15:1 1.3 ± 0.4 1.5 ± 0.4 2.1 ± 0.8 2.9 ± 0.7 
16:1
 
2.7 ± 0.9 3.1 ± 1.3 4.9 ±1.3 5.6 ± 1.3 
17:1 0.7 ± 0.2 1.2 ± 0.4 2.6 ± 0.8 3.7 ± 1.0 
18:1
 
4.1 ± 1.2 4.9 ± 2.1 5.3 ± 1.8 6.7 ± 1.1* 
20:1 1.3 ± 0.5 1.5 ± 0.5 2.4 ± 0.7 2.5 ± 0.8 
22:1 1.1 ± 0.3 1.3 ± 0.7 1.7 ± 0.5 2.1 ± 0.6 
24:1 7.5 ± 3.1 7.8 ± 1.4 12.3 ± 2.9 14.8 ± 2.3 
18:3n3 0.9 ± 0.2 0.9 ± 0.1 0.8 ± 0.2 0.7 ± 0.1 
20:3n3 1.5 ± 0.6 1.2 ± 0.6 1.0 ± 0.3 0.9 ± 0.3 
20:5n3 1.1 ± 0.3 1.0 ± 0.3 nd nd 
22:6n3
 
5.3 ±  1.2 5.1 ± 2.3 4.7 ± 2.1 4.3 ± 1.7 
18:2n6 2.8 ± 2.4 2.6 ± 0.3 2.3 ± 0.8 1.9 ± 0.4 
18:3n6 1.2 ± 0.7 1.1 ± 0.5 0.9 ± 0.1 0.7 ±0.3 
20:2n6 0.7 ± 0.3 0.7 ± 0.4 nd nd 
20:3n6 2.9 ± 1.1 2.7 ± 1.2 1.9 ± 0.5 1 ± 0.7 
20:4n6 1.9 ± 0.2 1.7 ± 0.6 1.4 ±0.9 0.9 ± 0.2 
22:2n6 8.6 ± 3.6 8.4 ± 2.5 6.1 ± 3.1 4.1 ± 1.0 
Total saturates 54.8 ± 3.6 53.3 ± 9.5 49.3 ± 2.4 47.4 ± 4.1 
Total monoenes 18.7 ± 2.5 21.3 ± 4.8 31.3 ± 9.5 * 38.3 ± 5.3 * 
n3 polyenes 8.8 ± 1.6 8.2 ± 0.9 6.5 ± 1.2 6.3 ± 0.8 
n6 polyenes 18.1 ± 6.4 17.2 ± 4.2 12.9 ± 1.4 8.0 ± 1.3 * † 
UI 107 ± 3 * 104 ± 8 95 ± 7 89 ± 6 * 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI,  n a   a   n  nd x = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.3. Percent mole fraction of phosphatidylethanolamine of extensor digitorum 
longus muscles from mdx and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
14:0 1.0 ± 0.2 1.1 ± 0.5 1.2 ± 0.2 0.9 ± 0.4 
15:0 1.5 ± 0.4 1.4 ± 0.3 1.3 ± 0.6 2.1 ± 0.8 
16:0 0.8 ± 0.2 0.7 ± 0.4 0.9 ± 0.3 1.1 ± 0.6 
17:0 9.7 ± 3.2 10.2 ± 3.6 10.7 ± 5.3 11.2 ± 0.5 
18:0 1.4 ± 0.4 1.3 ± 0.7 1.8 ± 0.5 1.9 ± 0.4 
20:0 18.9 ± 5.2 19.2 ± 6.8 20.1 ± 5.3 20.5 ± 6.2 
14:1 1.3 ± 0.4 1.5 ± 0.5 1.4 ± 0.3 2.2 ± 0.5 
15:1 1.3 ± 0.5 1.4 ± 0.3 1.2 ± 0.4 1.5 ± 0.6 
16:1 4.8 ± 1.1 4.7 ± 1.1 4.5 ± 1.1 4.7 ± 3.4 
17:1 0.5 ± 0.2 0.7 ± 0.2 2.6 ± 0.6 3.1 ± 1.9 
18:1 1.4 ± 0.4 1.5 ± 0.6 4.5 ± 2.3* 4.7 ± 1.5* 
20:1 0.7 ± 0.3 1.1 ± 0.3 1.0 ± 0.2 1.1 ± 0.4 
18:3n3 8.2 ± 2.1 8.8 ± 3.6 14.7 ± 4.3 14.8 ± 3.4 
20:3n3 1.2 ± 0.9 1.0 ± 0.4 0.8  ± 0.4 1.0 ± 0.4 
22:6n3 1.9 ± 0.5 2.1 ± 0.6 1.8 ± 0.5 1.7 ± 0.3 
18:2n6 13.5 ± 2.7 11.7 ± 4.9 7.2 ± 3.6 * 5.9 ± 3.1 *
†
 
18:3n6 0.8 ± 0.2 0.9 ± 0.3 1.2 ± 0.4 1.9 ± 0.4 
20:3n6 4.6 ± 2.1 4.2 ± 2.2 3.1 ± 1.8 2.2 ± 0.7 
Total saturates 1.9 ± 0.4 1.4 ± 0.3 0.5 ± 0.2 0.6 ± 0.2 
Total monoenes 40.8 ± 9.8 41.5 ± 11.6 43.1 ± 8.2 46.1 ± 13.1 
n3 polyenes 12.1 ± 3.6 13.1 ± 2.9 23.6 ± 6.9 26.6 ± 5.8 
n6 polyenes 20.9 ± 12.7 18.3 ± 6.7 12.1 ± 0.5* 10.7 ± 4.1* 
UI 172 ± 5 169 ± 9 142 ± 5 131 ± 6 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI, unsaturation index = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.4. Percent mole fraction of phosphatidylserine of extensor digitorum longus 
muscles from mdx and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
14:0 1.1 ± 0.5 1.2 ± 0.4 1.1 ± 0.6 1.1 ± 0.4 
15:0 1.2 ± 0.8 1.6 ± 0.8 1.4 ± 0.5 1.7 ± 0.8 
16:0 1.9 ± 0.8 2.1 ± 0.8 1.6 ± 0.6 1.9 ± 1.0 
17:0 15.8 ± 6.5 16.1 ± 6.5 20.9 ± 6.7 14.4 ± 6.4 
18:0 23.7 ± 11.2 23.1 ± 11.8 16.5 ± 3.7* 15.8 ± 4.6* 
20:0 0.9 ± 0.6 1.3 ± 0.4 1.3 ± 0.8 1.7 ± 0.4 
14:1 2.5 ± 1.1 2.7 ± 1.1 2.4 ± 0.7 2.1 ± 0.8 
15:1 0.8 ± 0.2 0.9 ± 0.3 1.5 ± 0.8 1.8 ± 0.3 
16:1 1.1 ± 0.5 1.3 ± 0.4 1.7 ± 0.4 1.7 ± 0.7 
17:1 2.1 ± 0.4 2.4 ± 1.1 7.8 ± 3.4 6.5 ± 1.1 
18:1 0.9 ± 0.3 1.7 ± 0.5 3.9 ± 1.2* 4.3 ± 2.1* 
20:1 6.3 ± 3.0 6.9 ± 3.4 18.4 ± 9.2 25.3 ± 5.8 
18:3n3 3.1 ± 1.2 3.3 ± 1.0 5.6 ± 2.1 4.2 ± 1.9 
20:3n3 1.0 ± 0.3 nd nd 1.1 ± 0.7 
20:5n3 1.8 ± 0.5 1.8 ± 0.4 1.3 ± 0.4 1.1 ± 0.4 
22:6n3 6.2 ± 3.1 5.8 ± 2.2 4.8 ± 2.2 3.1 ± 1.3 
18:2n6 4.4 ± 2.1 3.8 ± 1.3 3.5 ± 1.1 2.4 ± 1.1 
18:3n6 9.3 ± 1.5 9.2 ± 3.1 3.3 ± 1.3 2.2 ± 0.6 
20:2n6 1.1 ± 0.4 1.3 ± 0.6 1.1 ± 0.6 0.7 ± 0.4 
20:3n6 1.3 ± 0.6 1.1 ± 0.5 0.9 ± 0.3 0.8 ± 0.3 
20:4n6 7.6 ± 2.3 7.3 ± 2.1 3.1 ± 1.1 1.9 ± 0.8 
Total saturates 47.1 ± 11.5 48.1 ± 6.7 45.2 ± 14.0 38.7 ± 12.7 
Total monoenes 16.1 ± 3.8 16.5 ± 3.8 38.9 ± 11.3 44.9 ± 11.9 
n3 polyenes 13.3 ± 2.4 12.2 ± 4.8 10.2 ± 9.8 7.2 ± 3.1* 
n6 polyenes 23.5 ± 3.8 23.2 ± 5.8 5.7 ± 1.8* 5.0 ± 1.5* 
UI 137 ± 6 131 ± 5 110 ± 7 
 
95 ± 4* 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI,  n a   a   n  nd x = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.5. Percent mole fraction of phosphatidylinositol of extensor digitorum longus 
muscles from mdx and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
14:0 1.2 ± 0.5 1.1 ± 0.4 0.9 ± 0.4 0.9 ± 0.4 
15:0 3.8 ± 1.1 3.7 ± 1.1 3.6 ± 1.2 3.3 ± 1.1 
16:0 1.4 ± 0.5 1.4 ± 0.8 1.1 ± 0.3 0.9 ± 0.3 
17:0 9.4 ± 3.4 8.9 ± 2.1 7.8 ± 1.5 6.3 ± 2.4 
18:0 27.1 ± 11.8 25.4 ± 9.7 23.8 ± 12.0 22.3 ± 6.7 
20:0 1.4 ± 0.8 1.3 ± 0.8 1.6 ± 0.7 1.1 ± 0.6 
14:1 0.8 ± 0.4 0.7 ± 0.2 0.7 ± 0.3 0.7 ± 0.4 
15:1 0.8 ± 0.3 0.6 ± 0.2 0.9 ± 0.3 1.1 ± 0.4 
16:1 1.2 ± 0.6 1.3 ± 0.5 1.7 ± 1.0 2.3 ± 1.0 
17:1 4.6 ± 1.2 5.5 ± 1.5 8.9 ± 3.7 9.3 ± 3.1 
18:1 nd nd 1.2 ± 0.5 1.7 ± 1.0 
20:1 3.5 ± 2.1 4.9 ± 1.3 17.1 ± 9.4 20.1 ± 5.9 
18:3n3 0.8 ± 0.4 1.0 ± 0.6 1.6 ± 0.4 2.9 ± 1.4 
20:3n3 nd nd 1.3 ± 0.4 1.5 ± 0.6 
20:5n3 1.3 ± 0.4 1.6 ± 0.5 1.2 ± 0.4 0.9 ± 0.4 
22:6n3 13.9 ± 6.7 14.1 ± 7.8 10.5 ± 3.1 9.8 ± 3.8 
18:2n6 5.3 ± 1.1 4.9 ± 1.8 2.1 ± 0.4 1.9 ± 0.6 
18:3n6 10.3 ± 2.3 10.4 ± 3.5 6.3 ±2.1 5.8 ± 1.8 
20:2n6 1.3 ± 0.8 1.2 ± 0.4 0.8 ± 0.3 0.9 ± 0.6 
20:3n6 4.7 ± 1.8 4.8 ± 2.1 2.4 ± 1.0 2.3 ± 1.8 
20:4n6 2.7 ± 1.1 2.8 ± 1.1 0.7 ± 0.3 0.7 ± 0.3 
Total saturates 46.8 ± 11.0 43.9 ± 12.8 41.0 ± 16.7 37.2 ± 11.8 
Total monoenes 10.9 ± 2.7 13.3 ± 6.3 32.7 ± 6.1* 38.9 ± 8.2* 
n3 polyenes 20.5 ± 3.7 20.6 ± 3.4 13.8 ± 8.1 12.1 ± 4.1 
n6 polyenes 21.8 ± 5.9 22.2 ± 7.0 12.5 ± 6.4* 11.8 ± 3.0* 
UI 139 ±8 142 ±3 108 ± 8* 109 ± 4* 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI, unsaturation index = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.6. Percent mole fraction of cardiolipin of extensor digitorum longus muscles 
from mdx and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
16:0 2.8 ± 1.1 4.3 ± 2.1 5.1 ± 2.1 4.6 ± 2.1 
18:0 6.1 ± 1.5 6.6 ± 2.8 8.0 ± 3.1 8.3 ± 1.7 
16:1 2.1 ± 1.0 2.2 ± 1.0. 7.5 ± 2.2 8.3 ± 2.1 
17:1 1.0 ± 0.5 1.3 ± 0.5 1.3 ± 0.8 1.4 ± 0.4 
18:1 9.2 ± 3.4 9.8 ± 3.0 18.3 ± 6.2 20.6 ± 11.8 
20:1 0.7 ± 0.3 1.3 ± 0.4 3.2 ± 1.1 3.8 ± 1.5 
20:3n3 1.1 ± 0.3 1.3 ± 0.5 1.1 ± 0.4 1.6 ± 0.4 
22:6n3 3.3 ± 2.1 3.5 ± 1.2 1.2 ± 0.6 1.3 ± 0.5 
18:2n6 63.5 ± 9.6 60.4 ± 8.0 41.9 ± 9.3* 37.9 ± 10.7* 
20:2n6 2.7 ± 1.3 2.3 ± 1.8 1.8 ± 0.7 1.5 ± 0.8 
20:3n6 3.4 ± 1.4 1.0 ± 0.3 0.9 ± 0.5 0.8 ± 0.3 
20:4n6 1.3 ± 0.6 1.1 ± 0.7 1.7 ± 0.4 1.4 ± 0.4 
Total saturates 9.1 ± 2.1 11.5 ± 3.1 14.1 ± 6.2 14.3 ± 2.0 
Total monoenes 13.3 ± 2.4 15.3 ± 4.0 31.7 ± 3.4* 36.2 ± 11.8* 
n3 polyenes 4.4 ± 1.2 4.8 ± 3.1 2.3 ± 0.4 2.9 ± 1.0 
n6 polyenes 
 
70.9 ± 20.3 64.8 ± 11.5 46.3 ± 11.0* 41.6 ± 12.8* 
UI 
UI 
184 ± 2 173 ± 5 139 ± 1* 135 ± 6* 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI, unsaturation  nd x = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.7. Percent mole fraction of cardiolipin in soleus muscles from mdx and wild type 
mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
14:0 1.3 ± 0.5 1.4 ± 0.3 1.4 ± 0.4 1.6 ± 0.4 
15:0 0.9 ± 0.3 0.9 ± 0.2 1.1 ± 0.4 1.1 ± 0.6 
16:0 5.3 ± 1.7 5.5 ± 1.3 5.8 ± 1.8 5.9 ± 0.8 
17:0 2.9 ± 0.5 3.2 ± 0.9 3.2 ± 1.1 3.4 ± 1.1 
18:0 8.9 ± 3.6 9.1 ± 1.7 10.0 ± 2.6 9.8 ± 1.2 
20:0 1.1 ± 0.3 1.4 ± 0.4 1.5 ± 0.4 1.3 ± 0.5 
14:1 nd nd nd 1.3 ± 0.2 
15:1 3.1 ± 0.2 2.7 ± 1.0 2.8 ± 0.4 3.4 ± 1.3 
16:1 0.9 ± 0.1 1.3 ± 0.5 1.4 ± 0.3 1.8 ± 0.4 
17:1 2.9 ± 0.4 3.1 ± 0.9 3.2 ± 1.9 3.2 ± 1.4 
18:1 4.8 ± 1.6 5.1 ± 1.5 5.6 ± 2.1 5.9 ± 2.3 
20:1 1.2 ± 0.4 1.1 ± 0.5 0.9 ± 0.3 1.0 ± 0.3 
18:3n3 1.9 ± 0.4 1.6 ± 0.9 1.4 ± 0.9 1.5 ± 0.5 
20:3n3 4.3 ± 1.7 4.2 ± 1.8 3.9 ± 1.5 3.8 ± 1.2 
20:5n3 1.8 ± 0.9 1.8 ± 0.7 1.9 ± 0.6 1.4 ± 0.5 
22:6n3 3.2 ± 1.6 3.3 ± 1.2 3.1 ± 0.9 3.2 ± 1.4 
18:2n6 43.7 ± 9.7 43.1 ± 12.1 42.9 ± 8.7 39.8 ± 5.8 
18:3n6 4.5 ± 2.3 4.3 ± 3.1 4.0 ± 1.3 3.8 ± 1.1 
20:2n6 1.9 ± 0.9 1.7 ± 0.9 0.8 ± 0.3 0.7 ± 0.2 
20:3n6 2.7 ± 0.9 2.8 ± 0.8 2.4 ± 0.7 2.5 ± 1.1 
20:4n6 1.2 ± 0.4 1.0 ± 0.5 1.1 ± 0.6 1.0 ± 0.2 
Total saturates 21.1 ± 5.4 22.1 ± 4.7 23.8 ± 2.9 24.1 ± 2.7 
Total monoenes 12.9 ± 2.1 13.3 ± 3.2 13.9 ± 1.7 17.4 ± 4.0 *† 
n3 polyenes 11.2 ± 4.5 10.9 ± 3.0 10.3 ± 1.7 9.9 ± 2.7 
n6 polyenes 54.8 ± 3.2 53.7 ± 12.1 52.0 ± 4.9 48.6 ± 11.7 * 
UI 178 ± 7 176 ± 4 170 ± 5 165 ± 7 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; † d n        n f  an  ma n  ffect for 
age. WT, wild type; UI, unsaturation index = ∑m ×n  w     m         m    p    n a   and n         n m    
of carbon-carbon double bonds of the fatty acid. 
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Table A.8. Percent mole fraction of sphingomyelin in soleus muscles from mdx and wild 
type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
12:0 1.6 ± 0.5 1.9 ± 0.4 2.1 ± 0.8 2.4 ± 1.1 
14:0 1.1 ± 0.6 1.5 ± 0.6 1.9 ± 0.6 2.1 ± 0.9 
15:0 2.8 ± 1.1 3.2 ± 1.1 3.7 ± 2.4 4.2 ± 2.1 
16:0 10.5 ± 2.5 11.8 ± 2.5 12.5 ± 3.4 13.8 ± 3.8 
17:0 3.7 ± 1.1 4.1 ± 1.2 4.0 ± 1.5 3.6 ± 1.7 
18:0
 
23.6 3.1 23.8 ± 6.5 26.7 ± 3.7 26.9 ± 9.2 
20:0 1.6 ± 0.8 1.9 ± 0.4 2.3 ± 0.8 3.1 ± 0.8 
22:0 2.2 ± 1.1 2.0 ± 0.6 2.7 ± 1.1 2.9 ± 1.1 
23:0 1.8 ± 0.9 1.6 ± 0.5 1.6 ± 0.8 1.7 ± 0.8 
14:1 0.9 ± 0.2 1.6 ± 0.8 1.6 ± 0.5 2.1 ± 1.4 
15:1 0.6 ± 0.3 1.2 ± 0.6 1.3 ± 0.4 1.3 ± 0.8 
16:1
 
1.7 ± 0.6 1.6 ± 0.8 2.1 ± 0.7 2.7 ± 1.0 
17:1 0.8 ± 0.4 1.0 ± 0.4 1.3 ± 0.8 1.3 ± 0.8 
18:1
 
3.6 ± 1.1 3.7 ± 1.1 5.1 ± 2.2 5.6 ± 2.8 
20:1 1.1 ± 0.6 1.3 ± 0.6 1.6 ± 0.7 1.9 ± 0.8 
24:1 2.9 ± 1.1 2.6 ± 1.0 2.9 ± 1.0 3.5 ± 1.8 
18:3n3 1.7 ± 0.8 1.8 ± 0.6 1.9 ± 0.7 1.3 ± 0.9 
20:3n3 3.5 ± 2.1 3.4 ± 1.0 2.3 ± 1.1 2.1 ± 1.0 
20:5n3 nd nd nd nd 
22:6n3
 
5.7 ± 2.1 4.9 ± 1.5 4.7 ± 1.4 4.2 ± 1.8 
18:2n6 11.3 ± 3.1 11.6 ± 3.0 9.8 ± 3.4 6.8 ± 2.2 
18:3n6 5.7 ± 2.2 5.1 ± 1.5 3.2 ± 1.4 2.7 ± 1.1 
20:2n6 2.3 ± 1.0 2.0 ± 0.7 1.3 ± 0.8 1.0 ± 0.8 
20:3n6 4.9 ±1.0 3.6 ± 0.9 2.7 ± 0.7 `2.1 ± 0.8 
20:4n6 1.8 ± 0.8 1.2 ± 0.7 nd nd 
22:2n6 1.7 ± 0.6 1.6 ± 0.8 nd nd 
Total saturates 48.9 ± 11.0 51.8 ± 11.7 57.6 ± 4.7 60.7 ± 11.7 
Total monoenes 11.6 ± 6.8 13.0 ± 2.8 16.5 ± 3.8* 19.1 ± 9.7* 
n3 polyenes 10.9 ± 5.2 10.1 ± 3.7 8.9 ± 1.7 7.6 ± 3.1 
n6 polyenes 28.6 ± 9.0 25.1 ± 6.5 17.0 ± 6.4* 12.6 ± 3.4* 
UI 131 ± 7 119 ±3 97 ± 2* 84 ± 5*† 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI, unsaturation index = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.9. Percent mole fraction of phosphatidylethanolamine in soleus muscles from 
mdx and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
12:0 0.9 ± 0.3 1.1 ± 0.3 0.7 ± 0.3 1.7 ± 0.4 
14:0 1.1 ± 0.6 1.7 ± 0.4 1.6 ± 0.5 3.0 ± 0.9 
15:0 2.3 ± 1.1 1.3 ± 0.5 0.9 ± 0.4 2.2 ± 0.7 
16:0 12.3 ± 6.2 11.9 ± 4.0 14.3 ± 3.8 14.9 ± 2.8 
17:0 2.3 ± 1.2 2.9 ± 0.5 2.0 ± 0.8 1.5 ± 0.7 
18:0
 
19.9 ± 6.8 18.6 ± 6.1 18.9 ± 5.7 20.8 ± 6.8 
20:0 2.3 ± 0.6 1.7 ± 0.4 0.9 ± 0.3 0.6 ± 0.3 
22:0 1.3 ± 0.9 0.8 ± 0.3 1.0 ± 0.4 nd 
23:0 0.8 ± 0.4 0.8 ± 0.2 0.9 ± 0.3 0.5 ± 0.3 
14:1 1.1± 0.3 0.9 ± 0.4 1.0 ± 0.2 1.3 ± 0.6 
15:1 0.9 ± 0.2 1.1 ± 0.5 1.3 ± 0.4 0.9 ± 0.4 
16:1
 
2.1 ± 0.8 2.3 ± 0.9 2.6 ± 1.1 3.1 ± 1.9 
17:1 0.7 ± 0.3 0.7 ± 0.4 0.9 ± 0.5 1.2 ± 0.8 
18:1
 
5.3 ± 1.7 5.9 ± 2.5 9.3 ± 2.0* 9.1 ± 2.4* 
20:1 1.3 ± 0.2 1.0 ± 0.4 1.0 ± 0.4 1.1 ± 0.4 
24:1 0.6 ± 0.2 0.9 ± 0.2 1.1 ± 0.5 1.0 ± 0.3 
18:3n3 1.2 ± 0.5 1.1 ± 0.5 0.9 ± 0.2 0.9 ± 0.4 
20:3n3 2.3 ± 1.4 2.1 ± 0.8 0.8 ± 0.3 0.9 ± 0.3 
20:5n3 0.9 ± 0.6 0.8 ± 0.3 1.1 ± 0.5 1.2 ± 0.5 
22:6n3
 
8.3 ± 2.1 7.8 ± 2.5 7.9 ± 1.2 8.2 ± 2.8 
18:2n6 24.6 ± 10.1 25.9 ± 6.3 23.1 ± 6.1 20.3 ± 9.7 
18:3n6 2.3 ± 0.5 3.2 ± 1.1 2.9 ± 1.1 2.1 ± 1.0 
20:2n6 3.5 ± 2.0 1.2 ± 0.7 1.3 ± 0.7 1.0 ± 0.4 
20:3n6 1.9 ± 0.6 1.2 ± 0.9 1.1 ± 0.4 0.8 ± 0.3 
20:4n6 3.1 ± 1.2 1.9 ± 0.5 1.8 ± 0.5 1.1 ± 0.4 
22:2n6 43.2 ± 6.9 40.8 ± 13.5 41.2 ± 11.2 45.2 ± 9.7 
Total saturates 43.2 ± 6.9 40.8 ± 13.5 41.2 ± 11.2 45.2 ± 9.7 
Total monoenes 12.8 ± 3.7 13.7 ± 6.4 17.9 ± 8.4 18.3 ± 6.5 
n3 polyenes 12.7 ± 4.3 11.8 ± 3.4 10.7 ± 3.4 11.2 ± 5.6 
n6 polyenes 31.3 ± 7.1 33.8 ± 9.7 30.2 ± 10.0 25.3 ± 9.8* 
UI 152 ± 6 145 ± 3 140 ± 4 132 ± 4* 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI,  n a   a   n  nd x = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.10. Percent mole fraction of phosphatidylcholine in soleus muscles from mdx 
and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
12:0 1.3 ± 0.2 1.2 ± 0.7 1.9 ± 0.8 2.1 ± 0.5 
14:0 1.6 ± 0.4 1.9 ± 1.2 2.3 ± 1.1 2.4 ± 1.1 
15:0 0.8 ± 0.3 0.7 ± 0.3 1.3 ± 0.5 1.5 ± 0.6 
16:0 20.3 ± 5.6 19.3 ± 6.8 21.3 ± 9.8 22.3 ± 11.0 
17:0 2.3 ± 1.2 1.9 ± 0.5 2.8 ± 1.1 2.1 ± 0.5 
18:0
 
11.8 ± 3.8 10.7 ± 5.1 14.9 ± 6.5 15.7 ± 4.9 
20:0 0.8 ± 0.2 0.8 ± 0.3 1.3 ± 0.7 1.9 ± 0.8 
23:0 1.3 ± 0.8 1.1 ± 0.8 1.4 ± 0.7 1.5 ± 0.4 
14:1 0.7 ±0.4 1.1 ± 0.6 1.2 ± 0.3 1.3 ± 0.7 
16:1
 
5.7 ± 2.1 6.1 ± 2.1 7.1 ± 2.9 7.2 ± 5.1 
17:1 1.1 ± 0.4 1.2 ± 0.5 2.6 ± 0.4 2.5 ± 1.1 
18:1
 
2.3 ± 1.1 2.6 ± 2.5 9.3 ± 2.9* 10.2 ± 6.9* 
20:1 1.5 ± 0.5 1.8 ± 0.4 1.9 ± 0.7 2.1 ± 0.9 
18:3n3 0.6 ± 0.3 0.7 ± 0.3 0.9 ± 0.6 1.1 ± 0.5 
20:3n3 8.3 ± 2.1 8.4 ± 4.6 9.1 ± 4.0 
.1 
10.7 ± 3.9 
22:6n3
 
4.8 ± 2.1 4.7 ± 2.0 5.5 ± 3.4 5.9 ± 3.5 
18:2n6 24.7 ± 12.1 24.9 ± 6.7 9.1 ± 5.3 5.3 ± 2.2 
18:3n6 3.6 ± 1.8 3.9 ± 1.2 1.1 ± 0.4 0.8 ± 0.4 
20:2n6 1.1 ± 0.6 1.6 ± 0.7 0.9 ± 0.6 0.7 ± 0.3 
20:3n6 3.5 ± 1.1 3.5 ± 1.8 1.8 ± 0.4 1.2 ± 0.7 
22:2n6 3.6 ± 1.8 3.9 ± 1.2 1.1 ± 0.4 0.8 ± 0.4 
Total saturates 40.9 ± 9.8 38.2 ± 13.8 47.8 ± 14.9 50.2 ± 22.3 
Total monoenes 11.8 ± 5.1 13.5 ± 5.7 23 ± 8.5* 24.2 ± 6.8* 
n3 polyenes 14.4 ± 6.1 14.4 ± 6.0 16.3 ± 3.8 17.6 ± 8.5 
n6 polyenes 32.9 ± 7.9 33.9 ± 10.5 12.9 ± 4.2* 8 ± 2.2*† 
UI 143 ± 7 147 ± 2 118 ± 7* 117 ±5* 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI,  n a   a   n  nd x = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.11. Percent mole fraction of phosphatidylinositol in soleus muscles from mdx 
and wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
12:0 1.9 ± 0.2 1.3 ± 0.5 2.3 ± 0.5 2.4 ± 1.1 
14:0 2.6 ± 1.1 2.8 ± 0.8 3.6 ± 0.9 3.3 ± 2.0 
15:0 1.7 ± 0.5 1.6 ± 0.7 1.4 ± 0.4 1.6 ± 0.4 
16:0 12.1 ± 5.6 13.3 ± 5.1 14.9 ± 3.7 15.9 ± 6.8 
17:0 4.9 ± 3.0 3.5 ± 2.3 3.7 ± 2.4 4.1 ± 2.7 
18:0
 
24.6 ± 12.8 28.8 ± 9.2 29.3 ± 6.2 31.2 ± 10.2 
22:0 nd 0.8 ± 0.4 1.2 ± 0.5 1.5 ± 0.6 
23:0 0.9 ± 0.3 1.3 ± 0.8 1.8 ± 0.5 nd 
14:1 1.3 ± 0.5 1.1 ± 0.3 1.3 ± 0.6 2.4 ± 0.6 
15:1 1.6 ± 0.8 1.7 ± 0.4 1.5 ± 0.4 1.6 ± 0.4 
16:1
 
2.0 ± 0.5 2.3 ± 0.9 2.5 ±1.1 3.6 ± 1.8 
17:1 1.4 ± 0.4 1.7 ± 0.8 2.1 ± 0.9 4.2 ± 2.4 
18:1
 
4.3 ± 2.2 4.9 ± 2.2 5.3 ± 2.8 6.8 ± 3.7 
20:1 0.8 ± 0.6 1.3 ± 0.9 1.2 ± 0.4 1.7 ± 0.4 
24:1 nd 0.6 ± 0.2 0.9 ± 0.6 1.3 ± 0.6 
18:3n3 2.9 ± 1.1 3.0 ± 1.3 3.4 ± 1.7 3.9 ± 1.1 
20:3n3 1.2 ± 0.5 1.2 ± 0.5 0.9 ± 0.4 0.6 ± 0.3 
20:5n3 1.9 ± 1.0 1.4 ± 0.4 1.5 ± 0.8 1.3 ± 0.9 
22:6n3
 
0.8 ± 0.3 1.3 ± 0.6 1 ± 0.4 0.8 ± 0.4 
18:2n6 9.4 ± 3.5 6.3 ± 2.4 4.1 ± 1.7* 3.6 ± 1.6* 
18:3n6 4.3 ± 2.7 3.6 ± 1.2 2.9 ± 2.4 2.3 ± 1.1 
20:2n6 1.3 ± 0.4 1.1 ± 0.8 1.6 ± 0.8 1.1 ± 0.5 
20:3n6 6.3 ± 2.6 4.9 ± 2.5 3.8 ± 0.3 0.6 ± 0.2 
20:4n6 3.7 ± 2.9 3.9 ± 1.3 3.4 ± 2.2 1.6 ± 0.5 
22:2n6 4.8 ± 2.0 4.1 ± 2.4 3.1 ± 0.4 1.5 ± 0.5 
Total saturates 49.4 ± 14.0 53.4 ± 14.0 58.2 ± 17.2 60.0 ± 11.5 
Total monoenes 14.3 ± 6.7 16.6 ± 5.7 18.2 ± 6.3 25.5 ± 3.9* 
n3 polyenes 6.5 ± 2.7 6.1 ± 2.3 4.7 ± 1.8 3.8 ± 1.5 
n6 polyenes 29.8 ± 9.4 23.9 ± 10.7 18.9 ± 6.0* 10.7 ± 5.1* 
UI 120 ± 8 108 ±2 89 ±58 69 ± 3*† 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI,  n a   a   n  nd x = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
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Table A.12. Percent mole fraction of phosphatidylserine in soleus muscles from mdx and 
wild type mice at 10 and 20 weeks old. 
Fatty WT mdx 
acid 10 wks 20 wks 10 wks 20 wks 
12:0 1.7 ± 0.5 1.6 ± 0.5 1.5 ± 0.5 1.7 ± 0.5 
14:0 1.6 ± 0.4 1.5 ± 0.6 1.7 ± 0.9 2.1 ± 0.5 
15:0 0.9 ± 0.6 1.2 ± 0.4 1.4 ± 0.5 1.5 ± 0.4 
16:0 6.3 ± 2.5 6.2 ± 3.2 6.7 ± 3.4 6.9 ± 2.3 
17:0 3.4 ± 0.7 3.2 ± 1.1 3.5 ± 1.1 3.4 ± 1.1 
18:0
 
30.1 ± 11.2 29.7 ± 13.2 30.5 ± 12.6 32.8 ± 11.3 
20:0 1.4 ± 0.4 1.5 ± 0.7 1.8 ± 0.6 0.9 ± 0.4 
22:0 0.9 ± 0.3 0.8 ± 0.3 0.9 ± 0.3 1.2 ± 0.5 
23:0 4.3 ± 2.2 4.4 ± 2.1 4.7 ± 1.2 3.8 ± 1.1 
14:1 2.1 ± 0.4 1.9 ± 0.7 2.1 ± 0.9 2.3 ± 0.8 
16:1
 
1.7 ± 0.3 1.5 ± 0.4 1.8 ± 0.7 2.5 ± 1.3 
18:1
 
6.6 ± 2.2 7.1 ± 3.4 8.1 ± 1.4 10.7 ± 6.8* 
24:1 0.8 ± 0.4 0.7 ± 0.4 0.9 ± 0.3 1.2 ± 0.4 
18:3n3 1.4 ± 0.8 1.8 ± 0.7 1.8 ± 1.0 2.2 ± 1.0 
20:3n3 0.6 ± 0.2 0.8 ± 0.3 0.6 ± 0.4 0.7 ± 0.3 
20:5n3 3.2 ± 1.1 3.4 ± 1.4 2.9 ± 1.2 2.1 ± 1.1 
18:2n6 7.4 ± 2.2 7.1 ± 3.2 6.9 ± 2.4 6.4 ± 1.8 
18:3n6 6.5 ± 3.1 6.6 ± 3.0 5.2 ± 2.0 4.9 ± 2.4 
20:2n6 1.8 ± 0.8 1.7 ± 0.6 2.1 ± 1.2 1.8 ± 1.0 
20:3n6 7.9 ± 2.1 7.6 ± 2.4 6.5 ± 3.4 5.4 ± 3.2 
20:4n6 3.9 ± 2.4 3.5 ± 1.6 2.9 ± 1.1 1.7 ± 0.8 
22:2n6 1.5 ± 0.4 1.1 ± 0.3 1.2 ± 0.8 0.6 ± 0.2 
Total saturates 50.6 ± 11.1 50.1 ± 12.5 52.7 ± 9.7 54.3 ± 11.7 
Total monoenes 13.2 ± 6.8 13.8 ± 6.4 15.6 ± 3.4 19.6 ± 6.8* 
n3 polyenes 7.2 ± 2.4 8.5 ± 2.7 6.9 ± 1.9 5.3 ± 1.8 
n6 polyenes 29.0 ± 12.5 27.6 ± 8.2 24.8 ± 11.08 20.8 ± 7.5 
UI 124 ± 7 127 ± 9 112 ±9 97 ± 7* 
Values are expressed as means ± SEM, percent mole fractions of fatty acids below 1% across all genotypes 
and ages are not shown. * denotes significant main effect for genotype; 
†
 denotes significant main effect for 
age; WT, wild type; UI, unsaturation  nd x = ∑mi×ni where mi is the mole percentage and ni is the number 
of carbon-carbon double bonds of the fatty acid. 
  
173 
 
APPENDIX B 
Laboratory procedures 
Part I: Stretch injury 
Functional testing of mouse skeletal muscles requires a minimum of four 
components: a force transducer to monitor force production, a stimulator and electrodes 
    x         m     , a  a        p  f        m      w     xy  na  d R n   ’         n, 
and a device to record force production. The system used at Brock University included 
the Aurora Scientific (Aurora, ON) that has been optimized for monitoring function in 
small tissues. Force transducer for isometric and lengthening contractions was a dual 
Mode (Force/Position) Servomotor that was able to control muscle length. The stimulator 
was an internal stimulator provided by Data Acquisition Controller hardware to deliver 
square wave (0.2 ms) electrical pulses.  
After muscle dissections, the excised muscle was placed immediately into 
oxygenated Ringer solution (maintained at 25 
º
C) and equilibrated for 5-10 min. silk 
suture was tied to the proximal and distal tendons during dissection and used as anchors 
to maintain resting length in the dish. 
Solution:  
NaCl (120mM), KCl (5 mM), CaCl2 (2mM), KH2PO4 (1mM), MgSO4 (1mM), Glucose 
(5mM), pH (7.3)  
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EDL stretch injury: 
1- Attach muscle to apparatus (one end of the muscle is tied to the lever arm of the 
position feedback servomotor and tie the other end of the muscle to a force 
transducer). 
2- Establish optimum length (L0 ). 
3- Subject the muscle to another series of isomeric and tetanic twitch 3 min apart. 
4- Control measurement of P0 and Pt:  Stimulate the muscle at 150 Hz for 0.5 ms to 
establish the control Pt.  To minimize muscle fatigue rest the muscles for 3 min, then 
stimulate at 150 Hz for 500 ms to establish control Po. 
5- Stimulated the muscle at 80 Hz for 700 ms. During the first 500 ms, contraction is 
isometric at L0, whereas during the final 200 ms the muscle stretch the muscle at 0.5 
L0/s to yield a total displacement of 0.1 L0. 
6- Repeat the stretch for total 5 times with intervals of 4 min rest. 
7- Immediately after the final stretch measure the twitch and tetani tensions. Re-
measure in 15 min to minimize muscle fatigue. 
SOL stretch injury: 
1- Mount muscle to apparatus (one end of the muscle is tied to the lever arm of the 
position feedback servomotor and tie the other end of the muscle to a force 
transducer). 
2- Establish optimum length (Lo). 
3- Subject the muscle to another series of isomeric and tetanic twitch 3 min apart. 
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4- Control measurement of Pt and P0: Stimulate the muscle at 150 Hz for 0.5 ms to 
establish the control Pt.  To minimize muscle fatigue rest the muscles for 3 min, then 
stimulate at 150 Hz for 500 ms to establish control P0. 
5- Immediately after the isometric tetanus adjust the muscle length from Lo to 0.9 L0, 
and have the muscle rest for 4 min. 
8-  For eccentric contraction stretch the muscle from 0.9 Lo to 1.1 Lo with the velocity 
of 1.5 L0/S. 
9- Immediately stretching the muscle from 0.9 L0 to 1.1 L0 with the velocity of 1.5 L0/S 
@ 125 Hz. 
10- Repeat the eccentric contractions for total of 10 times, after each 4 min of rest. 
11- After the last stretch measure post Stretch Pt and P0. Re-measure after 15 min of rest. 
  
Part II: Membrane lipid analysis from whole muscle 
Solution:  
Tris HCl buffer, pH: 8 
Lipid Extraction (Bligh & Dyer, 1959) 
1- Put at least 5 mg of whole muscle in 1voulme of buffer. 
2-  Use eppendorf plunger to homogenize the muscle in the tubes. 
3- Transfer the homogenized muscle into kimex tubes 
4- Add 3.75 ml of Chloroform:Methanol (1:2) with 0.1% BHT and vortex well for 2 
min. 
5- Add 1.25 ml of chloroform and vortex for 10 seconds. 
6- Add 1.25 ml of double distilled water and vortex until white colour change (~2 sec). 
7- Centrifuge at 2000 RPM for 6 min. 
8- Collect the chloroform phase (bottom phase) carefully, not collecting any of the 
aqueous layer. 
9- Either freeze at - 20 or prepare for solid phase extraction. 
Thin Layer Chromatography (Mahadevappa and Holub, 1987) 
Solutions: 
DCF Solution (for 4 L): 
1) T  4 L m   an  :wa     1:1), add a     2    a   a  n ) 2’,7’-dichloroflourescein. 
2) Stir for about 7-8 hours in fume hood or covered (parafilm). 
  
3) Filter out precipitate. 
4) Wash filtrate with petroleum ether (about 500mL) in separatory funnel. 
5) Remove lower phase (DCF) and store in dark bottle. 
6% H2SO4: 
1) For 100 mL use 94 mL methanol, cool on ice. 
2) Carefully drip 6 mLs H2SO4 into methanol slowly (use a large beaker and drip the 
H2SO4 down the sides of the beaker). 
TLC Procedure: 
1- Using clean pointed object (e.g. pipette tip), press chromatography paper into corners 
of tank. 
2- Make up solvent system with Chloroform: methanol: acetic acid: water (100: 75: 7: 4 
mL) 
3- Pour into bottom of tank, cover and let sit ~ ½ hour. 
4- Transfer 2 mL sample into mini vial and dry down under N2. 
5- Add 200 µL C:M (2:1) w/ BHT (50µg/ml), vortex, transfer into GC vial and dry 
down under N2.  
6- Add 100 µL C:M (2:1) w/ BHT (50µg/ml), vortex and dry down under liquid N2. 
7- In a fume hood, using template, mark off 4 lanes (4 divisions wide) on plate. Leave a 
lane (2 divisions wide) on each side and one at the top (1 division wide) to stop 
solvent. 
  
8- Resuspend sample in 15 µL of C:M (2:1). 
9- Spot the 15 µL sample onto plate using microsyringe. 
10- Add an additional 15 µL of C:M (2:1) to sample vial, vortex, spot over sample. 
11- Rinse syringe x5 in C:M (2:1) after each sample. 
12- For blank, spot 15 µL C:M (2:1).  
13- For STD, spot 10 µL C:M (2:1). 
14- Place plate in chamber (leaning against back) with silica side up. 
15- Takes about 2 2/1 hours to run (solvent should reach top). 
16- Remove plate from tank and let dry in fume hood for several minutes. 
17- Set plate in spraying chamber. 
18- Spray evenly with DCF solution. 
19- Set plate in chamber containing 25% ammonium hydroxide, for about 5 minutes. 
20- View plate under UV light: Band separation expected:  
              Solvent front: CL   PE  PI  PS  PC  SM  Origin 
   
21- Use pencil to mark bands. 
22- Remove excess silica with razor blades (rinse with C:M between uses). 
23- Scrape each band into a kimex tube. 
Methylation – Fatty Acid Methyl Esters 
  
 
Methylation of fatty acids is a crucial step before gas chromatography. Without prior 
methylation the fatty acids are not volatile substances, and thus will not enter gaseous 
state easily (which is imperative for gas chromatography). By the addition of the methyl 
group with an ester linkage the fatty acids are easily put into gaseous state, when heated 
at high temperatures. 
1- To each kimex tube with silica scrapings, add 2mL of 6% H2SO4 in methanol. 
 
2- As accurately as possible, add 10uL of 13:0 (External Standard; 1mg/mL hexane) 
then rinse syringe in hexane. 
3- Close tightly, and incubate for 2hrs at 80°C. 
 
4- Cool for 10 min, then break seal. 
 
5- Add 1mL DDW. 
 
6- Add 2mL petroleum ether, then vortex. 
 
7- Centrifuge for 6min at 2000 RPM. 
 
8- Extract petroleum ether phase (top) into mini vial. 
 
9-  Seal cap with parafilm and store at -20°C for future Gas chromatography analysis. 
 
Gas Chromatography 
Gas chromatography includes a stationary phase and a mobile phase. The 
stationary phase is via a column packed with diamataceous earth and the mobile phase is 
helium gas. When the fatty acid methyl esters enter into gaseous state (depending on what 
temperature is needed for them to do this), they will be dissolved into the helium gas. 
Depending on size of the fatty acid and stability into gaseous state, they may be held by 
the solid phase, whereby they must wait for higher temperatures to enter into gaseous 
  
state. Then a flame ionizing detector, will blow up the fatty acids into ions that is read by 
the detector, and we are then left with peaks, where the concentration is related to the 
area under the curve. 
1- Transfer FAMEs to GC vials. 
2- Dry down under gaseous nitrogen. 
3- Reconstitute in 10uL of hexane or dichloromethane. 
4- Seal cap very well (otherwise the samples will evaporate). Use 1ul injection method. 
5- Calibrate the standard. This calibration involves having the 13:0 matching the 13:0 of 
the samples in terms of retention time. 
6- Inject only 1 ul of FAME mix (or any volume to make sure that the peak heights will 
be as close to the heights of the sample peak heights). 
Part III: Embedding of muscle  
 
1- After dissection, the muscles (e.g. EDL and SOL) are mounted on a small mound of 
cryomatrix that is placed on a cork disc. 
2- Ensure that the muscles are totally covered by the cryomatrix (Use the minimum 
amount of cryomatrix possible to cover the muscles, thus allowing rapid freezing to 
occur). 
3- Place a cold-resistant beaker of isopentane into liquid nitrogen and allow cooling to         
-150°C  W  n               mp  a        a  a n d “   d  ” w    app a   n          m 
of the isopentane). 
4- Freeze the embedded muscle by placing it into the cooled isopentane for 20-40 
seconds (longer contact times can result in the formation of cracks in the samples; 
insufficient time can result in freezing artifacts). 
  
5- Cover the embedded muscle in aluminium foil.  
6- For short-term or long-term storage keep the samples in -20°C or -80°C freezer, 
respectively. 
 
Cryosectioning 
1- To achieve a thermal equilibration before cryosectioning, store the samples overnight 
in the -20°C freezer and place them into the cryostat for at least 20 minutes before 
further processing.  
2- Mount the sample on the round metallic mount of the cryostat with cryomatrix. The 
knife should be pre-cooled to -20°C and the muscle sample to -22°C.  
3- Ma   12, 10 and 5 μm-thick sections for fibre typing, masson trichorom staining and 
immunohistochemistry and collect them on warm (RT) Superfrost colorfrost Plus 
slides. 
4- Let the sections dry at RT for 1hr and then store the unstained slides at -20°C or -
80°C for short term and long term storage, respectively. 
 
Part IV: Masson trichorom staining (Meinen et al., 2007) 
W      ’     n   ma  xy  n stains the nuclei in black, Biebrich scarlet-acid 
fuchsin stains cytoplasm & muscle fibres in red and after treatment with phosphotungstic 
and phosphomolybdic acid, collagen is stained in blue with aniline blue. 
Staining procedure: 
1- Preparation: Bring the slides to room temperature 
2- For 1° Fixation fix the cryosections in 10% Formalin at RT for 1hr in the fume hood. 
  
3- For 2° Fixation re-fix sections in Bouin's solution at RT overnight to intensify the 
colors and increase the contrast between the tissue components. 
4- Wash slides for 1-2 minutes under running tap water (18–26°C) to remove yellow 
color from sections. Then rinse briefly in DDW. 
5- W      ’  H ma  x   n S a n n : Mix equal parts of Hematoxylin Solution A and 
Solution B (stable for 10 days). Incubate the sections for 5 minutes w    W      ’  
Iron Hematoxylin Solution to stain the nuclei dark. Discard the Hematoxilin solution. 
6- Blueing: Put the slides in a glass chamber and wash under warm running tap water 
for ~10 minutes to remove excess of Hematoxylin and to intensify the black color. 
Rinse 1 minute in DDW. 
7- Cytoplasm Staining: Incubate the sections for 5 minutes with Biebrich Scarlet-Acid 
Fuchsin Solution to stain the fibres red. Discard the Solution. 
8- Washing: Wash 3x 1minute with DDW. 
9- Collagen Staining: To prepare the uptake of the aniline blue stain, incubate the 
sections with Phosphotungstic/Phosphomolybdic Acid Solution for 3-4x 3minutes. 
For preparation of Phosphotungstic/Phosphomolybdic Acid Solution (Discard after 
use) add 1 volume of Phosphotungstic Acid Solution, 1 volume Phosphomolybdic 
Acid Solution, 2 volumes DDW.  
10-  After incubation, drain the slides on a tissue before proceeding and directly (without 
rinsing) incubate the slides for 5 minutes with the Aniline Blue Solution to stain 
collagen in blue. 
11- Washing: Wash 3x 1 minute with DDW. 
  
12- Differentiation: Incubate the sections for 2 minutes with 1% of Acetic Acid to render 
the shades of color more delicate and transparent. Discard this solution after use. 
13- Washing: Wash 2x 1minute with DDW. 
14- Dehydration: Drain successively in 
-70% EtOH for 3 minutes 
-90% EtOH for 3 minutes 
-100% EtOH for 3 minutes 
-Xylol for 5 minutes 
-Drain the slides on a tissue 
15- Mounting: Mount the slides with 1-2 drops of a xylene-based mounting media and 
cover with cover slides, avoid bubbles.  
16- Press the slides under heavy weight for 10 minutes at room temperature. 
17- Store the slides at room temperature. 
 
Part V: Fibre typing 
The principle relies on the ability of the enzyme to remove the terminal phosphate 
from the ATP, which then combines with calcium in the incubation solution to form an 
insoluble calcium phosphate. Cobalt is then exchanged for the calcium, which, after 
reaction with ammonium sulphide, forms a black, insoluble cobalt sulphide at the site of 
enzyme activity. 
Reagents: 
1% calcium chloride: 
  
Calcium chloride   5.0 g  
Distilled water   500ml 
 
2% Cobalt chloride: 
Cobalt chloride   10.0 g 
Distilled water   500 ml 
 
1% Ammonium sulphide: 
20% ammonium sulphide   0.5 ml 
Distilled water               9.5 ml 
    
Alkaline Stock: 
   
7.05% Glycine  2ml 
7.5% Calcium Chloride          2ml 
5.625% Sodium Chloride 2ml 
3.5% Sodium Hydroxide  2ml 
  
Distilled water  42ml 
 
ATP Incubating Medium: 
Alkaline Stock   25 ml 
ATP (Sigma A-7699)   40 mg 
Adjust to pH 9.4 - 9.5 with 0.1M HCl  
Staining procedure: 
1- Place one slide from each sample in a separate, labelled Coplin jar for each pre-
incubation solution. 
2- Incubate in the solution with the pH of 10.20 for 15 minutes. 
3- After the incubation time period, pour out the solution and rinse one time with DDW 
for 3 min. 
4- Pour the ATP solution into the staining jar and leave for 15 minutes. 
5- Wash staining jars with 3 changes of 1% calcium chloride for a total of about 10 
minutes (~3min each). 
6- Add 2% cobalt chloride to each jar for 10 minutes. 
7- Rinse 3 x 3min with DDW   
8- Incubate with 1% Ammoniumsulfide for 1 min at room temp until the color 
develops.  
9- Rinse 3 x 3min with DDW. 
10- Drain successively in 
  
- 70% EtOH for 3 minutes 
- 90% EtOH for 3 minutes 
- 100% EtOH for 3 minutes 
- Xylol for 5 minutes 
-Drain the slides on a tissue 
11- Mount the slides with 1-2 drops of a xylene-based mounting media and cover with 
cover slides, avoid bubbles.  
12- Press the slides under heavy weight for 10 minutes at room temperature. 
13- Store the slides at room temperature. 
Pre-incubation PH Fibre type 1 Fibre type 2 
10.2 Light Dark 
 
Part VI: Immunohistochemistry 
Reagents 
TBS: 
To Prepare 1 L add 24.2 g Trizma base (C4H11NO3) and 80 g sodium chloride   (NaCl) 
to 1 L dH2O. Adjust pH to 7.6 with concentrated HCl. To prepare 1 L of TBS add 100 ml 
10X TBS to 900 ml dH2O 
Blocking buffer: 5% BSA, 0.3% Triton X100 in 9.5 ml TBS  
                          1X BSA from 100X: 10 micro BSA in 990 micro TBS. 
 TBS/0.3% triton: 997 ml TBS+3 ml triton 
  
Blocking buffer: 50 ml BSA to 950 ml TBS/0.3% triton to 4750 micro 1X 
TBST and add 250 µl BSA 
DAB preparation of stock Solutions: 
1% DAB (20x) in Distilled Water: Add 0.1g of DAB (3, 
3’d am n   nz d n , Sigma Cat#D8001 or DAB-tetrahydrocholoride) in 
10 ml distilled water. Add 10 N HCl 3-5 drops and solution turns light 
brown color. Shake for 10 minutes and DAB should dissolve completely. 
Aliquot and store at –20 °C. DAB Working Solution: Add 250 µl of 1% 
DAB to 5 ml of PBS, pH 7.2 and mix well. Add 250 µl of 0.3% H2O2 and 
mix well. 
Fixation 
1- Fix slides by immersion in cold acetone (-20°C) for 2 minutes or other suitable 
fixative (e.g. alcohol, formal alcohol, formalin, etc.), air dry at RT and proceed to 
staining. Then Place slides in TBS bath. Gently change TBS bath several times to 
remove residual acetone. 
2- Alternatively, the frozen section slides can be stored for a short period of time at -
80°C in a sealed slide box. When ready to stain, remove slides from freezer and 
warm to -20°C in the cryostat or -20°C freezer, fix for 2 minutes in cold fixative 
(acetone or other suitable fixative) and allow adjusting to RT to continue with the 
staining. 
3- When staining cryostat sections stored in a freezer, thaw the slides at room 
temperature for 10-20 minutes to equilibrate.  
  
Staining 
1- Quickly transfer the slides to 1 X TBS and wash, dipping in and out of the solution 
twice for 5 minutes. 
2- Incubate for 10 minutes at room temperature in 3% H2O2 diluted in methanol (To 
prepare, add 10 ml 30% H2O2 to 90 ml methanol and Store at -20°C). 
3- Transfer to another Coplin jar containing TBS and wash twice for 5 min.  
4- Transfer to another Coplin jar for a second wash in TBS for 5 min. 
5- After wash in TBS add blocking serum for 30 min to block nonspecific bindings.  
6- Remove blocking solution without washing. 
 
7- Apply 250 µl of primary antibody at 1/100 dilution, and incubate for 2 h at room 
temperature in a humid chamber. To keep the chamber humid, a paper towel soaked 
with H2O placed at the bottom of the chamber will suffice. To optimize the dilution 
of antibody use TBS + 1% of BSA or the blocking buffer at the diluent. 
8- After incubation with the primary antibody, wash slides two times in TBS for 3 min.  
 
9- Add 250 µl secondary antibody, diluted in blocking solution. Incubate 30 minutes at 
room temperature. 
10- Remove secondary antibody solution and wash sections three times in wash buffer 
for 5 minutes each. 
11- Application of ABC solution: P  f  m     ABC   mp  x  y m x n  10 μL  f av d n 
and 10 μL  f      n-peroxidase in 1 mL of TBS and incubating for 10 min. Apply 
100 μL  f ABC        n     a                n f   30 m n a     m   mp  a    .  
12-  Wash slides three times in TBS for 3 min 
 
  
13-  Incubate slides in DAB solution. The DAB solution should be made up fresh for 
each staining procedure just before use in fumehood (DAB is known to have 
carcinogenic effects). The DAB development reaction should be monitored closely 
under the microscope. The usual development reaction takes 10–20 min.  
14- As soon as the sections develop, immerse slides in DDW. 
15- Counterstain in hematoxylin for 2 min.  
16- Wash sections in DDW 2 x 5 minutes each. 
17- Dehydrate sections in 
- 70% EtOH for 3 minutes 
- 90% EtOH for 3 minutes 
- 100% EtOH for 3 minutes 
- Xylol for 5 minutes 
-Drain the slides on a tissue 
- Xylol for 5 minutes 
-Drain the slides on a tissue 
18- Mount the slides with 1-2 drops of a xylene-based mounting media and cover with 
cover slides, avoid bubbles.  
19- Press the slides under heavy weight for 10 minutes at room temperature. 
20- Store the slides at room temperature 
